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This thesis contains studies concerning the treatment and follow-up of respiratory diseases 
in primary care, especially chronic obstructive pulmonary disease (COPD) and asthma.  
 The background paragraph in this introduction provides a short overview of the nature 
of these chronic diseases as well as a summary of guideline recommendations for their 
regular follow-up. Furthermore the research questions are presented: questions regarding 
tools to stimulate the management of COPD and asthma (in particular the regular 
monitoring of patients) and regarding two randomised controlled trials in general practice. 
In the second paragraph the principles for the development of tools for needs assessment 
and monitoring are described more in detail. The interventions in the two trials, i.e. 
feedforward of quality of life information during consultations and the implementation of a 
computerised monitoring system in routine daily care, are accounted for in the third 
paragraph. Finally, the outline paragraph describes the information to be expected in the 
various chapters of this thesis. 
 
Background 
 
COPD and asthma 
According to the definition of the Global Initiative for Chronic Obstructive Lung Disease 
(GOLD)1, COPD is a disease state characterised by airflow limitation that is not fully 
reversible.The airflow limitation is usually both progressive and associated with an 
abnormal inflammatory response of the lungs to noxius partciles or gases. A study 
published by the World Bank/World Health Organization predicts that COPD will rank 
fifth in 2020 as a worldwide burden of disease2. Smoking behaviour and passive smoking 
are considered to be major causes of COPD3-5. It is estimated that about 70% of the COPD 
mortality is caused by smoking behaviour, which was estimated at 3322 deaths in men and 
1660 in women in The Netherlands in 20026. Based on general practice morbidity 
registrations and epidemiological studies the prevalence of COPD was estimated at 2,4% in 
men and 1,7% in women, with highest figures in elderly men: 1,3% in the age of 40-44, 
5,7% in the age of 60-64, 16,8% in men of age 80-847. It is expected that the prevalence of 
COPD in women will increase in the next decennia as a result of their growing smoking 
behaviour in the past8,9. The prevalence is highest in people with a low social-economic 
status9. 
 Typical symptoms of COPD are cough, sputum production, and dyspnoea. COPD is 
divided in classes of disease severity based on these symptoms and spirometric results. In 
The Netherlands most of the patients in the mild stage (FEV1/FVC < 70% predicted, FEV1 
≥ 80%, either or not chronic symptoms) and moderate stage (FEV1/FVC < 70% predicted , 
50% ≤ FEV1 < 80% predicted, either or not chronic symptoms) are treated in general 
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practice. It was estimated that about 83% of the patients with COPD can be classified as 
mild to moderate10. In the Netherlands this amounts to a total number of about 249.000 
patients who are predominantly treated in primary care. 
 Asthma is another major chronic obstructive airway disease characterised by an 
underlying airway inflammation. Although COPD can coexist with asthma the 
inflammation characteristics of asthma are distinct from these of COPD. According to the 
definition of the Global Initiative for Asthma (GINA)11, asthma is a chronic inflammatory 
disorder of the airways in which many cells and cellular elements play a role. The chronic 
inflammation causes an associated increase in airway hyperresponsiveness that leads to 
recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly 
at night or in the early morning. These episodes are usually associated with widespread 
but variable airflow obstruction that is often reversible either spontaneously or with 
treatment. 
 Asthma may develop in early childhood, but mostly a definitive diagnosis can only be 
made when the child is older. Usually a distinction is made between predisposing factors 
for developing asthma (i.e. atopy and gender) and causal factors like indoor and outdoor 
allergens, aspirin and occupational sensitizers. Several factors may contribute to the onset 
of asthma, e.g. respiratory infections or active and passive smoking. Allergy is the 
predominant feature associated with asthma in children.  
 International figures for mortality because of asthma vary widely (from 0.12 per 
100.000 in Sweden to 0.86 per 100.000 in Australia)11. In the Netherlands asthma mortality 
figures are low and declining13. 
 Most children with mild asthma have a good prognosis but the children with moderate 
or severe asthma will probably continue to have some airway hyperresponsiveness 
throughout life. Moreover, 5 to 10 percent of children with mild asthma will suffer from 
severe asthma in later life. Asthma onset in adult life is also possible, due to sensitizing 
agents at the workplace or development of atopy. So asthma affects all age groups and 
based on general practice registrations the prevalence in The Netherlands among adults 
was estimated at 1,3%12. After a strong increase of prevalence among children during the 
last decades a slight downward trend in asthma prevalence seems to occur in recent years14. 
Socioeconomic status has a complicated association to the prevalence of asthma: high 
prevalence in developed countries because of lifestyle (dietary habits, family size, access to 
health care, passive smoking, allergen exposure) and higher prevalence in poor regions 
compared to the richer regions inside the developed countries (fewer access to health care). 
 Like COPD, asthma too can be classified in severity. In case of asthma the classification 
is based on the presence of clinical features (frequency of symptoms and spirometric 
results) before treatment is started and/or by the amount of daily medication required for 
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optimal treatment. The classes are: intermittent, mild persistent, moderate persistent and 
severe persistent11,12. In the Netherlands a recent survey in 23 practices showed that about 
80% of the patient with asthma were solely treated in primary care21. 
 
Guidelines for the treatment of COPD and asthma 
Various (national) guidelines combine latest evidence and consensus regarding the 
treatment and follow-up of COPD and asthma. Some of the studies presented in this thesis 
were performed when Dutch general practice guidelines for COPD and asthma were still 
entwined, based on the hypothesis of common origins or mechanisms of both diseases15,16. 
Part of the studies were performed when new guidelines had been released tuned to the 
international definitions and distinctions12,17,18. Given the complexity of distinguishing 
between the two respiratory diseases due to their variability in airway obstruction and 
responses to bronchodilator treatment and the numerous, elderly patients suffering from 
both diseases, it is still difficult for many ordinary general practitioners (GPs) to adopt their 
clinical performance to the old as well as the new guidelines. Smeele et al.19 analysed the 
management of 383 exacerbations of asthma and COPD in adults by 52 GPs. Cross-
sectional analysis revealed that recommended oral steroids were only presribed in 26% of 
the cases and that contrary to recommendations in 60% of the cases antibiotics were 
prescribed. Jans et al.20 demonstrated that in 14 general practices the average compliance 
with concrete recommendations for the treatment of adult COPD and asthma ranged from 
33% (ordering spirometry) to 98 % (peak flow measurement). In between was the check on 
inhalation technique (38%), adjustment of medication (42%), control frequency (46%), 
check on medication compliance (62%), influenza vaccination (62%) and allergy testing 
(78%). GPs had their reasons for non-compliance, e.g. disagreement with the 
recommendations on control frequency and spirometry test ordering or patients' individual 
situation. Nevertheless, overall complaince was considered as suboptimal.  
 
Recommendations for the follow-up of COPD and asthma 
Guidelines provide scarce and vaguely formulated recommendations for the monitoring 
and follow-up of patients with COPD and asthma in the treatment phase. From an 
inventory of guidelines we derived the topics to be monitored. They are presented in tables 
1 and 21,11,12,17,18,21-35. Most guidelines contain recommendations for the follow-up of 
symptoms like cough, dyspnoea, sleep disturbance and limitation of activities. They all 
indicate that lung function should be monitored but recommendations differ regarding the 
parameters in detail. In some guidelines monitoring triggers is recommended with the 
focus in asthma guidelines on various triggers like allergens, whereas in COPD guidelines 
the main focus lies on smoking. As far as the management of the diseases is concerned, 
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aspects like checking side-effects of medication and inhalation techniques are generally 
recommended. However, detailed recommendations on other aspects like patient education 
and action plans are often lacking, especially in COPD guidelines. 
 Concerning the process of follow-up: few guidelines contain recommendations for the 
frequency of monitoring and if so, these are not based on scientific evidence but on 
national or regional consensus. The guidelines vary heavily on the organisation of the 
follow-up, especially concerning the roles of patients and their self-management on the one 
side and the pro-active role of professionals on the other. Considering the impact of regular 
follow-up on patients' life, on the process of care delivery and the burden of follow-up on 
manpower and economic resources it is astonishing to see how little attention is paid to this 
topic in former as wel as a lot of more recent guidelines.  
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Disease management and monitoring of chronic patients 
Up till now large numbers of chronic patients do not receive care to the best standards 
agreed upon by the medical community. Patients with chronic diseases like COPD and 
asthma are in need of care provision not guided by ad hoc interventions, but 'by planned, 
regular interactions with their caregivers, with a focus on function and prevention of 
exacerbations and complications. This interaction includes systematic assessments, 
attention to treatment guidelines, and behaviorally sophisticated support for the patient's 
role als self-manager. These interactions must be linked through time by clinically relevant 
information systems and continuing follow-up initiated by the medical practice'36 . 
 This type of organisation of the care process is usually called "disease management". 
Taken literally 'disease management' simply means handling the disease and its 
consequences. However, in the past decades specific connotations were attached to this 
concept, varying from financially driven standardisation of care for categories of patients 
to individualised self-management of patients. The more economic approach with a focus 
on controlling supply and demand in which efficiency, quality, price and amount of care 
are the variables in the model, is often called 'managed care'. Especially in Europe the 
'disease management' approach is distinguished from 'managed care' by a broader view on 
professional treatment of chronic diseases and a focus on the following elements of care 
delivery:  
• co-ordinated comprehensive care delivery along the continuum of a disease and 
across health care delivery systems 
• according to (self-management-) protocols for groups of patients  
• targetted at systematic quality improvement of care using evidence on (cost-
effectiveness.  
• yet stimulating patient-centredness and needs assessment. 
Information and communication technology is an important medium to support this 
approach. 
Structuring the follow-up of patients with COPD and asthma can be considered as a core 
element in the management of these diseases.  
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Figure 1 provides an overview of the aspects involved in a disease management approach.  
A recently founded national Dutch consortium, Stichting Ketenkwaliteit COPD, uses this 
model to stimulate integrated care delivery along the continuum of the disease stages.  
 
Figure 1: Disease management model: stages and process components 
prevention diagnosis treatment (after)care Reintegration,
palliative care
Medical
education Guidelines,
protocols
Evaluation,
feedback
Patient
education
Funding Communication,
tuning
Registration,
information
Practice
support
Care continuum: performance
Supportive process components
 
Source: Kruijff AF, Adema I. Lucht via lijnen. STG, 2000 37 
 
Other models, such as the model for Effective Chronic Illness Care of Wagner et al.38, 
depart from the larger context of community resources and the national or regional 
organisation of the health care system, but in the end the categories indicating supportive 
processes (e.g. self-management support, delivery system design, decision support, clinical 
information systems) cover the same issues of disease management at the level of actual 
care delivery as presented in the model in figure 1. 
 Reviews on disease management programmes for chronic diseases showed that various 
components contribute to provider adherence to guidelines and disease control, e.g. 
programmes including provider education, feedback and reminders39. Most disease 
management programmes incorporate patient education (79%) and use of a 
multidisciplinary team (57%), whereas provider education, provider feedback and patient 
reminders were incorporated less frequently (37 to 26%)47.  Many reviews have evaluated 
the impact of single components of disease management systems. For instance a Cochrane 
review showed that primary care based asthma clinics (mostly led by nurses) yielded 
favourable patient outcomes (more peak flow meters and fewer wake up at nights)40. 
However, evidence is limited as only one study met the inclusion criteria. Vrijhoef et al.41 
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demonstrated that stable patients with COPD treated by nurse practitioners in respiratory 
outpatient clinics had better psychosocial outcomes than patients treated by 
pulmonologists. On the other hand Taylor et al.45 found little evidence for benefits or harm 
arising from nurse led management interventions for COPD and Sin et al.43 conclude in 
their review that disease management programmes have not yet been shown to improve 
clinical outcomes in patients with COPD.   
 Essentially, researchers have the difficult task not only to evaluate specific components 
of disease management programmes, but also to evaluate the (cost-)effectiveness of disease 
management programmes as a whole44,49. In his research agenda Wagner48 made a plea for 
a standardised set of structure, process and outcomes measures to describe and evaluate 
chronic disease management programmes. The Grassic study42 as an example evaluated a 
programme for outpatients withs asthma. The programme was based on a collaboration 
between an outpatient clinic and general practices in the region with a focus on mutual 
information provision (partly patient-provided) before every protocolised control visit of 
patients with asthma. After the trial the patients treated on the basis of the integrated care 
scheme were not better off than patients treated in usual care. Up till now evidence on the 
(cost-)effectiveness of integrated packages for patients with mild to moderate chronic 
diseases, whether hospital or primary care based, is still inconclusive. 
 Debates on who should have the lead in disease management programs for categories of 
chronic diseases, e.g. primary care, hospital care or a carved-out categorial organisation, 
are going on for more than a decade now46,50. Arguments why primary care or general 
practice should take the leading position in disease management programs for chronic 
diseases take into account the multi-morbidity in many elderly chronic patients, the 
necessary focus on prevention and life style issues and subsequently on the patient as a 
person and the small-scale, close to home organisation which could have a positive 
influence on the compliance of the patients. Evidence-based integrated care programmes 
bypass the leadership issues by arranging care delivery according to evidence and 
consensus-based multidisciplinary protocols. Primary care and general practice in 
particular can build an important chain of actions in the disease management process. 
Disease management of COPD and asthma can benefit from improving this chain. 
 
Goals of the studies 
Current practice guidelines give only few clues how to deal with the follow-up of asthma 
and COPD and, if recommendations are present, GPs experience difficulties in performing 
accordingly. Moreover, there is still little evidence on the effectiveness of disease 
management systems which combine several supportive process components. So, main 
purpose of the studies presented in this thesis was to develop components of a general 
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practice-based patient-tailored disease management system for asthma and COPD and 
explore their combined effectiveness in daily care. 
 
In general, there are two ways to deal with a limited application of guidelines in daily 
practice: either stimulate the implementation of the guidelines or revise/complete them on 
the basis of new evidence concerning the effects or feasibility in routine care. Both 
approaches are represented in this thesis. In Section One tools are presented which were 
developed to stimulate the management of COPD and asthma according to general practice 
guidelines. In Section Two we report the results of two randomised controlled trials in 
which a patient-tailored monitoring system to stimulate the application of key 
recommendations of national guidelines was tested on effectiveness in daily care. 
Prototypes of the tools presented in Section One were incorporated in the monitoring 
systems for patients with COPD and asthma in general practice.  
 Both sections cover key recommendations for follow-up of patients with COPD and 
asthma in general practice, with a focus on: 
• evaluation of complaints and patients' quality of life 
• lung function  
• patient education and smoking cessation advice 
• medication prescription 
• follow-up frequency. 
 
Tools: development of instruments to support disease management in primary care 
Stimulating patient-centredness and needs assessment is an important component of a 
disease management approach. Regardless the clinical guidelines, which categorise 
diseases and patient groups, daily care has to deal with individual patients, their needs and 
capacities. The professional has to cope with the tension between evidence based protocols 
and the individual patient's wishes. To stimulate patient-centredness we developed some 
tools to help the medical professional to integrate attention for continuity as well as a focus 
on patients' needs in the context of guidelines-based care. These tools were developed in 
general practice. The mission of general practice has been defined as generalised, 
personalised, continuous and accessible care.51 Following this mission general practice 
could set an example of continuous, personalised care in the context of disease 
management taking account of patients' worries, complaints and preferences. 
 
Quality of life monitoring instrument 
Reducing symptoms and mortality because of the disease are the acknowledged goals of 
medical treatment. The ultimate goal of medical attention and treatment is to stabilise and 
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preferably improve disease-related quality of life (qol). Guidelines for diagnosis and 
follow-up recommend to pay attention to complaints and qol. How can health professionals 
be informed about patients' qol and pay systematic attention to this aspect of history-
taking? Intuitively, physicians address this issue in questions such as 'How are you feeling 
today Mrs Johnson?'. A more specified and focused approach might lead to better tailoring 
of care to individual needs52-54. It is important that the patients present their own perceived 
health-related quality of life, as this may differ substantially from physicians' inferred 
perception of the impact of the disease55-61. 
 
In recent years several generic or disease-specific instruments have been developed to 
gather qol information in a standardised way. But few instruments are simple and valid 
enough to be used for individual and real-time history-taking during routine care. And 
none are targetted to patients under treatment in primary care for mild to moderate chronic 
respiratory diseases, which are sometimes difficult to classify as asthma or COPD. 
 Therefore we developed a one-page instrument (10 items) for respiratory diseases to 
assess patients' qol before a consultation. Completion should give the practitioner a quick 
impression of several domains of patients' present disease-related qol to stimulate patient-
centred interaction during a practice visit. Moreover, the instrument should be suitable for 
repeated application and recording in order to provide an overview of changes in the 
impact of the disease to which further treatment can be tuned to.  
 Our research questions focussed on the possibilities of shortening and reshaping an 
already existing research instrument for assessing the quality of life in adult respiratory 
patients and on the psychometric properties of the resulting shortform.  
 
Formats for electronic medical records 
Continuity of care in modern society heavily relies upon conscientious and unequivocal 
registration. Having an evidence-based format for electronic medical recording can be 
helpful to structure diagnosis, treatment and follow-up62, to raise quality of care63 and to 
transfer information between medical professionals64. But how to establish such a format? 
Two approaches seem possible: a rational analysis of all decision steps during the care 
process or a consensus-based approach65. As the decision-based approach is very time-
consuming and hardly inclined to include a focus on care processes and intuitive 
perspectives of care providers66, we tested a consensus-based developmental procedure to 
outline the medical records for COPD and asthma in general practice. Clinical relevance, 
easy access and tuning to the needs of medical professionals were the main goals to aim at 
during the development. The procedure for asthma is presented in this thesis. 
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Apart from IT-specialists clinicians should be involved in the assessment of the content 
and the structure of a medical record. In a series of adapted Delphi procedures67 and a 
consensus meeting we involved a panel of general practitioners in selecting relevant and 
feasible recording topics and in choosing the recording formats. The basis formed a set of 
general practice guidelines for the diagnosis and treatment of COPD and asthma. Content 
analyses by a multidisiplinary team lead to a proposal of topics to be judged on relevance 
and recording feasibility in daily practice. In the following written and oral Delphi rounds 
the selection of topics was refined and registration formats were assessed. The research 
question was if this approach was feasible and could lead to a relevant and applicable 
format for a medical record as a supportive tool for the management of asthma and COPD 
in general practice.  
 
Educational needs assessment instruments 
Good and understandable education of patients with chronic diseases is an essential aspect 
of disease management. Patient education is an important means to reach treatment goals. 
Improvement of the content and/or format of information to patients can lead to a healthier 
lifestyle68, health status improvement69 and better coping with the disesase. The ways 
education is provided, the interaction between the health profesional and the patient as well 
as the information itself can all influence treatment outcomes70-73. Patient compliance is 
mediated by their comprehension of the treatment goals and the prescribed pharmaceutical 
and non-pharmaceutical treatment69,74. Despite these possible consequences actual patient 
education is often suboptimal and not patient-directed75,76. It is well-known that patients 
often forget large parts of the information provided and that their needs of information are 
not met76. Although literature shows mixed or limited positive influences on health 
outcomes of stimulating patients' question-asking78, it can can lead to more active 
involvement of patients in treatment choices80 and more patient satisfaction with care 
delivery77,79. We assume that promotion of interactive personalised education in which 
educational needs are well assessed raise the quality of patient education73,81 and is 
promising for improvement of health outcomes82. However, tools are needed to support 
this type of education. 
 
In the past decade we derived concrete guidelines for patient education by professionals 
from national clinical guidelines for the diagnosis and treatment of COPD and asthma83. 
They list the topics patients should be informed about during diagnosis, treatment and 
follow-up in general practice. Both general practictioners and patients were involved in the 
development of these educational guidelines. However what patients need to know 
according to the guidelines is not necessarily similar to what patients want to know. To 
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stimulate patient-centredness as well as patients' question asking we developed instruments 
for eduational needs assessment to be fed forward just before or during a consultation. 
Moreover, the instruments also had to support the monitoring of education asked for by the 
patients and the education actually provided by the medical professional. We studied if 
these instruments were relevant to and acceptable for the target population and met 
psychometric criteria of validity and reliability.  
 
Effects: implementation of monitoring systems 
Clinical guidelines for COPD and asthma are rather complex compared to those for most 
other chronic diseases. Recommended diagnostic procedures include lung function 
measurements before and after medication intake, assessment of symptom severity and 
exploration of various causes such as allergy or smoking. Treatment and follow-up of both 
respiratory diseases can vary depending on the severity of the disease, and in some cases 
pharmaceutical tests are needed to decide which medicine to provide. This complexity 
makes it difficult for medical professionals to adhere to the recommendations of the 
guidelines, particularly to the rather vague recommendations for the follow-up of patients 
with COPD or asthma. Therefore we set up two trials to evaluate strategies to stimulate the 
implementation of follow-up recommendations in routine general practice and to study 
their feasibility and effectiveness.  
 
So far, various strategies to stimulate guideline implementation in daily care have been 
proven to be effective. In a review of reviews Bero et al.84 found that outreach visits, 
decision support and reminders, interactive education, multifaceted interventions and mass 
media interventions were mostly effective. Other strategies had mixed effects (audit and 
feedback, opinion leaders, local consensus meetings, patient-oriented interventions) or had 
little nor no effects (educational materials, courses and conferences). To stimulate the 
implementation of follow-up recommendations in general practice we selected a 
combination of presumably effective interventions. In the first trial the intervention 
consisted of feedforward of patient-mediated information on quality of life and periodic 
feedback of process and patient data. In the second trial the feedforward and feedback of 
information was supplemented by the introduction of computerised monitoring formats 
attached to the electronic patient records to support clinical decision making and the 
recording of monitoring data. Both trials presented in this thesis could add to the body of 
knowledge concerning the effectiveness of multitfaceted implementation strategies by 
studying how the strategies effected care processes and patient outcomes. 
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Trial 1. Monitoring quality of life 
General practice guidelines recommend regular attention to patients' physical complaints 
and a few recommend monitoring the quality of life (qol), but they give no clear indication 
on how to do so. During periodic medical control visits various physical outcomes are 
usually assessed, but the issue of patient-perceived qol usually receives less systematic 
attention53,86. However, subjective health perception and coping with the disease are 
relatively independent factors in the treatment process, influencing the outcomes of 
medical interventions. Gathering information on these factors might help the physicians to 
tailor their interventions to patients' needs and preferences. This is particularly relevant as 
in asthma and COPD individual patients' health perceptions or health-related qol cannot be 
directly deduced from their symptoms or lung function58,87-89. As studies show, physicians 
can neither rely upon their own assessments about patients' qol58,60,61. As already was stated 
above a disease management approach means protocolised yet patient-centred care for 
categories of patients. In case of asthma or COPD this approach may benefit from a more 
regular and systematic identification of problems in patients' qol with the assumption that 
patients are partners in the care process. However, there is hardly any knowledge of the 
effects of systematic monitoring of qol during routine care. 
 
To explore the effectiveness of such qol monitoring we performed a pragmatic randomised 
controlled trial in 12 general practices. In the intervention group patient-completed 
prototypes of the shortform for qol-monitoring (RIQMON-10) were fed forward to the 
general practitioner during regular control visits. The forms were completed just before or 
during a consultation, thus giving real-time information on disease-related qol. Periodic 
written feedback of patients at risk (low or deteriorating qol) was sent to the general 
practice. Our research questions were whether repeated feeding forward of standardised 
identification of disease-related qol just before or during regular primary care consultations 
and periodic feedback of the results would improve physicians' follow-up performance on 
the one hand and on the other hand if this would improve patients' biomedical, 
psychosocial and behavioural outcomes.  
 
Trial 2. A computerised monitoring system in general practice 
In the second trial improvement of guidelines-based professional performance and of 
patient-centredness in COPD and asthma care were stimulated at the same time. The 
intervention strategy combined various former devices to implement the treatment 
guidelines for asthma and COPD: 
− feeding forward of qol-information during practice visits; 
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− a supportive computerised recording system to focus the attention of the general practice 
professionals to the guidelines for COPD and asthma. The recording system (a simple 
protoype of the treatment and follow-up section of the format presented in chapter 3) 
was attached to the electronic patient record and had to facilitate the follow-up of 
patients with COPD and asthma and to stimulate the monitoring of key-issues from the 
guidelines; 
− periodic feedback of the monitoring results on process (included patients and frequency 
of follow-up), treatment (smoking cessation advice, prescriptions) and patient outcomes 
(lung function, smoking behaviour, qol).  
So, the intervention was partly organisational by delivering procedures and (computerised) 
tools for qol assessment and quidelines-based recording, and partly educational as recorded 
patient data and professional behaviour were monitored and fed back to the practice, thus 
focussing attention to professionals’compliance with major recommendations of the 
guidelines. 
 
This cluster randomised controlled trial was performed in 24 ordinary general practices. At 
baseline both experimental groups received education on spirometry and a similar type of 
spirometer to equalise their point of departure. The central research questions concerned 
the effect of this multifaceted approach on patient outcomes and if the computerised 
monitoring system was applicable during routine care and acceptable to general practice 
professionals and patients. 
 
Outline of the thesis 
The thesis is divided in two sections. The first concerns the development and evaluation of 
tools to support the application of disease management principles in primary care, 
especially in general practice. In the second section (prototypes of) the instruments were 
incorporated in monitoring systems for patients with COPD and asthma in general practice. 
Their effects and feasibility in routine daily care were tested in two randomised controlled 
trials. 
 
Section 1: Tools 
 
In chapter 2 the development of a short instrument to assess and monitor quality of life in 
adults with COPD and/or asthma is presented. The psychometric and feasibility criteria are 
described in this chapter as well as statistical procedures, using three large databasis, to 
construct the instrument. The resulting 10-item instrument, the RIQ-MON10, is accounted 
for. 
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Chapter 3 describes the procedure to establish the contents of an electronic medical record 
to support the disease management of asthma. Content analysis of guidelines as well as 
successive Delphi procedures among GP-experts in the field of respiratory diseases had to 
lead to a structure for the systematic recording of diagnosis, treatment and follow-up of the 
disease. Evidence base, relevancy and feasibility were the criteria for the content selection. 
The resulting format for the medical record is described as well as the opportunities to 
support follow-up of patients. 
 
In chapter 4 the development of two other tools to support disease management of COPD 
and asthma im primary care are presented. Guidelines for the contents of patient education 
had been derived from the treatment guidelines for COPD and asthma of the Dutch College 
of General Practitioners. The chapter describes how these educational guidelines were 
transformed into two instruments to assess patients' educational needs. Individual and 
focus group interviews with both sides of the educational interaction (patients and general 
practitioners) were part of the developmental process. 
 
Section 2: Effects 
 
Chapter 5 reports the relationship between quality of life of patients with COPD and 
asthma just before of during a general practice consultation and the subsequent actions of 
the GPs. For the monitoring of quality of life a large prototype of the RIQ-MON10 was 
used. In cross-sectional repeated analyses the recordings on this prototype were related to 
self-reported actions of GPs in the domains of patient education, prescriptions, counselling, 
referrals and follow-up appointments. 
 
The randomised controlled trial in chapter 6 describes if and how the use of quality of life 
monitoring instruments during general practice consultations effected patients' health status 
and their satisfaction with patient education and care delivery. In this experiment six 
general practices of the Nijmegen Monitoring Project (NMP) used a prototype of the RIQ-
MON10 during regular follow-up visits. In multilevel multivariate analyses the patient 
outcomes in the intervention condition were compared to those in six other NMP practices 
applicating their usual monitoring routine. 
 
In chapter 7 a randomised controlled trial is reported in which an inclusive computerised 
monitoring system for patients with COPD and asthma was implemented in ten non-
academic general practices. Patient outcomes after a year were compared to those in the 
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control condition in which usual care was continued. Multilevel multivariate statistical 
techniques were applicated in total and subgroup analyses. 
 
In chapter 8 the actual application of the computerised monitoring system is described 
based on figures from the monitoring system itself. The facilitators and barriers for routine 
use during practice visits are presented as well as patients' and GPs' views on the 
monitoring system. These were gathered through interviews and semi-structured 
questionnaires. 
 
Chapter 9 contains the conclusions and recommendations that arise from the studies. 
Some thoughts about implications for guideline development in the area of asthma and 
COPD treatment, especially concerning follow-up recommendations, are elaborated. The 
opportunities for actual use of the developed tools in disease management systems are 
considered. 
 
In the Appendices the developed tools are presented in detail. 
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Abstract 
Background 
As doctors' judgements about the burden of a disease often differ from patients' own 
assessments a manageable method to incorporate the latter into routine care might support 
patient-centered decision-making. For this purpose we shortened the 55-item Quality of 
Life for Respiratory Illness Questionnaire (QoL-RIQ). 
Methods 
Secondary analyses of the data of 3 controlled studies (n=328, 502 and 555).  
Procedures 
inter-item correlations, scale distributions, Cronbach's alpha and factor analysis. Dyspnoea, 
forced expiratory volume in 1 s (FEV1), COOP/WONCA charts, the Medical Research 
Council-ECCS symptoms questionnaire and the MOS-SF 36 served as criteria to test 
validity and responsiveness.  
Results 
Item-reduction resulted in a 10-item shortform (alpha's 0.87-0.90), consisting of 2 5-item 
factors: (1) physical and emotional complaints and (2) physical and social limitations. The 
correlations of the shortlist with dyspnoea (r from 0.57 to 0.60), the generic health status 
instruments (r from 0.39 to 0.59) and lung function (r from 0.10 to 0.15) fulfilled the 
criteria.  
Further results 
A clinical relevant score difference (>0.5) between upper and lower quartiles of the 
convergent instruments, an intraclass correlation between repeated scores in a stable group 
of 0.82 and a standardised response mean of 0.86 in an improved group of patients. 
Conclusions 
The short form (RIQ-MON10) maintained the psychometric properties of the original 
instrument and is promising for asssessing quality of life during routine primary care visits.  
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Introduction 
The objective of asthma and chronic obstructive pulmonary disease (COPD) management 
is to prevent or treat symptoms, improve pulmonary function and functional status/quality 
of life (qol)1,2. Physicians need to assess the burden of disease in order to be able to 
provide appropriate support and prescribe adequate treatment for patients. Symptoms only 
partially reflect the perceived burden of the disease3 and there is a considerable 
discrepancy between patients' assessment of their own health and their doctors' judgement 
4-8. For this reason, practitioners are encouraged to take into account health-related qol9, as 
this might help tailoring care towards individual patients' needs and preferences. A method 
to measure patients' perceived burden of disease or qol in a systematic and simple way may 
provide important support for practitioners. However, 'the key issue is not simply the 
measurement of qol but rather measuring qol in such a manner as to provide information 
for decision-making by patients and practitioners'10. In other words, such an instrument 
should provide relevant and unique information, focus the practitioners' attention to 
important aspects for the patient, and be easy to administer during routine care. 
 Although in recent years several generic or disease-specific instruments have been 
developed for that purpose11-16, none of them was developed for patients under treatment in 
primary care for mild to moderate chronic respiratory diseases, which are sometimes 
difficult to classify as asthma or chronic obstructive pulmonary disease (COPD). In this 
study we try to create a short instrument which can yield signals for impaired qol in this 
category of patients and which can be embedded in routine primary care procedures. The 
instrument should not only provide information about experienced bother of symptoms but 
also about other domains of qol and should be fit for completion by patients just before or 
during practice visits. Completion could give the practitioner a quick impression of several 
domains of patients' present disease-related qol to stimulate patient-centered interaction 
during a practice visit. However, the instrument might also serve another purpose as 
repeated application and recording could provide an overview of changes in the impact of 
the disease to which treatment can be tuned to. The study was based on an existing 
instrument, the Quality-of-Life for Respiratory Illness Questionnaire (QoL-RIQ) that 
already enabled identification of various domains of perceived burden of disease in 
patients with asthma or COPD17,18. With this instrument important changes for the 
individual can be measured, with the perspective of targeted support19. However, the 
instrument has 55 items, which makes it unsuitable for application in routine primary care. 
Therefore the aim of our study was to construct a short questionnaire from this 55-item 
instrument, while preserving its psychometric properties. 
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Methods  
A descriptive study was performed with secondary analyses of the data from three 
controlled studies on patients with asthma or COPD. The studies, performed in primary 
care during the period 1993 till 199820-22, provided data on the QoL-RIQ and additional 
clinimetric data: lung function i.e forced expiratory volume in 1 sec (FEV1), respiratory 
symptoms measured by the Medical Research Council-ECCS questionnaire (MRC-
ECCS)23, functional status measured by the Darthmouth COOP Functional Health 
Assessment Charts/WONCA (COOP/WONCA charts)24 and generic QoL measured by the 
MOS-SF 3625. An item reduction was done on the 55 questions of the original QoL-RIQ, 
aiming at a core set of 6-8 questions: a QoL-RIQ short form. The MRC-ECCS, 
COOP/WONCA charts and the MOS-SF 36 served as external criteria to test validity and 
responsiveness of the QoL-RIQ short form. 
 The QoL-RIQ consists of 55 questions with answer categories shaped in a 7-point Likert 
scale (range 1= not troubled at all - 7= cannot do so, too much troubled by the disease). It 
covers, in seven subscales, experienced physical, functional, mental and social problems 
related to the respiratory disease. In its development procedure patients' preferences and 
opinions have guided the item selection according to the methodology applied by Guyatt et 
al.26. Reliability, validity and sensitivity to change have been documented19. 
 In the studies used for this secondary analysis 328, 502 and 555 patients had been 
included. In table 1 the patient characteristics and their scores on QoL-RIQ, MRC-ECCS, 
MOS SF-36 and COOP/WONCA charts are presented. 
 
Table 1: Characteristics of patients involved in the three studies used in the construction and validation 
procedure 
 
Patient characteristics Study 1 (n=328) Study 2 (n=502) Study 3 (n=555) 
mean age (sd) 
male (%) 
COPD (%) 
50.7 (15.6) 
50 
37.8 
50.5 (16.6) 
40 
n.a. 
50.9 (17.4) 
52 
59.8 
FEV1 % predicted 
≤ 60 % 
60 – 80%  
≥ 80% 
76.2 (21.6) 
23 
31 
46 
n.a. 73.1 (23.5) 
29 
29 
42 
median score dyspnoea, R0-3 (IQR) 1 (2) 1 (2) 1 (2) 
mean score on QoL-RIQ (sd) 2.1 (0.9) 2.1 (0.8) 2.1 (0.8) 
mean score on MOS-SF 36: 
physical component (sd) 
mental component (sd) 
 
47.2 (9.5) 
49.9 (10.5) 
 
 n.a. 
 n.a. 
 
46.4 (9.2) 
50.3 (10.2) 
median score on MRCQ, R1-8 (IQR) 
median score COOP-charts (IQR) 
3 (3) 
n.a. 
4 (3) 
10 (4) 
3 (3) 
n.a. 
 
 The study covered two phases: item reduction and validation. Considering the large 
numbers of respondents in the first two studies we decided to restrict the reduction 
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procedure to these two. In most of the validation procedures however we used all three 
studies. By doing so we could see whether the results from the third study were consistent 
with those of the first two studies. When repeated measurements were needed (testing 
reliability and responsiveness to change) only data from the third study were available. 
 Item reduction was focussed on applicability in routine primary care. Therefore the 
opinions of general practitioners (GPs) on relevance of the items and the results from 
former tests of prototypes were taken into account beside the statistical procedure. The 
latter was aimed at (1) elimination of redundancy, (2) safeguarding sufficient scale 
distribution, and (3) establishing consistency while keeping several domains of qol 
covered. Criteria were derived from current recommendations27,28.  
1) Eliminating redundancy means avoiding overlap between the items and between the 
scales. A selection was made between items having an inter-item correlation ≥ 0.70. 
Procedure: selection of the item(s) with highest factor load on the original instrument 
(measured by rotated standard regression coefficients) and/or contributing highest to 
the consistency of the subscale (measured by Cronbach's alpha). 
2)  By safeguarding scale distribution we tried to avoid floor effects due to the mild or 
moderate severity of the disease in the primary care population. As the items should 
give discriminative information about patients items with ≥ 70% of answers in 
category 1 or 2 and at the same time less than 5% in category 4 or more were 
removed. 
3)  To enhance consistency, meaning that the items in a scale refer to a common  
attribute, a minimum of Cronbach's alpha's ≥ 0.70 in the subscales, newly found by 
factor analysis, was required and a Cronbach's alpha ≥ 0.80 in the complete short 
form. Procedure: removal of items not loading ≥ 0.40 on one of the newly found 
factors. 
 Patients had been involved in the item selection procedure of the original instrument and 
in the testing of former prototypes of the short form. To safeguard the applicability in 
routine primary care the clinical views of two GPs, having ample experience in treating 
patients with chronic respiratory diseases, could be weighed in the decision procedure in 
addition to the statistical arguments. The item selection was finally presented to a panel of 
15 GP-experts on asthma and COPD to judge the clinical relevance regarding future 
routine assessment in primary care. Only in case of 70% agreement the selection could be 
accepted. 
 Validation performed on the data of all three studies was aimed at establishing (1) the 
validity, (2) reliability and (3) responsiveness of the short form. 
 1) By construct validation one tries to confirm the relationship of the instrument with 
the underlying concept, in this case qol. A strong Spearman rank correlation (≥ 0.70) with 
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the original disease-specific QoL-RIQ instrument can be presupposed. As the correlations 
of disease-specific questionnaires with general health status and symptoms instruments are 
generally moderate29-32, correlations between 0.30 and 0.70 with the convergent 
instruments MRCQ-ECCS, the MOS-SF 36 and the COOP-charts were supposed to be 
sufficient. 
 We related the shortlist questionnaire to measures of lung function and dyspnoea. Other 
studies and the original instrument show a fair or poor correlation (≤ 0.30) of qol measures 
with lung function (FEV1)3,33,34 and a moderate to strong correlation with dyspnoea (r 
between 0.30 and 0.70)3,35-38. Dyspnoea-scores were derived from the MRC-questionnaire 
and they ranged from 0 = no dyspnoea till 3 = having to stop for breathtaking or worse. 
 2) To test reliability we performed a test-retest analysis on a stable group of patients 
based on the repeated measurements in the third study. An intra-class correlation (ICC) 
between the results of both tests of ≥.85 was considered to be sufficient39,40. We defined 
stability as an equal degree of dyspnoea and no more than 5% deviation from the basic 
measurements on the physical and mental scales of the MOS-SF 36. 
 3) Discriminative responsiveness as defined by Hyland et al.11 indicates the ability of the 
instrument to make distinctions between groups of respondents. We calculated the mean 
difference in scores on the shortlist between the subgroups scoring highest (upper 25%) 
and lowest (lower 25%) on the original instrument and on the MOS-SF 36 and assessed the 
significance of the difference with the Wilcoxon test. A difference of at least 0.5 between 
the upper and lower quarters was considered to be clinically relevant according to the 
validated minimal clinical important difference of the original instrument19. Furthermore 
we expected statistical significant relations (Wilcoxon test) between mean short form 
scores and subgroup scores of reported dyspnoea (yes or no), COOP-charts (good = mean 
1-2, bad = mean 3-5) and symptoms scores (MRCQ sum score good = 0-4, bad = 5-8). 
Considering the usual low correlation between lung function and qol measures we 
expected no statistical significant relation (Kruskall-Wallis test) between mean short form 
scores and degrees of lung function impairment (severe: FEV1 ≤ 60% predicted, moderate: 
FEV1 >60<80%, mild: FEV1 ≥ 80%). Responsiveness to change was measured indirectly, 
based on the repeated measurements performed in the third study. From this study we 
selected a group of patients reporting diminished dyspnoea (change in score ≥ 1) as well as 
improvement on the MOS-SF 36 mental and physical scales (≥ 5%). A standardised 
response mean (SRM) of the shortlist was calculated, i.e., the mean change in score 
divided by the standard deviation of the change in score39,41. Usually a SRM ≤ 0.2 is 
considered to be small, 0.5 as moderate and ≥ 0.8 as large considering the benchmarks of 
Cohen 42. 
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Results 
Item reduction 
In the two studies used in the reduction procedure the data on the seven-item subscale 
'bother of triggering factors' showed hardly any variation over time. Therefore this subscale 
was considered not to be suitable for repeated and frequent assessment and excluded from 
further analysis. Furthermore five items showing little distribution (patients reported hardly 
any trouble on the topics) were removed. So 43 items were submitted to further reduction 
and streamlining.  
 The inter-item correlation procedure showed that 30 of those items had a correlation of 
≥ 0.70 with at least one other item. When this level of correlation was the same in both 
studies, the items concerned were selected for further inspection. First of all, those items 
were selected which were closely related to more than one other item so that they could 
serve as a substitute for several other items. This was especially the case in the domains of 
'emotions' and 'limitations in physical and social activities'. From the other inter-correlated 
items those were chosen with the highest factor loadings on the factors of the original 
questionnaire and/or with the best contribution to the Cronbach's alpha. Items not loading ≥ 
0.40 on one of the factors were removed. As a result of this redundancy elimination 
procedure another 22 items could be removed from the original questionnaire and a 
selection of 21 items in 6 domains remained.  
 Eight more items were removed as a result of the assessment of clinical applicability by 
the general practitioners. Four items because they were strongly related to upper 
respiratory diseases and were considered to be more fit for occasional screening purposes 
than for regular monitoring. Two items because of diffuseness of symptoms, one other 
because of gender specificity ('polishing') and one because of some overlap ('waking up 
because of breathing problems' instead of 'waking up with breathing symptoms'). Because a 
remaining item concerning 'difficulties with sexual intercourse' showed a lot of missings 
and was considered to be not applicable for a lot of single older patients with COPD and 
some cultural groups, the highly inter-correlated (r=0.76-0.81) but more neutral and 
general social item of 'having difficulties with cuddling and kissing' was preferred. 
 The data on the remaining 13 items were put into factor analyses. The standard 
regression coefficients and the oblique rotated factor patterns were inspected. In both 
studies three factors appeared: the first containing the physical complaints, the second the 
emotional bother and the third containing the physical and social limitations. Two items 
about physical complaints were removed because of inconsistent loading and lowering the 
short form's alpha and one item about emotional complaints was removed because it had 
also a high loading on the limitations factor. Appendix 1 gives an overview of the items in 
the original instrument and the main reasons for removal. The remaining concept-short 
CONSTRUCTION AND FIRST VALIDATION OF THE RIQ-MON10 
40  
 
form consisted of 10 items: 5 about physical and emotional complaints because of the 
respiratory disease (in study 1 and 2 Cronbach's alpha's 0.81 and 0.76 respectively) and 5 
about experienced physical and social limitations (in study 1 and 2 Cronbach's alpha's 0.84 
and 0.88 respectively). The results of a forced two factor-analysis in the two studies on the 
whole selection of items are presented in table 2. The consistency of the short form as a 
whole proved to be good (Cronbach's alpha's of 0.87 and 0.90). 
 The majority of the expert panel of 15 GPs judged positively about the suitability of the 
contents of the short form (the RIQ-MON10) for monitoring purposes.  
 
Table 2: Rotated factor patterns (n=2) of the selected 10 items (standardised regression coefficients) and 
Cronbach's alpha's 
 
Items Study 1 (n=328) Study 2 (n=502) 
 factor 1 factor 2 factor 1 factor 2 
1. Having difficulties with breathing in  -0.091   0.697   0.033   0.780 
2. Wheezing   0.041   0.704  -0.096   0.776 
3.  Waking up in the night or early in the morning because 
of breathing problems 
  0.062   0.757  -0.016   0.794 
4.  Being puzzled about breathing problems   0.004   0.730   0.384   0.450 
5.  Being short-tempered, impatient with others  -0.021   0.750   0.311   0.420 
6.  Being unable to do one's daily activities   0.755   0.116   0.751   0.131 
7.  Going upstairs   0.760   0.086   0.704   0.088 
8.  Shopping   0.963  -0.099   0.904  -0.084 
9. Going out for a day-trip   0.919  -0.044   0.920  -0.128 
10. Having difficulties with cuddling and kissing   0.591   0.297   0.738   0.086 
Cronbach's alpha: 0.90 0.87 
 
Validation 
 
CONSTRUCT AND CRITERION VALIDITY 
The results of the construct and criterion validation procedures are presented in table 3. A 
high correlation between the 10-item short form and the original instrument could be 
confirmed (Rs between 0.89 and 0.92). The Spearman rank correlations between the two 
domains of the short form and the related domains of the original instrument were 
moderate to high (ranging from 0.66 to 0.89). 
 The correlations of the short form with the convergent symptoms and generic qol 
instruments were moderate, as was expected (between 0.40 and 0.59). The correlations 
between the domains of the short form and the domains of the MOS-SF 36 were as 
expected; however the correlations with the domains of the COOP-charts were lower. All 
above correlations were highly statistical significant (p ≤ 0.001). 
 The correlations with the criterion measure dyspnoea (moderate to strong) and the 
discriminant measure lung function (poor) were as supposed. 
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Table 3: Construct and criterion validation: Spearman rank correlations of the RIQ-MON10 with the original 
and concurrent health status and qol measurements, dyspnoea, absenteeism and lungfunction (FEV1 
% predicted)* 
 
 RIQ-MON10 in: 
 study 1  
(n=328) 
study 2 
(n=502) 
study 3 
(n=555) 
original instrument: 
QoL-RIQ 
 
concurrent instruments: 
MOS-SF 36 physical 
MOS-SF 36 mental 
COOP-charts (change item excluded) 
MRCQ- ECCS 
 
criterion measures: 
dyspnoea 
 
discriminant measure: 
FEV1 % predicted 
 
 0.92  
 
 
-0.57 
-0.40 
n.a. 
0.57 
 
 
0.60 
 
 
-0.15 
 
 0.89  
 
 
n.a. 
n.a. 
0.47 
0.49 
 
 
0.57 
 
 
n.a. 
 
 0.91  
 
 
-0.59 
-0.39 
n.a. 
0.48 
 
 
0.57 
 
 
-0.10 
 Domain complaints (5 items) of RIQ-MON10 
domains complaints original instrument: 
breathing problems in QoL-RIQ 
 
0.77  
 
 .70  
 
 0.70  
physical problems in QoL-RIQ  0.77   .66   0.75  
emotions in QoL-RIQ 
 
domains complaints concurrent instruments: 
mental health in MOS-SF 36 
general health in COOP-charts 
feelings in COOP-charts 
 0.81  
 
 
-0.38 
n.a 
 n.a. 
 .67  
 
 
n.a. 
.35 
.27 
 0.77  
 
 
-0.46 
n.a. 
n.a. 
 Domain limitations (5 items) of RIQ-MON10 
domain limitations original instrument: 
daily activities in QoL-RIQ 
 
 0.89  
 
 0.86  
 
 0.81  
social activities in QoL-RIQ 
 
domain limitations concurrent instruments: 
physical functioning in MOS-SF 36 
social functioning in MOS-SF 36 
physical fitness in COOP-charts 
daily activities in COOP-charts 
social activities in COOP-charts 
0.78  
 
 
-0.67 
-0.49 
n.a. 
n.a. 
n.a. 
 0.70  
 
 
n.a. 
n.a. 
0.19 
0.28 
0.31 
 0.71  
 
 
-0.60 
-0.48 
n.a. 
n.a. 
n.a. 
* All values were highly statistical significant (p ≤ 0.001), except for FEV1 % pred. (p = respectively 0.01 and 0.02) 
 
RELIABILITY 
In the third study 362 patients completed two repeated measurements with an interval of 12 
months. Of these patients 48 belonged to the stable group according to our definition. The 
test-retest results on the RIQ-MON10 from this group showed an ICC of .82. 
 
RESPONSIVENESS 
The discriminative properties of the short form are presented in table 4. In the three studies 
the patients in the upper and lower score group (quartiles) on the original instrument 
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significantly differed in scores on the shortlist: mean differences of 1.9, 1.75 and 2.01 
points, respectively. The short form could also discriminate between the patients with high 
or low scores on the MOS-SF 36 (differences of 1.25-1.34 in the physical domain and of 
0.78-0.9 in the mental domain between high and low scoring groups). A difference in mean 
scores of 1.04 was found between the subgroups scoring good or bad on the COOP-charts 
in study 2. 
 
Table 4: Discriminative properties of the RIQ-MON10: mean sumscores correlated with level of measured qol 
and disease severity (FEV1 % predicted and dyspnoea) 
 
RIQ-MON 10 in: 
 study 1 study 2 study 3 
 mean (sd) test   mean (sd) test   mean (sd) test 
QoL-RIQ: 
- good (lowest 25%) 
- bad (upper 25%) 
 
1.14 (.15) 
3.04 (.79) 
 
W * 
 
1.19 (.20) 
2.94 (.86) 
 
W * 
 
1.18 (.20) 
3.19 (.96) 
 
W * 
MOS-SF 36 physical: 
- good (upper 25%)  
- bad (lowest 25%) 
 
1.40 (.50) 
2.65 (1.10) 
 
W * 
 
n.a. 
  
1.37 (.36) 
2.71 (1.04) 
 
W * 
MOS-SF 36 mental: 
- good (upper 25%)  
- bad (lowest 25%) 
 
1.54 (.54) 
2.32 (1.01) 
 
W * 
 
 n.a. 
  
1.56 (.53) 
2.46 (1.11) 
 
W * 
- COOP-charts: 
- good (1-2) 
- bad (3-5) 
 
n.a. 
  
1.65 (.64) 
2.69 (1.30) 
 
W * 
 
n.a. 
 
MRCQ: 
- good (0-4) 
- bad (5-8) 
 
1.65 (.64) 
2.45 (.95) 
 
W * 
 
1.71(.66) 
2.45 (.94) 
 
W * 
 
1.85 (.88) 
2.63 (1.07) 
 
W * 
dyspnoea: 
- no 
- yes 
 
1.51(.58) 
2.22 (.87) 
 
W * 
 
1.56 (.82) 
2.12 (.74) 
 
W * 
  
1.48 (.48) 
2.21(1.0) 
 
W * 
lung function impairment:  
- mild 
- moderate 
- severe 
 
1.75 (.69) 
2.08 (. 93) 
2.07 (1.04) 
 
 
KW ** 
 
 
n.a. 
  
1.84 (.80) 
1.95 (.94) 
2.07 (.98) 
 
 
KW n.s. 
W = Wilcoxon 2-sample test, KW =Kruskall –Wallis test, * = p< 0.0001, ** = p< 0.05 
 
As expected the scores on the short form discriminated between patients either or not 
suffering from respiratory symptoms according to the MRCQ and more specifically from 
dyspnoea (differences in mean scores of 0.71 and 0.73). All correlations were highly 
statistical significant (p ≤ 0.0001). In accordance with our expectations the short form 
could hardly discriminate between patients with different grades of lung function 
impairment. 
 For the indirect testing of the sensitivity to change only a group of 15 primary care 
patients (4%) in the third study met our criteria for improvement. For this group the SRM 
of the RIQ-MON10 was nearly as high as the SRM of the original instrument (0.86 
compared to 0.89).  
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Discussion 
We developed a short form questionnaire for the routine qol monitoring of adult patients 
with chronic respiratory diseases in primary care. In our descriptive study we performed 
the first steps in validating this short form (the RIQ-MON10). Application of a qol-
instrument during regular doctor-patient interaction, aimed at tailoring the care to patients' 
needs, implies that the instrument 
1) offers information important to the patient and related to the specific disease; 
2) is reliable when repeatedly completed; 
3) can discriminate between patients (cross sectional sensitivity); 
4) is sensitive for individual changes (longitudinal sensitivity); and 
5) is easy to administer and interpret and can be fit into the practice routine. 
 The RIQ-MON10 meets several of these criteria, especially those for construct and 
criterion validity (1) and discriminative properties (3). Considering the large number of 
respondents in the 3 studies we used for analysis (a total of 1385 patients) and their 
representativeness as sufferers from mild to moderate respiratory diseases, we assume that 
the shortlist questionnaire really contains discriminative items suitable for application in 
primary care. We set a rigid criterium for a minimal clinically important difference of 0.5, 
which was calculated on the results of a seriously impaired population. For a mildly to 
moderately impaired primary care population the criterium to detect a minimal important 
difference would probably lie between 0.3 and 0.5 19. With regard to the reliability of the 
instrument (2) the intra-class correlation in a test-retest procedure on a stable group of 
patients was close to the preset criterium. Although indirectly tested on existing databases 
the instrument's responsiveness to change (4) measured by SRM seems very promising. 
However, this test for longitudinal sensitivity could only be based on a small number of 
improved patients. Testing the short form's reliability and responsiveness to change both 
suffered from the long interval between the repeated measurements in the third study. 
Further validation in prospective studies on an individual level with short intervals is 
needed to enhance our knowledge about these properties. As for the practical applicability 
(5) provisional conclusions can be drawn from a study in which a 25-item prototype was 
tested. In that experiment the questionnaire was handed over to the patients and completed 
in a couple of minutes just before consultation. The experiment showed promising results 
concerning the applicability of the prototype form as a stimulus for doctor-patient 
interaction and a (shared) decision aid during routine care21. The shorter and more well-
balanced RIQ-MON10 offers even better prospects to be integrated in routine primary care 
processes. 
 Why bother to create another disease-specific qol-instrument? First of all: generic 
instruments are less sensitive for individual patient assessment and monitoring in clinical 
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practice and therefore disease-specific instruments are preferred32,33,38,43,44. Furthermore, 
following the recommendations of Hyland to make a 'shopping bag' for a particular 
purpose45, the RIQ-MON10 was especially developed for a target population with mild to 
moderate respiratory diseases treated in primary care and special attention was paid to 
avoiding floor effects, considering the skewness of the scores on the original form in this 
population. Finally, in the development procedure and former prototype testing ample 
consideration was given to applicability in routine primary care, indicating future 
implementation chances. The importance to direct the attention of physicians to the 
subjective burden of the disease and to assess the patient's perceived health status in a 
systematic way is often emphasised46,47. Short questionnaires, providing reliable and valid 
information on several disease-related domains, could stimulate tailoring the treatment to 
the needs of the individual patient. As physicians perceive barriers to involve those 
instruments in their normal care48-51, in our opinion the number of questionnaires to be 
used in a complex routine care process should be very limited to enhance their acceptance 
and actual application. Therefore we strived for an optimum between discriminatory and 
evaluative capacities52 in a single questionnaire, instead of developing two different 
instruments for screening and needs assessment on the one hand and monitoring the burden 
of disease on the other. An instrument to be completed by primary care patients during 
most visits should contain items that show enough variation over time and over patients to 
be adopted as a useful procedure in routine care by the patients as well as by the primary 
care professionals. After this first validation of the RIQ-MON10 further prospective testing 
during normal primary care seems justified to get an insight into the potential additional 
value of this short form as an aid for (shared) decision making and individual patient 
monitoring. 
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Appendix 1. Results of item-reduction procedure: main reason for removal of items and presentation of the 
remaining short form (shaded items) 
 
QoL-RIQ, 55 items insensitive 
to change 
floor/low 
discrimi-
nation 
strongly 
related  
(r >0.70) 
lowering α/ 
low or diffuse 
factor loading 
low clinical 
relevance/ 
other 
reasons 
1.  Breathing problems      
 Difficulty breathing in      
 Wheezing      
 Heavy breathing    x  
 Chest tightness or shortness of breath    x  
 An itchy throat     x 
 The need to clear your throat frequently     x 
 Coughing    x  
 Recurrent colds     x 
 A stuffed-up nose     x 
2.  Physical problems      
 Sleeping limbs   x   
 Feelings of pins and needles    x  
 Feeling your heart is racing    x  
 Tiredness     x 
 Exhaustion   x   
 Waking up in the morning with breathing 
symptoms 
    x 
 The need to rest frequently during the day   x   
 Waking up in the night or early in the 
morning because of breathing problems 
     
 Poor appetite  x    
3.  Emotions      
 Worried about breathing problems   x   
 Puzzled about breathing problems      
 Concerned about the future consequences of 
breathing problems 
  x   
 Down in the dumps, depressed    x  
 Restless, nervous   x   
 Short-tempered, impatient with others      
 Moody   x   
 Feeling dependent upon others    x  
 Upset by too much sympathy of others  x    
4.  General activities      
 Unable to do one's daily activities      
 Problems with 'getting started' in the morning 
because of chest problems 
  x   
 Less pleasure in one's daily activities due to 
chest problems 
   x  
 Problems with doing hobby's   x   
5.  Triggering factors      
 Being in airconditioned buildings x     
 Being outside on cold days x     
 Being outside on foggy days x     
 Being outside on humid days x     
 Being outside during the pollen season x     
 Domestic animals or pets x     
 Flowers, trees, plants x     
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QoL-RIQ, 55 items insensitive 
to change 
floor/low 
discrimi-
nation 
strongly 
related  
(r >0.70) 
lowering α/ 
low or diffuse 
factor loading 
low clinical 
relevance/ 
other 
reasons 
6.  Daily activities      
 Going upstairs      
 Running a short distance   x   
 Cycling   x   
 Lifting a heavy object     x 
 Going to the toilet  x    
 Taking a bath or shower and/or getting 
dressed 
 x    
 Washing yourself  x    
 Polishing     x 
 Looking after the family   x   
 Shopping      
7.  Social activities      
 Going out for a day-trip      
 Going to (birthday) parties   x   
 Visiting friends and relatives    x  
 Having difficulties with cuddling and kissing      
 Having no sexual desire due to chest 
problems 
  x   
 Difficulties with sexual intercourse due to 
chest problems 
  x   
 Being too tired to have sexual intercourse 
due to chest problems 
  x   
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Abstract 
Introduction 
An electronic patient record (EPR) with disease-specific data may support improvement of 
the quality of care for patients with chronic diseases. The structure and content of such a 
record can only be assessed by clinicians in co-operation with IT-specialists, because, the 
result has to be clinically relevant, easily accessible and adjusted to the information needs 
of different workers in primary care.  
Methods 
We applied a modified Delphi-procedure —a method characterised by anonymous written 
comments by an expert panel. The panel had to agree about the question whether or not an 
item should be included in the EPR. The questions for the written comments were prepared 
by a steering committee (general practitioners (GP) and health scientists, either expert in 
asthma and disease management or IT-specialist) based on the guidelines for diagnosing 
and treating asthma of the Dutch College of General Practitioners (DCGP). When 
agreement within the panel was ≤ 70%, we sent a modified format to the expert panel for 
reassessment.  
Results 
Three written commentary rounds were necessary, in which 95 potential items were 
discussed with the expert panel. In the first round they selected 50 items relating to 
diagnosing asthma and 22 concerning the treatment of asthma. During the second round 17 
items were still under discussion and six were rejected. In subsequent rounds, the expert-
panel assessed the best registration format (operationalisation). The written rounds failed to 
create a full consensus. Therefore the study ended with a consensus meeting of the expert 
panel. Due to the presence and contribution of nearly all experts, consensus could be 
reached about the structure and contents of the EPR on asthma.  
Discussion 
The modified Delphi procedure, proved to be a feasible method for selecting the optimal 
content of an electronic registration protocol. Both, written and verbal commentary rounds 
were necessary. The existence of a set of guidelines was essential.  
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1. Introduction 
The treatment and follow-up of a patient with a chronic disorder often needs involvement 
of more than one professional. The provision of care needs to be monitored and adapted to 
the needs of the patient. This adaptation is often sub-optimal1-4. The concept of disease 
management focuses on efficiency as well as on a patient-centered approach of the process 
of care5,6. It is only possible to manage this process effectively when all the people 
involved have access to the right information at the right moment. An electronic patient 
record (EPR), in which all the relevant disease specific data can be registered according to 
a standard protocol, is an important tool to support this7. It was our purpose to integrate 
adaptive data-entry forms in the new electronic medical record (EMR)-systems that were 
under development at the time of the study. The existing EMR-systems used in general 
practice were character based, in the new systems a graphical interface was going to be 
used.  
 The structure of EPR, the various ways of entering the medical narratives (notes, letters, 
reports, etc) and ways to retrieve them, using free text searches or keywords or diagnostic 
codes, has been subject of research by IT specialists8. This has resulted in practical screen-
input forms that are easy to use in everyday practice (intuitive, ergonomic and requiring a 
minimum of special training). However, little is known about the value of the content of 
the EMR for actual disease management. In particular the key markers of the care process 
of patients with chronic diseases that should be monitored have not been investigated 
intensively. IT specialists and clinicians together should determine the relevant content of a 
case record for these patients. It should result in relevant indicators for the course of illness 
to be seen or revised by the general practitioners (GP) at any consultation. We explored a 
method that can be used for this purpose. The description of the method to determine the 
content of a care record and the results of its process are the subjects of the present paper. 
We chose asthma as the chronic disease to be recorded. Asthma was selected, because it is 
a common disease in primary care with an increasing incidence and yet still under-
diagnosed. Most patients with mild asthma are treated by their GP. A registration protocol 
could be an instrument to support early recognition of a patient with asthma or to detect the 
deterioration from mild to severe asthma.  
 At the very start of this project we recognized two possible approaches: (1) a rational 
analysis of all the decision steps during the care process and (2) a consensus-based 
approach to select the items for registration in the patient record. The rational decision 
analysis begins with defining the clinical problem and leads to a flow diagram (decision 
tree) consisting of, (a) alternative diagnostic and/or therapeutic actions, (b) the events that 
proceed from these actions and which can sometimes affect decisions about new actions 
and (c) the final health outcomes (utility) of every possible set of decisions and 
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consequences. In this way, the value (utility) of each successive step in the diagnosis, the 
treatment and its effect on the course of asthma can be quantified. In other words, it 
calculates the probability of a particular outcome on the basis of the scientific evidence 
available. The decision steps that predict the best outcome can then be incorporated into 
the registration protocol. This decision-based approach is demanding, very time-consuming 
and takes no account of the intuitive clinical perspective of those in the front line of 
provision of care9,10. It is complicated by the fact that the number of items that can be 
registered about the process of care for a chronic disorder, like asthma, is very large. 
Moreover, disease management requires not only recording of disease related subjects, but 
also of subjects referring to the care process. In view of this complexity we tried to assess 
if a consensus approach would be a practical alternative to design a clinically relevant 
protocol for an electronic record that would be suitable for general practice.  
 
2. Method 
In this exploratory study we applied a modified Delphi procedure. This is a group 
consensus method, involving series of anonymous written commentary rounds in which the 
opinions of a panel of experts are elicited. The original method was developed in 1948 by 
the RAND Corporation of California and is characterised by three important features: 
anonymity, iteration with controlled feedback and aggregation of responses at group 
level11. 
 Various variations within this framework can be applied according to the advice to suit 
the method to the problem instead of the problem to the method12,13. The modified Delphi 
method used here had the following characteristics:  
 Preparation by a steering committee. 
 Anonymous written commentary rounds from a panel of experts. 
 Final consensus meeting with the panel of experts. 
 The consensus meeting after the anonymous written commentary rounds is a regular 
applied adaptation that seemed to be suitable for our problem. We assumed consensus 
when 70% or more of the panel members agreed with the selection and operationalisation 
of the chosen item. Although the ≥ 70% threshold for consensus we used in this study is 
arbitrary, it has been used in earlier studies14,15. An extra postal round was performed when 
consensus was between 50 and < 70% agreed. When less than 50% of the panel agreed on 
a particular item, it was rejected. As a starting point we took the already-formulated 
consensus in the Dutch College of General Practitioners (DCGP)-guidelines for the 
diagnosis and treatment of asthma16,17.  
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2.1. Procedure 
2.1.1. PREPARATION BY A STEERING COMMITTEE 
The written commentary rounds were prepared by a small group of experts. This steering 
committee consisted of: one GP being an expert in computerisation, one GP being an 
asthma expert, one medical sociologist involved in disease management research and two 
health scientists. Two members of the steering committee collected all possible items from 
the latest DCGP-guidelines16,17 and the resulting list of items was sent by mail to the expert 
panel.  
 Items were defined as: all aspects of care, stated in the guidelines and relevant for 
monitoring the course of illness, which could be registered or transferred in measurable 
units. For example, in the guidelines it is advised that the GP should ask for the impact of 
dyspnoea on daily life. But how do you measure impact? Does it mean that we should 
register how often the patient awakens at night? And is this relevant?  
 The panel was asked to select the items to be registered in the patient record. Thereafter, 
the steering committee proposed a registration format for the (clinical relevant) items such 
as: measurement scales, expiration date of the registration, design of the registration and 
the position in the record. As a mean to structure the information, the proposal was 
presented to the panel on paper as a screen input-form.  
 
2.1.2. WRITTEN COMMENTARY ROUNDS WITH THE PANEL OF EXPERTS 
The written commentary rounds were anonymous and confidential. The national expert 
panel consisted of 17 clinical active and experienced GPs, who were also associated with a 
university or a general practice–training course either as a researcher or as a teacher. Their 
disease-specific expertise was noted by their recent research in this area or through their 
direct involvement in writing the DCGP guidelines for the diagnosis of asthma and 
COPD16,17. The panel of experts individually evaluated the operationalisation of the chosen 
items from the steering committee. The responses of the panel were scrutinised (and 
collated) by the steering committee, who next compiled a comprehensive list of consensus 
items and a list of items not agreed upon. The latter was resubmitted to the panel for 
reconsideration. The replies were collated once more and the process repeated.  
 
2.1.3. CONSENSUS MEETING WITH THE EXPERT PANEL 
Although, not planned in advance a consensus meeting had to be organized for the final 
determination of the content of the protocol. During the meeting consensus had to be 
reached on questions concerning measurement scales and cut off points (consensus ≥ 70%) 
for which the written rounds had failed to give clear solutions.  
In Appendix A the procedure described above is illustrated with two items.  
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3. Results 
3.1. Response 
The panel originally consisted of 17 members. Seventeen questionnaires were sent out for 
the first round, of which 15 were fully completed and returned (two missing). Three 
members left the panel, one after the first round and two after the second round. Nine of 
the remaining 14 panel members were present at the consensus meeting. Two more 
members had previously been interviewed regarding the remaining questions so that, in 
total, 11 votes could be counted at the meeting (79%).  
 
3.2. Results of the assessment rounds 
3.2.1. PHASE 1 (SELECTION OF CORE ITEMS) 
The results of this first written round are shown in Table 1. The guidelines were subdivided 
into separate items. In total 95 items from the DCGP guidelines for diagnosis (n=65) and 
treatment (n=30) of asthma were submitted to the panel. The panel members were asked 
for each item (frequency of respiratory tract infections as a child, the impact of the illness 
on the patient's life, peak flow variability, etc.) to assess whether it should be included in 
the registration protocol and, if so, whether it should be included in record-forms with 
diagnostic data or with treatment data. As a result 50 items relating to diagnosis and 22 
relating to treatment were selected for further elaboration. Six were rejected (<30% 
consensus of the panel), e.g. premature birth, duration of bacterial infections and severity 
of coughs. Nine diagnosis-related and eight treatment-related items about which no 
consensus (>50<70% of the panel) could be reached were provided with comment by the 
steering committee and re-submitted to the panel in the second round. 
 
Table 1: Number of items after the first selection round by a panel of GPs (n=15) 
 
 Number of 
items 
> 70% of the panel 
support inclusion 
> 50% <70% of the 
panel support inclusion 
> 50% of the panel 
oppose inclusion 
Diagnosis of asthma  65 50 9 6 
Treatment of asthma 30 22 8 0 
 
3.2.2. PHASE 2 AND 3 (WRITTEN COMMENTS) 
Both phase 2 and 3 dealt with the items selected for the diagnostic phase and comprised of 
two different actions (see Table 2).  
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Table 2: Phases of an adapted Delphi procedure  
 
SELECTION AND ASSESSMENT BY RESULT 
   
PHASE 1 
Steering 
committee 
Analysis of the DCGP guidelines for the diagnosis and 
treatment of asthma, 95 items that could be included in 
the protocol  
Selection of items for diagnosis and 
treatment that must be included in the 
protocol  
Expert 
panel 
72 items included in the protocol, 6 items not, 17 items 
still under discussion 
 
 
  
 
 
 
 
 
 
PHASE 2 
Steering 
committee 
Proposal for the way of registering the diagnostic items 
that must be included in the protocol (50) Summary and 
feedback of the discussion with respect to the diagnostic 
items for which there is doubt (9) 
Assessment of the proposed 
operationalisation (A) and re-assessment of 
the selection (B) relating to the diagnosis of 
asthma 
Expert 
panel 
A) 33 items are completed, the proposed development 
of 17 items is rejected  
B) 2 items are included in the protocol, 3 are not and 4 
referred to the consensus meeting  
 
  
 
 
 
 
 
PHASE 3 
Steering 
committee 
The discussion is summarised and the way of 
registering is adjusted  (17) Proposal for the registration 
of the items that again were included (2) 
Re-assessment of the proposed 
operationalisation 
Expert 
panel 
Some items remain under discussion. No further 
consensus is reached.  
 
  
 
 
 
 
 
PHASE 4 
Steering 
committee 
Prepare the consensus meeting: the remaining problems 
in diagnosis and the development of differences in 
registration between diagnosis and treatment 
Consensus meeting, remaining questions are 
put to the panel and, after discussion, voting 
takes place   
Steering 
committee 
and Expert 
panel 
Proposal for the content of a registration protocol for an 
electronic care record for asthma 
 
3.2.2.1. APPROVAL OF THE PROPOSED OPERATIONALISATION 
Fifty items (selected in phase 1) were reformulated in measurable units and submitted to 
the panel in a questionnaire. The proposed operationalisation of 33 of the 50 items was, 
with minor changes to the wording, approved in phase 2. The proposed operationalisation 
of 17 items was rejected. These items were re-written, provided with comment and re-
submitted to the panel (phase 3). This again failed to lead to consensus on these 17 items.  
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3.2.2.2. FURTHER SELECTION OF DOUBTFUL ITEMS FROM PHASE 1 
Of the nine doubtful items re-submitted to the panel two items (accessory respiratory 
muscles and thoracic X-ray) were finally included in the protocol. Three items —low birth 
weight as risk factor, predicted peak flow, alpha-1 antiprotease deficiency— were 
definitely rejected and the remaining four items were passed on to the consensus meeting, 
because, no written agreement could be reached in phase 2. The two items —accessory 
respiratory muscles and thoracic X-ray— that had finally been selected in this phase were 
re-formulated into measurable units, submitted to the panel and approved in phase 3 
according to the proposal of the steering committee.  
 
3.2.3. PHASE 4 (CONSENSUS MEETING) 
The remaining questions about the content (yes/no inclusion of four items) and the 
operationalisation (between 50 and 70% agreement on 17 items) were put to a panel, 
chaired by a member of the steering committee. After a short discussion the panel voted on 
the proposed solution, which was in all cases agreed upon by majority role.  
The four phases have been summarised in Table 2.  
 We decided to skip the commentary rounds planned for the operationalisation of the 
selected items in the treatment phase. The reason was that the items to be registered for the 
diagnosis of asthma and their registration format in the patient record were almost 
consistent with the items to be registered for the treatment of asthma. At most, one could 
argue about the extent of the registration of the location in the record. This was discussed 
during the consensus meeting.  
 
3.3. Structure of the protocol 
The structure of the protocol developed gradually during the meetings of the steering 
committee. In designing the protocol the steering committee was guided by the structure of 
new Electronic Medical Record-systems, which were under development at the time of the 
study and in which the registration protocol was supposed to be fully integrated. In the end 
the protocol consisted of six forms (input-screens); four basic forms (diagnosis, intake, 
follow-up, and exacerbation), two supporting forms (lung-function, smoking-cessation), 
and two patient linked profiles (risk-profile and disease-profile).  
 
4. Discussion 
A modified Delphi procedure proved to be applicable to make decisions on the structure 
and content of a protocol for the electronic registration of the process of care for patients 
with asthma. It led to a proposal for screen input forms that should be easy to use in daily 
practice and can give a good overview of the course of illness and the results of the 
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delivered care18. The structure of the screens and the different ways of organising the 
medical data should make it possible to look at the course of illness from different 
perspectives, such as intake, diagnosis, treatment, follow-up etc.19,20. A pre-test in a small 
group of GPs and subsequent evaluation of the protocol in a randomised trial is part of our 
plan. At the moment, we experience difficulties in preparing a test since, nearly all the 
software houses in the Netherlands experience difficulties in developing and delivering 
their new GP EMR-systems. However, the DCGP has integrated the majority of our 
protocol for asthma in its new electronic monitoring protocol for chronic diseases. A stand-
alone version will soon be tested as an add-on to the existing GP systems.  
 The Delphi method itself is not beyond criticism, mainly aimed at the lack of 'scientific' 
value and the definition of the concept of an 'expert panel' 11,12,21. As advised by Linstone, 
the Delphi method we used in this case was adapted to the problem (establishing the 
content of a registration protocol in an effective way)13. The alternative rational decision-
based approach appears more transparent but is very time-consuming and does not 
necessarily lead to a different result22. Integrated care is complex and detailed unraveling 
of the whole chain of care in the form of a decision tree, is not only unfeasible in view of 
the complexity, it also creates a great many decision or choice nodes to which no utility 
can be ascribed to, because of lack of evidence. A solution must then be imposed by 
consensus. Moreover, this approach gives no room to the personal, experience-based 
knowledge of the GP that plays such an important role in daily practice. The personal 
images and references about specific diseases that a clinician uses every day need to be 
incorporated into the registration if it has to be in tune with daily practice23.  
 Although, it has been shown that a modified Delphi procedure is a workable method for 
determining the content of an electronic registration protocol, it also produces a number of 
pitfalls. Firstly, it requires a considerable effort from the expert panel. Secondly, 
incorporation of a recently updated guideline of high quality is essential for the assessment 
of registration items24. For this study, the DCGP-guidelines served this purpose. As such it 
is a good premise but guidelines obviously do not offer the details needed for the 
registration of the process of care (such as case finding, reminder system, decision support) 
that can be incorporated in an electronic registration system25. This 'shortage' can only be 
solved by the expertise of the clinicians in the expert panel.  
 In the development of a disease specific registration protocol, the determination of the 
data content should ideally be done in a systematic way, comparable with the process of 
development of evidence based guidelines. In this phase, disease or care experts play a 
major role. After that issues, such as the design of a feasible user-interface, good inter-
operability with other systems and security, have to be dealt with, mainly by IT-specialists. 
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In our commentary rounds, we noted that the latter issues got a lot of attention of the expert 
panel and a good solution of the issues will be critical for user acceptance.  
 Partly the comments on structure and interface were evoked by the presentation of the 
questions on paper and the lack of a pre-existing structure, since, the basic EMR was still 
under development. This made it difficult to visualise the proposals and it was the main 
reason that no consensus was reached on the re-submitted 17 items in phase 3. The 
gradually developed structure of the protocol together with the ideas and considerations 
that helped to shape it proved difficult to explain on paper. Therefore, we organised a 
consensus meeting with the expert panel, which solved the problem. Having and keeping 
the expert panel focused on its task is something that needs special attention in performing 
the Delphi-procedure.  
 
5. Conclusion 
A modified Delphi procedure is an applicable method for determining the content of a 
registration protocol for an electronic case record. Both written and oral commentary 
rounds are necessary. A starting point, such as a set of pre-existing guidelines is essential. 
The tension between the mandatory structure of the electronic record and the demands of 
experts regarding the content of the registration could be solved by the modified Delphi 
procedure. A final step should be the adjustment of the protocol to the feedback from 
actual users in daily practice. 
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Appendix A. Application of the method: illustrated with two items 
 
NHG guidelines for the diagnosis 
and treatment of asthma 
Where there is periodic re-occurrence of dyspnoea, 
(sibilant) wheezing, a productive or a non-productive 
cough or protracted coughing, a diagnosis of asthma or 
COPD should be considered. If there are reasons to 
consider this diagnosis, the GP inquires about the 
nature and seriousness of the following complaints: 
- productive (morning cough) – degree of dyspnoea 
- the impact and the frequency of the complaints 
Additional diagnosis where asthma is suspected 
 
If a suspicion of asthma, peak flow is measured to 
find starting values. This is  repeated following 
bronchodilation  (the reversibility test) either 
during or after the consultation. 
Analysis of the guidelines by two 
researchers (Steering committee) 
Item: coughing 
Aspects: duration, degree, severity, productivity 
Item: peak flow reversibility 
Aspects: starting value, bronchodilation 
Phase 1 (selection by panel) 
Questions: 
1. How desirable (D) is 
[continuous] registration? 
 
2. In which screen-input form(s) 
does this subject belong? 
 
Result               ND D VD 
Degree/severity 6 36 28 
Frequency 23 21 46 
Duration 29 21 50 
 
Asthma 100%  COPD 96% 
 
Result 
Less or not desirable   6% 
Desirable  27% 
Very desirable  67%  
 
Asthma 100% COPD 38% 
Phase 2 A (assessment of proposed 
operationalisation by the panel) Reformulating the item in measurable units Reformulating the item in measurable units 
 Coughing Yes/No 
If yes, especially  Daytime/ At night/ Day and 
night  
Since 1 day/ 3 days/ 1 week/ Longer 
During exercise    Yes/No 
If yes, during Light/Moderate/Heavy exercise 
Productive           Yes/No 
If yes, description Clear/Coloured/Contains blood 
Reversibility test with peak flow meter 
Chronic maintenance therapy used
 Yes/No 
Best personal value …..L/sec 
PEF-before  1)  .L/sec PEF-after   ….L/sec 
      2)  .L/sec    ….L/sec 
      3)  .L/sec    ….L/sec 
Reversibility shown  Yes/No 
With  ………. (medicine used)  
 Circle correct answer Agree Disagree Circle correct answer Agree Disagre
e 
 Explanation: 
If you disagree, what should be different? 
Explanation: 
If you disagree, what should be different? 
 Result:  Agree 87% Disagree 13% 
Commentary: 
Description: Clear or coloured can go 
Too much, everything can go except cough Yes/No 
Since: ……open question 
Only coughing : with exercise 
Conclusion: accepted, needs changes 
Result:  Agree 60% Disagree 40% 
Commentary: 
Reversibility cannot be measured reliably with 
PEF, only note best value, report percentage 
reversibility, PEF before and PEF after need to go 
Conclusion: not accepted 
Phase 3  
Re-assessment of the modified 
operationalisation. The result and the 
commentary from the previous 
round was sent with it for 
consideration 
Not necessary PEF-Reversibility test with peak flow meter 
Date: ..-..-.. 
Reversibility test with ……………… 
Before  .... Min. after Difference % 
PEF …L/min PEF ….L/min …… % 
After the modification 
Asthma 
Diagnostic screen 
 
Coughing >3 weeks (productive or non-productive) 
 During the day 
 At night 
 With exercise > Activities of Daily Life 
 
Proposed help text: 
Reversibility exists when PEF increases >15% 
with respect to the initial value 
<60 years show reversibility 10 minutes after 
administration of a β2-adrenoreceptor stimulants. 
>60 years show reversibility 45 minutes after 
administration of ipratropium bromide 
Circle correct answer Agree Disagree 
Explanation: 
If you disagree, what should be different? 
After the modification 
Asthma 
Control screen 
Exacerbation screen  
Coughing 
 During the day 
 At night 
 With exercise > Activities of Daily Life Result: Agree 60% Disagree 40% 
Phase 4 
Consensus meeting 
Question for the panel: Is coughing > 3 weeks the 
correct norm? Panel: re-formulate as: coughing for 2 or 
more weeks 
Question to panel: Does it need to be registered 
whether and, of so, for how long administration of 
bronchodilators was stopped? 
 
Panel: Registration is not necessary; it is a 
precondition for a good test. For how long has it 
been in the guidelines? 
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Abstract 
Background 
Educational guidelines were transformed into educational needs assessment instruments for 
patients with asthma and COPD, to be used during daily practice. The study's purpose was 
the validation of the instruments, the QPEN-A and QPEN-C, from the patient's point of 
view.  
Design and measures 
a) secundairy analyses of trial data to test content validity, internal consistency, sensitivity 
to change and acceptability. b) Individual reading tests and focus group-interviews to test 
readability and acceptability. 
Setting and participants 
a) 104 patients with GP-diagnosed asthma in eight general practices having completed a 
prototype QPEN-A and a structured questionnaire. b) GPs from four practices recruited 18 
and 13 patients for the interviews. 
Results 
a) the 28 topics of the protoype could be classified in five domains of which four showed a 
moderate to high internal consistency (α from 0.46 to 0.79). The sensitivity to change was 
demonstrated in the reduction of the educational needs after provision of education: 
discussed topics (n=247) versus not-discussed topics (n=420), T – 5.556, sd 0.6604, 
p<0.001. Almost all patients confirmed the instrument's clarity and ≥ 90% confirmed the 
usefulness and applicability in normal care. b) Reading tests, however, revealed that some 
items were difficult to understand. Patients preferred completion at home before practice 
visits, especially shortly after diagnosis of the disease.  
Conclusions 
Additional qualitative procedures above quantitative evaluation were needed to establish 
validity, acceptance and applicability of the needs assessment instruments. The instruments 
were adapted to the results and can be used to stimulate patient-tailored structuring of 
education during routine primary care. 
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1. Introduction 
The present study describes the evaluation of the use of instruments to identify real-time 
educational needs of patients with chronic obstructive pulmonary disease (COPD) and 
asthma visiting general practice. Clinical practice guidelines were the basis of these 
instruments. 
 Good and understandable education of patients with chronic diseases is an essential 
component of disease management. Improvement of the content and format of information 
to patients can lead to health status improvement and better coping with the disesase1,2. 
That is why in various guidelines for the management of COPD and asthma3-6,7-9much 
emphasis is given to patient education besides pharmaceutical interventions and medical 
follow-up. However, education to patients is often not optimal10,11 and on average about a 
quarter of the patients is dissatisfied with the information they receive12. To enhance the 
communication between patients and health care professionals education should be tailored 
to the needs and capacities of the individual patient on the one hand. On the other hand it 
should fit within the tasks and care delivery profiles of the health care professionals and 
show congruence and continuity. Above all the content of the information should be 
correct.  
 As the majority of patients with COPD and asthma are treated in primary care, primary 
care professionals are an important source of information for these patients. Here too there 
is much room for improvement13-15. For that reason we performed a research programme 
on methods to improve the quality of patient education delivered by general practitioners 
(GPs). First, we derived recommendations on education from the Dutch national general 
practice guidelines for the diagnosis and treatment of COPD and asthma3,4,16. Delphi 
prodecures with GPs, groups of patients and educational experts resulted in 55 concrete 
education guidelines, 28 for asthma and 27 for COPD17. Second, a study relating the actual 
provided edcuation to these guidelines in 25 general practices showed a considerable 
discrepancy between GP and patient-reports of the education given during consultations18. 
Third, we then hypothesised that interactive personalised education in which educational 
needs are well assessed can improve conformity in treatment goals between professional 
and patient and may lead to a better disease control19 as well as to higher satisfaction with 
care delivery.20-22 To support the interactive education during practice visits we developed 
a set of instruments (derived from the recommendations in the educational guidelines) for 
the assessment of the educational needs of primary care patients with asthma and COPD. 
They are focused both on the structure and the contents of education during routine care. 
Before introducing them into normal care, such instruments need to meet specific criteria 
of validity, consistency, sensitivity to change, readability and acceptability by users. The 
present study evaluated if the instruments met these criteria and if they can be considered 
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as potentially valuable instruments for supporting the education process during 
consultations. 
 
2. Methods 
In a two-staged developmental approach we used quantitative as well as qualitative 
methods to evaluate the use of the instruments for the assessment of patients' educational 
needs in asthma (QPEN-A) and COPD (QPEN-C). We started with the 28 asthma 
education guideline topics, which formed the basis of a prototype version of the QPEN-A. 
This prototype was shaped into a one-page needs assessment form which patients could 
complete and present to the GP before a consultation. The answering categories were:  
(+)  I have received enough information about this topic 
(+/-)  although I have received information about this topic, I would like to know more 
about it 
(-)  I have received no information about this topic or  this topic is not relevant for me. 
 In study A we tested the face validity, internal consistency, sensitivity to change and 
acceptability for patients of the QPEN-A prototype. The results of this prototype validation 
were next used to construct new versions of the QPEN-A as well as a version the QPEN-C. 
In study B these new versions of both instruments were tested on readability and 
acceptance by patients.  
 
Study A.  
Test of content validity, internal consistency, sensitivity to change and acceptability  
The QPEN-A prototype was tested as part of a trial on self-management among patients 
with asthma from eight primary care practices, which was presented elsewhere23. Patients 
(n=104) were between 16 and 60 years of age and in need of inhaled corticosteroids 
according to national treatment guidelines for asthma. We used the available trial data to 
test content validity (frequencies of completion per item, detection of non-asked items to 
be removed from the instrument), internal consistency (Cronbach's alpha's >0.70 would be 
considered as good) and sensitivity to change (paired t-test in a subgroup of 24 patients 
subjected to repeated measurements before and 3 weeks after having received self-
management education, 95% confidence interval). To assess the instrument's acceptance 
the patients were asked to judge it's clarity, usefulness and practical applicability in a 
structured questionnaire with four answering categories (correct, partly incorrect and partly 
correct, correct, no opinion).  
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Study B. Test of readability and acceptability 
On the basis of the first study we adapted the asthma instrument and constructed the 
COPD-instrument. The new versions focussed more heavily on feed forward to clinicians 
of needs assessment information by making space for adding three questions formulated by 
the individual patient and by suggesting to make a top three priority. The instruments were 
shaped in one double-sided form with a large letter font. 
 1) These next versions were put to a reading test in semi-structured interviews with 
individual patients with asthma (n=11) and COPD (n=7). Patients were recruited by 
general practitioners in four practices. The patients covered various age groups: 4 patients 
≤ 40 with asthma, 7 patients between 41 and 64 with asthma or COPD and 7 patients ≥ 65 
years of age of which 5 had COPD. Eight patients had a low educational level, six had 
medium and four had a high educational level.  
 We followed recommended methods24,25 and focussed on troubleshooting concerning 
the understanding of words or phrases during and after the patients read aloud the 
instructions and the items of the instruments. The interviews were taperecorded and during 
the reading test the results were scored on prestructured forms. The number of patients 
experiencing trouble in reading concrete parts of the instruments were counted. When more 
than 20% of the patients had trouble in understanding parts of the text, alterations were 
planned. 
 2) Acceptance was evaluated in 1,5 hour focusgroup-interviews with three groups of 
patients: patients with asthma, patients with COPD and a group of patients recruited from 
the self-management trial. The patients in this latter group, who had experience with the 
prototype-version of the QPEN-A, now could give their opinion on the next version of the 
instrument. The groups were recruited by four general practitioners. One group consisted 
of five patients, two groups were composed of four patients. Further composition 
characteristics:  
− four men, nine women, mean age 49.7 (R 23 – 65) 
− six lower ecudation, six medium level education, two high level education   
− mean duration asthma 31.7 years (R 10-62) , mean duration COPD 22.5 years (R 5-48). 
The interviews had a semi-structured shape and were taperecorded. Aim was to get indepth 
information and generate critical remarks on usefulness of the instrument by stimulating 
interaction between group members26. Benefits and disadvantages of alternative layouts (a 
tear-off pad or lose sheets in a file) were discussed. The groups were chaired by a senior 
researcher and a junior researcher made notes. The successive topics of the interviews 
were: the usual information seeking behaviour, the usefulness of alternative layouts of the 
instrument, the preferred frequency of use, the design of the instrument and the ways to 
disseminate the instrument. During analysis the interview contents were ordened according 
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to the prestructured topics and summarised by two independent researchers. Differences in 
conclusions were discussed to obtain full aggreement.  
 
3. Results 
Study A.  
Test of content validity, internal consistency, sensitivity to change and acceptability 
Inspection of frequencies of the answers given just before a pracitice visit (n=107) showed 
that there were no items about which the patients did not need information. The last 
answering category was not used correctly by some patients and was sometimes left empty 
in case of perceived personal irrelevance of a topic.  
 The 28 topics of the protoype could be classified in five domains of which four showed 
a moderate to high internal consistency: general information on asthma, general treatment, 
treatment without or besides medication and treatment with medication (from 0.46 to 0.80, 
see Table 1). Analyses were performed with exclusion of the last answering category. The 
"examinations" domain was not consistent. 
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Table 1:  Frequencies and internal consistency of the prototype asthma instrument (n=104 patients) 
 
% of patients reporting the 
information was 
 
 
 
Topics 
 
enough 
not 
enough 
not received/ 
not relevant
General information on asthma (α 0.72) 
What exactly is the disease asthma? 
What is known about the causes of asthma? 
What causes breathlessness in asthma? 
What is allergy, how does it arise and what can I do to prevent complaints? 
What is meant by hypersensitivity (hyperreactivity) of the airways and to which 
substances do my airways react? 
How is the future (prognosis) of my asthma? 
 
87 
75 
88 
76 
75 
 
44 
 
12 
19 
10 
20 
24 
 
50 
 
  1 
  6 
  2 
  4 
  2 
 
  6 
Examinations ( α -0.05) 
What is an allergy test and why it is done on me? 
What is a lung function test?  
Why do I have to measure my 'peak flow' and what I should I pay attention to when I 
blow in the peak flow meter (e.g. lips around the mouthpiece)? 
 
82 
86 
94 
 
  8 
  8 
  5 
 
  9 
  6 
  1 
General treatment (α 0.46) 
What does my GP try to achieve with the treatment of my asthma? 
Why do I have to pay regular control visits to my GP? 
For what reasons can the GP refer me to a chest physician/pulmonologist?  
 
82 
80 
66 
 
16 
  8 
13 
 
  2 
11 
21 
Treatment without or besides medication (α 0.46) 
What measures can I take at home to diminish as much as possible the exposure to 
substances that irritate my airways? 
What is the effect of smoking and passive smoking on my respiratory complaints? 
In what way can measures be taken at work to diminish exposure to irritating 
substances? 
What is exercise induced asthma, how it is caused and what I can do to prevent it? 
What is the benefit and importance of the annual flu vaccination? 
What are the activities of the Dutch Asthma Foundation and the patient association 
VbbA? 
What is the relationship between physical exercise and my respiratory complaints? 
 
74 
 
75 
53 
 
64 
75 
44 
 
59 
 
17 
 
14 
19 
 
22 
13 
31 
 
28 
 
  9 
 
11 
28 
 
14 
12 
25 
 
13 
Treatment with medication (α 0.80) 
What are short-acting bronchodilators and why are they prescribed? 
What are long-acting bronchodilators and why are they prescribed?  
What are inhalation corticosteroids and why are they prescribed? 
When do I notice effects of the use of inhalation corticosteroids? 
What are side-effects of inhalation corticosteroids? 
What should I take care of while inhaling my asthma medication and why is this so 
important? 
What are corticosteroid tablets and when are they prescribed? 
Information on other medication that I have to use because of my asthma 
When and how should I have a course of prednison and when should I get in touch 
with my GP because of exacerbation of my asthma? 
 
70 
64 
74 
59 
44 
78 
 
13 
51 
21 
 
25 
28 
20 
31 
41 
14 
 
23 
16 
19 
 
  5 
  8 
  6 
  9 
14 
  8 
 
65 
33 
60 
Total α   0.88 
 
 The sensitivity to change was demonstrated in the reduction of the educational needs of 
the 24 patients having received self-management education on certain topics mentioned in 
the prototype. There was a siginificant reduction in educational needs concerning the topics 
discussed during the visits (n=247) compared to the topics which were not discussed 
(n=420) (T – 5.556, sd .6604, p<0.001). 
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 From 88 of the 104 patients (85%) an evaluation of the acceptance of the needs 
assessment instrument could be obtained. Table 2 shows that 95% or more of the patients 
confirmed the clarity of the instructions and the language of the instrument. And 90% or 
more of the patients agreed that the instrument is useful to them and that the completion 
procedure in the waiting room just before a practice visit is feasible. 
 
Table 2:  Patient evaluations about the acceptability of the protoype asthma instrument assessing educational 
needs (percentages, n=88) 
 
  
incorrect
partly correct, 
partly incorrect 
 
correct
no 
opinion
At the top of the form is a short instruction (+, ±, -), do 
you find this instruction clear 
 
1.2 
 
2.4 
 
96.5 
 
- 
I find it easy to fill in this form - 3.4 96.6 - 
The subjects in this form have been written in understandable language - 4.6 95.4 - 
I had enough time to fill in the form before entering the consulting room 
of the GP 
 
- 
 
1.1 
 
98.9 
 
- 
I have enough privacy while filling in the form 2.2 8.0 89.7 - 
I can concentrate myself well when I fill in the form in the waiting room 1.2 8.2 90.6 - 
I think that the subjects that are important to me are mentioned in the 
form 
 
- 
 
4.6 
 
94.2 
 
1.1 
I find the form a useful aid to indicate which questions I have on asthma - 8.0 92.0 - 
I find the form a useful aid to remember which subjects have been 
discussed with the GP during previous consultations 
 
3.4 
 
6.9 
 
89.6 
 
- 
 
Study B. Test of readability and acceptability 
The QPEN-A prototype was adapted to the results of the former tests; the instrument for 
patients with COPD was adapted accordingly. To avoid unclearness in the answering 
categories the categories were changed into a single box to be ticked in case of education 
needs. User-friendliness was raised by dividing composed topics (amongst those two of the 
three items in the examinations domain) in more specific single items, thus raising the 
number of educational topics to 38 for asthma and 35 for COPD. 
 1) The individual interviews revealed that the instructions were well understood by most 
patients with asthma, but the older patients with COPD had some trouble understanding the 
aim of the needs assessment instrument and the proposed procedure. Table 3 presents the 
reading results for the asthma instrument. Most items were understood, but more than 20 % 
of the patients experienced trouble with nine of the 38 items in the asthma instrument. For 
patients with COPD this was the case with 11 of the 35 items. For both groups six items 
about hyperreactivity, the role of the patient organisations, and the role of types of 
medicine were difficult to understand. Moreover, the patients with asthma had trouble with 
items about peakflow measurement, the course of asthma, the goal of the treatment and the 
advantage of inhalation medication. For patients with COPD the items on spirometry, a 
corticosteroid test, lung revalidation and acetylcystein were hard to understand. 
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Table 3:  Results of the reading test of  the prototype instrument for asthma (n=11 patients) 
 
 + - -/+ 
What is asthma? 11   
What causes asthma? 11   
What exactly happens during an attack of shortness of breath? 11   
What is hyperreactivity?   3 8  
What is an allergy?  11   
What is the usual course of asthma?   6 5  
Why is my peak flow measured?   8 3  
How can I measure my own peak flow? 10 1  
In what way will I be tested for allergies? 11   
Am I allergic to something? 11   
What is the goal of the treatment of my asthma?   7 3 1 
How strictly should I follow the treatment instructions? 11   
When should I contact the GP? 10 1  
Do I have to see the GP for control visits?   9 2  
When will the GP refer me to a chest physician? 10 1  
What can I do to prevent allergic complaints?   9 1 1 
Which measures can I take at home to reduce trouble from irritating substances? 10  1 
Which measures can I take at my work to reduce trouble from irritating substances? 11   
How important is physical exercise (sports) for my asthma? 11   
What can I do to prevent exercise-induced asthma? 10 1  
What is the effect of smoking and passive smoking on my asthma?  11   
Why is quitting smoking important when you have asthma? 10  1 
How can I quit smoking?   8  3 
Why is it important for me to get a flu vaccination each year? 11   
What can I do about my fear of breathlessness?   9 1 1 
What do the Dutch Asthma Foundation and the patients’ association VbbA do?     6 5  
How do long-acting bronchodilators work?   7 3 1 
How do short-acting bronchodilators work?   8 2 1 
How does anti-inflammatory medication (corticosteroids) that has to be inhaled work?   4 6 1 
How does anti-inflammatory medication (corticosteroids) that has to be taken through the mouth 
work? 
  5 4 2 
Why should I take or not take specific medication? 10 1  
How often should I take my medication and how much? 11   
In what way should I take my medication? 11   
What are the side-effects of my medication? 11   
What is the advantage of inhaling (breathing in the medication)?   8 3  
 What is the right manner to inhale (breathing in the medication)?   9 2  
What can I do if I feel uncomfortable to take medication in company?   9 1 1 
What should I do if my complaints worsen? 11   
+ = well understood, - = not understood/unclear, -/+ = parts not understood, e.g. a single word 
 
The request to record the top three priorities amongst the items ticked was too complex to 
perform for some patients, others used the free space for noting down the item priorities 
instead of presenting personal topics not mentioned in the instrument. No suggestions to 
include new topics in the instrument were made. The interviewer noted that some patients 
forgot to turn over the page. 
 2) The three focusgroup interviews with patients revealed that most patients had no 
active information seeking behaviour. The group of patients having experience with the 
prototype instrument had received more information of their physician, the patients in the 
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other groups had not received any structured information. Patients remarked that visits 
were made during exacerbations when the need of physical relief was central and that "if 
you feel better, then you think I would like to know it. But then you are not there".   
 All three groups considered the instrument especially useful shortly after diagnosis of 
the disease and preferred completion at home. The patients with asthma in the group 
without experience with the prototype were sceptic about the further usefulness of the 
instrument. The patients who had formerly used the prototype had very different individual 
opinions regarding future use, varying from "I like it more in my own words than printed. 
Then I can express more clearly what I mean and how I feel" to "I would advice this for 
any disease. I think that you are a bit more attentive to yourself then". 
 All groups agreed that providing answers to the questions should be phased and that 
more than one visit would be needed. When most questions had been answered completion 
of the instruments should be stopped. The patients with COPD agreed that the instrument 
could be used in case of change of medication or deterioration of the disease.  
 The groups were positive about the double sided one-page design but had mixed 
opinions about the presentation either as a tear-off pad or as lose sheets in a folder with 
space for other information on the disease.  
 All three groups agreed that the initiative to disseminate the instruments should come 
from the general practice or the lung physician or that these should refer patients to the 
patient organisations as providers of the instruments. This would stimulate patients to 
overcome their inhibition to use them. However patients should be free in their decision to 
complete them or not. In the words of one patient "I think that every patient with asthma 
visiting a doctor either for a control visit or for problems who has not had such a form 
should complete it. No, not that you must complete it, but that you get the chance to do so". 
 
Final versions 
The reading test and the acceptability test in patients led to the definitive versions of the 
QPEN-A and QPEN-C (see Appendices I and II) having all items on one page and a more 
explicit and detailed user instruction leaving out instructions to prioritise. Items were 
rephrased in the direction of more personal relevance, e.g. "what do the patient 
organisations do" was changed into "what can the patient organisations do for me". 
Furthermore, wordings were changed according to suggestions of the patients, e.g. 
"medicine to be taken through the mouth" was changed into "medicine to be swallowed". 
Moreover, more information was now incorporated in the item itself, e.g. "what is 
hyperreactivity" became "what is hypersensitivity of the airways (hyperreactivity)" or 
"what does a spirometer measure" was changed into "what does a lung function meter 
(spirometer) measure". 
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 The general user instructions for health care providers now suggest a stuctured 
application in the treatment phase just after the first diagnosis, to disseminate the 
instruments with an intermediary role of physicians' practices and to have the instruments 
completed at home on a voluntary basis. Occasional use is recommended when symptoms 
or treatment change. 
 
4. Discussion 
This developmental study revealed the content validity, level of internal consistency, 
sensitivity to change and acceptability of a prototype instrument for the routine assessment 
in daily primary care of educational needs in patients with asthma. Almost all patients were 
positive about the procedure of feeding forward educational needs in a structured way. 
Despite these results additional qualitative approaches revealed pitfalls in wordings, 
phrases and design, which had to be corrrected in the latest versions of the instruments for 
asthma and COPD. Originally the translation of medical language in common speech was 
too easily taken for granted; the testing of readability in a series of individual interviews 
revealed reading problems which were not revealed by the quantitative analysis of the 
prototype test. A combination of alternate quantitative and qualitative methods for 
development and evaluation proved to have additional value above one of these alone. 
 The development of the education needs assessment instruments illustrates an attempt to 
merge four goals in one single approach: provision of guidelines-based education, 
stimulation of the expression of patients' needs of education, stimulation of assessment of 
educational needs by the professionals and realistic embedding of a procedure in normal 
daily care. Most guidelines for the treatment of COPD and asthma only contain brief 
information on the targets for education and the topics to be discussed. Development of 
disease-specific educational guidelines and providing instruments for their implementation 
may enhance patient-directed quality of treatment. A needs assessment instrument 
focussing on the content of the education does not guarantee that other aspects of the 
educational process, such as skills of talking and question asking, are patient-tailored and 
of good quality. However, other research has shown that the routine handing over of a 
needs assessment instrument and looking at it during a consultation may positively 
influence the quality of the communication as well27,28. 
 Bensing10 stated the need of tuning educational support materials to patients' needs and 
characteristics. Although the needs assessment instruments are based on professional 
guidelines stating what patients 'need to know' the instruments nevertheless focus on what 
patients 'want to know'. The needs assessment instruments can be considered as 
instruments for professionally accountable tailored patient education which may effect 
patient adherence to treatment advice and other outcomes. Our data show that mainly 
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elderly patients with lower educational background had trouble with completing the 
instruments and their pro-active role in the needs assessment procedure. At present 
younger patients or patients with relatively high education would benefit most of the 
procedure. 
 In this study we particularly involved patients in the development and evaluation 
process. A rigorous procedure to explore the whishes of both user groups (patients as well 
as primary care professionals) can enhance future adoption and large-scale implementation 
of these instruments in routine care. In the end the effectiveness of routine use on the 
quality and outcomes of care have to be demonstrated. In the meantime quality 
improvement of care means a continuous improvement of the supportive instruments as 
well. The present study is a contribution to that process.  
 
Practice implications 
Professional guidelines can be the basis of needs assessment instruments thus stimulating 
professionally accountable tailored patient education. Although they have been developed 
in and for general practice the instruments and their content might be applicable in other 
health care settings as well. Patient education is a central component of disease 
management29 and by structuring the education the instruments could support integrated 
care. The instruments can be integrated in multidisiplinary disease management of COPD 
and asthma and additional topics relevant for other health care providers (e.g. chest 
physicians, physiotherapists) could be added. Electronic versions (through internet, in 
common patient records) could stimulate broader use.  
 The QPEN-A and the QPEN-C could be better integrated in daily care when a direct 
link to the electronic medical record can be made. The instruments offer ample opportunity 
to integrate them in modern patient-directed disease management: e.g. printing them in the 
surgery during a visit, touch screen facilities in the waiting room and website versions to 
be downloaded and returned to the practice. The Dutch Asthma Foundation has made web-
versions of the instruments which are unrestrictedly accessible. However a direct 
integration with the patient record to monitor the patient needs and the provision of 
education has not been realised yet. 
 Using previsit questionnaires to enhance patient-tailored communication requires 
extensive exploration of the validity of the instruments and their adoptability in routine 
practice. Quantitative and qualitative evaluations have been undertaken to underpin the 
exploration. The presentation of some stages in the developmental and validation process 
in this paper can provide an example for the development of guidelines based educational 
needs assessment instruments for other chronic disease. 
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   Appendix 1 
YOUR QUESTIONS ABOUT ASTHMA 
All questions in this list are related to asthma. You can use the list as an aid for your visits to the general 
practice. If you would like to get an answer to some questions in this list you can tick them. In the practice 
you can hand over this list to the GP, the practice nurse or the receptionist. One of them can answer your 
questions. If you have many questions they may not be answered all together at the same time. For the 
remaining questions you can make a follow-up appointment.  
 
Asthma in general 
 What is asthma? 
 What causes asthma? 
 What exactly happens during an attack of 
shortness of breath? 
 What is hypersensitivity of the airways 
(hyperreactivity)? 
 What is an allergy?  
 What is the course of asthma in most people? 
 
Examination   
 What is a peakflow? 
 Why is my peakflow measured? 
 How can I measure my own peakflow? 
 In what way will I be tested for allergies? 
 Am I allergic to something? 
  
Treatment  
 What can be achieved with the treatment of 
my asthma? 
 How strictly should I follow the treatment 
instructions? 
 When should I contact the GP? 
 Do I have to see the GP for control visits? 
 When will the GP refer me to a chest 
physician? 
 
There are two ways to treat your asthma which 
can seperately or together lead to a reduction of 
the complaints: treatment without or besides 
medication and treatment with medication  
 
Treatment without or besides medication 
 What can I do to prevent allergic complaints? 
 Which measures can I take at home to reduce 
trouble from irritating substances? 
 Which measures can I take at my work to 
reduce trouble from irritating substances? 
 How important is physical exercise (sports) for 
my asthma? 
 What can I do to prevent exercise-induced 
asthma? 
 What is the effect of smoking and passive 
smoking on my asthma? 
 How can I quit smoking? 
 Why is it important for me to get a flu 
vaccination each year? 
 What can I do about my fear of breathlessness? 
 What can the Dutch Asthma Foundation and the 
patients' association VbbA mean to me?   
 
Treatment with medication 
 How do long-acting bronchodilators work? 
 How do short-acting bronchodilators work? 
 How do corticosteroids that you have to inhale 
work? 
 How do corticosteroids that you have to 
swallow work? 
 Why should I take or not take specific 
medication? 
 How often should I take my medication and 
how much? 
 In what way should I take my medication? 
 What are the side-effects of my medication? 
 What is the advantage of inhaling? 
 What is the right manner to inhale? 
 What can I do if I feel uncomfortable to take 
medication in company? 
 What should I do if my complaints worsen? 
 
Do you have any other questions about asthma 
that are not in the list? Please fill them in below. 
 ..........…………………………………….….
 
 ..........…………………………………….….
 
 ..........…………………………………….….
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 Appendix 2 
 
YOUR QUESTIONS ABOUT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 
All questions in this list are related to COPD. You can use the list as an aid for your visits to the general 
practice. If you would like to get an answer to some questions in this list you can tick them. In the practice 
you can hand over this list to the GP, the practice nurse or the receptionist. One of them can answer your 
questions. If you have many questions they may not be answered all together at the same time. For the 
remaining questions you can make a follow-up appointment.  
 
COPD in general 
 What is COPD (chronic bronchitis or lung-
emphysema)? 
 What causes COPD? 
 What exactly happens during an attack of 
shortness of breath? 
 What is hypersensitivity of the airways 
(hyperreactivity)? 
 What is the course of COPD in most people? 
 
Examination 
 What does a lung-function meter (spirometer) 
measure? 
 Why will a trial with corticosteroid tablets be 
performed on me? 
 What other examinations can the GP refer me for? 
 
Treatment 
 What can be achieved with the treatment of my 
COPD? 
 How strictly should I follow the treatment 
instructions? 
 When should I contact the GP? 
 Do I have to see the GP for control visits? 
 When will the GP refer me to a chest physician? 
 What is a pulmonary rehabilitation programme? 
 
There are two ways to treat your chronic bronchitis or 
lung-emphysema which can seperately or together 
lead to a reduction of the complaints: treatment 
without or besides medication and treatment with 
medication 
 
Treatment without or besides medication 
 What is the effect of smoking and passive 
smoking on my COPD? 
 How can I quit smoking? 
 Which measures can I take at work to be less 
troubled by my COPD? 
 How important is physical exercise (sports) 
for my COPD? 
 Why is it important for me to get a flu 
vaccination each year? 
 What can I do about my fear of 
breathlessness? 
 What can the Dutch Asthma Foundation and 
the patients’ association VbbA mean to me?   
 
Treatment with medication 
 How do long-acting bronchodilators work? 
 How do short-acting bronchodilators work? 
 How do anti-inflammatory medicines 
(corticosteroids) that you have to inhale work?
 How do anti-inflammatory medicines 
(corticosteroids) that you have to swallow 
work? 
 What is the reason to use acetylcysteine? 
 Why should I take or not take specific 
medication? 
 How often should I take my my medication 
and how much? 
 In what way should I take my medication? 
 What are the side-effects of my medication? 
 What is the advantage of inhaling? 
 What is the right manner to inhale? 
 What can I do if I feel uncomfortable to take 
medication in company? 
 What should I do if my complaints worsen? 
 
Do you have any other questions about COPD 
that are not in the list? Please fill them in below
 ..........…………………………………….…. 
 
 ...........……............………………………… 
 
 …........................................………………… 
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Abstract 
Objectives 
The aim of this study was to investigate the feasibility of systematic monitoring of patients' 
quality of life and its relationship to general practitioners' interventions concerning 
management of asthma and chronic obstructive pulmonary disease (COPD). 
Methods 
A cross-sectional study on patients' self-reported quality of life in relation to general 
practitioners' subsequent interventions during consultation was performed. Fourteen 
general practitioners (GPs) at six general practices in the Netherlands monitored 175 
patients aged 18 years and older with asthma and COPD. Directly before each planned 
follow-up consultation, patients completed a self-report questionnaire (27 items, five 
dimensions) about their quality of life; GPs reviewed the monitoring scores during 
consultation and recorded their diagnostic and therapeutic interventions. The relationship 
between patients' perceived quality of life and GPs' medication prescription, smoking 
cessation advice, patient education and counselling was analysed. 
Results 
During 15 months, 175 patients underwent 537 consultations. In 57% of the consultations, 
patients reported impairments in their quality of life. This information was significantly 
associated with subsequent GP interventions (Chi-square p ≤ 0.05), especially with 
providing patient education and counselling. Multivariate logistic regression analyses 
showed that reported physical complaints were positively associated with changes in 
medication prescription (OR 1.7; 95% CI 1.0-2.8) and with education about the control 
regimen (OR 1.9; 95% CI 1.1-3.3). Reported emotional complaints were related to extra 
follow-up appointments (OR 4.3; 95% CI 1.5-12.8) and to counselling (OR 7.3; 95% CI 
2.9-18.3). In general, more advanced age was related to less patient education. Patients' and 
GPs' opinions about the quality of life monitoring were positive.  
Conclusions 
Information about quality of life of patients, gathered systematically and routinely directly 
before consultation, could be integrated into a complex medical decision-making process; 
scores were related to various therapeutic interventions. 
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Introduction  
Management of patients with mild to moderate chronic diseases implies long-term follow-
up, in which the patient's condition is reviewed periodically and compared with the 
treatment objectives. The treatment can be adjusted on the basis of the results. As with 
most other chronic diseases, the monitoring of patients with asthma and chronic 
obstructive pulmonary disease (COPD) traditionally focuses on clinical aspects of the 
disease, in particular patients' symptoms and pulmonary function. However, increasing 
attention is being paid to 'quality of life' and the assessment of needs in (chronic) diseases1-
6. Patients have to integrate their chronic illness into their everyday life; thus quality of life 
information will reflect the impact of the disease on the patients' personal lives. Intuitively, 
physicians address this issue in questions such as 'How are you feeling today Mrs 
Johnson?'. A more specified and focused approach might lead to better tailoring of care to 
individual needs7-13. It is important that the patients present their own perceived health-
related quality of life, as this may differ substantially from physicians' inferred perception 
of the impact of the disease14-17. Although a number of studies have investigated patients' 
perceived quality of life during consultation, its relation to (general) practitioners' 
performance is unclear. In this study we explored this correlation in patients with mild to 
moderate asthma and COPD. At six general practices we introduced a short disease-
specific questionnaire for the routine monitoring of patients' quality of life. The aim of our 
study was to investigate the feasibility of systematic quality of life monitoring during 
regular follow-up consultations and to explore its relationship to general practitioners' 
(GPs') interventions. 
 
Methods 
Design 
A cross-sectional design was used to relate patients' self-reported quality of life to GPs' 
interventions during consultation. The study was performed at six general practices (14 
GPs) on 175 patients with asthma and COPD. During a period of 6 months, patients of 18 
years and older, not receiving treatment from a chest physician, were recruited by their 
own GP when they visited the practice for a regular follow-up consultation. Ninety per 
cent of the patients had already been monitored regularly by their GP during the past year. 
In the ongoing monitoring system, attention was paid to lung function, symptoms, 
medication, smoking behaviour and compliance with follow-up visits. At inclusion, the 
validity of the asthma/COPD diagnosis was checked and patients were only included if 
their status was in accordance with the following criteria: lung function (FEV1) < (FEV1 
predicted minus 1.64 SD) and/or a day-night variation > 15% and/or regular use of asthma 
MANAGEMENT OF PATIENTS WITH ASTHMA AND COPD 
82  
 
or COPD medication during the past year. Patients with serious physical or psychosocial 
co-morbidity did not participate in the monitoring system and subsequently were not 
invited to participate in the study. All patients gave written consent to participate. The GPs 
aimed at performing regular 3-monthly follow-up consultations in accordance with the 
clinical practice guidelines of the Dutch College of General Practitioners. Each patient had 
to be followed for at least 12 months. The study was part of a research project on quality of 
care for patients with asthma and COPD in general practice. The GPs had only been 
informed about the global study objectives, in order to prevent triggering from specific 
objectives.  
 
Instruments/measurements 
Directly before each regular follow-up consultation, patients were asked to complete a 
disease-specific quality of life self-report questionnaire in the waiting room and to give it 
to the GP at the beginning of the consultation. Thus, information about patient's quality of 
life was fed forward to the GP in a structured manner and added to the existing monitoring 
system. The questionnaire contained 27 items (see figure 1), divided into five dimensions 
of quality of life: physical complaints, emotional complaints, physical and social 
limitations and absenteeism (from domestic duties or work) due to the disease. 
 A statistical and content validation procedure had been applied to data from 1050 
patients, to derive a 25-item short version from a validated 55-item disease-specific 
questionnaire (QoL-RIQ).18 On the advice of a panel of GPs, two items about absenteeism 
from work and domestic duties were added to the short questionnaire. The answering 
categories on the first 25 items formed a four-point Likert scale (1 = not troubled at all; 2 = 
a little troubled; 3 = fairly or considerably troubled; 4 = much or very much troubled by the 
disease). GPs were instructed that a score of 3 or 4 might 'signal' a problem with patient's 
quality of life. 
 During the follow-up consultations, the GPs recorded their interventions on a research 
form which was attached to the patient questionnaire, specifying whether or not they 
performed: 
I) diagnostic interventions: spirometry, other (e.g. allergy testing, X-thorax); II) therapy: 
change of prescribed drugs, smoking cessation advice, extra follow-up appointment; III) 
patient education: on medication, on character of the disease, on control regimen, on life-
style, on other matters; IV)  counselling: about physical condition, emotional condition, 
social activities, other matters; and V) referrals. 
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Figure 1. QUESTIONNAIRE PERIODIC CONSULTATION FOR ASTHMA OR COPD 
 Please complete this questionnaire and hand it to your general practitioner 
 
1. PHYSICAL COMPLAINTS 
1a. During the past 4 weeks, how much were you troubled by the following physical complaints (because of your airway 
disease)? 
  
In each row, please circle the one answer  
that most precisely fits your situation 
 
not 
at all 
 
(very) 
little 
 
pretty or 
considerably 
 
(very) 
much  
difficulty breathing in .........................................................................
 
1 
 
2 
 
3 
 
4  
wheezing.............................................................................................
 
1 
 
2 
 
3 
 
4  
chest tightness  ...................................................................................
 
1 
 
2 
 
3 
 
4  
heavy breathing  ................................................................................
 
1 
 
2 
 
3 
 
4  
shortness of breath ..............................................................................
 
1 
 
2 
 
3 
 
4  
coughing .............................................................................................
 
1 
 
2 
 
3 
 
4  
coughing up mucous ...........................................................................
 
1 
 
2 
 
3 
 
4  
tiredness..............................................................................................
 
1 
 
2 
 
3 
 
4  
exhaustion...........................................................................................
 
1 
 
2 
 
3 
 
4  
waking up during the night or in the early morning  
 
1 
 
2 
 
3 
 
4 
 
1b. During the past 4 weeks, did you have a cold or the flu? yes no 
if yes: how many days? |__|__| day(s) 
 
2. EMOTIONS 
During the past 4 weeks, how much were you troubled by the following emotions (because of your breathing problems)? 
  
In each row, please circle the one answer  
that most precisely fits your situation 
 
not 
at all 
 
(very) 
little 
 
pretty or 
considerably 
 
(very) 
much  
worried about my breathing problems ..................................................
 
1 
 
2 
 
3 
 
4  
concerned about the future consequences of my breathing problems ...
 
1 
 
2 
 
3 4  
depressed, in low spirits........................................................................
 
1 
 
2 
 
3 
 
4  
unquiet, restless.....................................................................................
 
1 
 
2 
 
3 
 
4  
short-tempered, impatient with others...................................................
 
1 
 
2 
 
3 
 
4 
 
3. PHYSICAL AND SOCIAL ACTIVITIES 
During the past 4 weeks, how much were you troubled performing the following activities (because of your breathing 
problems)? 
  
In each row, please circle the one answer  
that most precisely fits your situation 
 
not 
at all 
 
(very) 
little 
 
pretty or 
considerably 
 
(very) 
much 
 
unable 
to do so 
 
I did not 
do this  
going upstairs.........................................................
 
1 
 
2 
 
3 
 
4 
 
5 
 
0  
running a short distance .........................................
 
1 
 
2 
 
3 
 
4 
 
5 
 
0  
cycling ...................................................................
 
1 
 
2 
 
3 
 
4 
 
5 
 
0  
lifting a heavy object .............................................
 
1 
 
2 
 
3 
 
4 
 
5 
 
0  
taking a bath or a shower .......................................
 
1 
 
2 
 
3 
 
4 
 
5 
 
0  
getting dressed .......................................................
 
1 
 
2 
 
3 
 
4 
 
5 
 
0  
cleaning..................................................................
 
1 
 
2 
 
3 
 
4 
 
5 
 
0  
doing odd jobs .......................................................
 
1 
 
2 
 
3 
 
4 
 
5 
 
0  
going out for a day trip ..........................................
 
1 
 
2 
 
3 
 
4 
 
5 
 
0  
going to (birthday) parties .....................................
 
1 
 
2 
 
3 
 
4 
 
5 
 
0  
kissing and/or cuddling..........................................
 
1 
 
2 
 
3 
 
4 
 
5 
 
0  
dining out...............................................................
 
1 
 
2 
 
3 
 
4 
 
5 
 
0 
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Figure 1.  (continuation) 
 
 
4. EMPLOYMENT, DAILY DOMESTIC ACTIVITIES AND ILLNESS 
4a. Do you have a job (salaried employment, voluntary, in your own company)? yes no 
 
If yes: how many days a week do you usually work?  |__| day(s) 
during the past 3 months, how many days were you unable to work  
because respiratory complaints were bothering you too much? |__| __| day(s) 
 
4b. During the past 3 months, were you unable to perform your usual domestic activities or other activities at home on any day 
because respiratory complaints were bothering you too much? yes no 
 
If yes: how many days during the past 3 months? |__|__| day(s) 
 
Please complete this questionnaire until here.  
Your general practitioner will complete the rest! 
 
 At the end of the study GPs and patients were asked to give their views about the 
monitoring by means of a semi-structured questionnaire. 
 
Analysis 
Chi-square tests were used to analyse the bivariate associations between each item of 
quality of life and each reported GP intervention. Patient data from the quality of life 
questionnaire were dichotomised: yes/no one or more items scored ≥ 3 on a dimension, 
yes/no absenteeism of ≥ 5 days from work and yes/no 'absenteeism' ≥ 7 days from 
domestic duties. Relationships between patients' quality of life, GP interventions and 
patients' age, sex, type and severity of the disease and measured lung function were 
explored in bivariate analyses. As patients' age, sex and measured lung function were 
significantly related to patients' quality of life as well as to GP interventions, these 
independent variables and the quality of life variables were put into a multivariate logistic 
regression model to assess their relative influence on the reported GP interventions. 
 
Results 
Population 
A total of 175 patients were included, of whom 55% had COPD. Table 1 shows the 
characteristics of the participating patients and general practices. The mean age of the 14 
GPs was 41.1 years (range 31-48); five of them were women and the average length of 
practical experience was 9.5 years (range 1-19). 
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Table 1: Practice and patient characteristics 
 
General practices: 
n: 
GPs:  
single-handed/duo/group: 
urban/rural: 
 
6 
14 
2/2/2 
2/4 
 Patients: 
n: 
% male/female: 
mean age (years) (sd): 
mean % FEV1, predicted(sd): 
% reversibility FEV1 ≥ 9% predicted: 
 
175 
56/44 
54 (16.8) 
74 (20.1) 
45 
 
Quality of life 
Data were recorded in 537 regular follow-up consultations. In the study period, 31 patients 
had only one consultation, 59 had two or three, 46 had the recommended four 
consultations and 32 patients had more (mean 3.07, range 1-6). The mean percentage of 
complaints reported (at least one score of ≥ 3 on a quality of life dimension or of ≥ one 
week's absenteeism) ranged from 7% (not having been able to perform one's domestic 
duties for at least a week) to 54% (physical complaints). There was little variation in the 
percentages on the various dimensions of quality of life during the successive consultations 
(Table 2). 
 Emotional burden and social limitations were reported less often than physical problems 
with the disease. 
 
Table 2: Time order of regular check-up consultations and amount of self-reported complaints  
 
 Percentage of complaints (score of  3 or ≥ 1 weeks' absenteeism)  
Time order of 
consultations 
physical 
complaints 
emotional 
complaints 
physical 
limitations
social 
limitations
domestic 
absenteeism
absenteeism 
from work 
Total number of  
check-up consultations 
first 
second/third 
fourth-sixth 
54 
54 
52 
25 
23 
23 
43 
49 
51 
18 
19 
22 
 4 
 8 
11 
24 
26 
18 
175 
246 
116 
mean: 54 24 47 19  7 24# 537 
 #   24% of 189 consultations by employed patients  
 
Association between quality of life scores and GP interventions 
When taken independently of each other, various dimensions of quality of life information 
were related to several GP interventions (Table 3). Referral has been omitted from the 
table, because its frequency (n=7) was very low during the study period. As a last step in 
the analysis, the combined quality of life information was placed with confounders in a 
logistic regression analysis. In table 4, only those GP interventions are presented for which 
the multivariate model proved to be fit statistically and for which significant associations 
were found as well. All quality of life dimensions were significantly associated with one or 
more GP interventions, with the exception of 'absenteeism from work', 'inability to perform 
domestic duties' and physical limitations. 
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Report of physical complaints was related to changes in medication and to more education 
about the control regimen. Report of emotional complaints was associated with more 
counselling and extra follow-up appointments. Social limitations were positively related to 
counselling, but negatively related to education about the control regimen. Age of the 
patients proved to be strongly related to education: the older the patient, the less education 
given. 
 
Table 4: Associations between forwarded quality of life information, known patient characteristics, lung 
function of patients (n=175) and GP interventions during 537 consultations 
 
GP interventions  
(537 consultations) 
Associated variables Odds Ratio (95% CI)  
or estimate # 
Change of medication prescription (n=118) Physical complaints *  1.70 (1.03-2.82) 
Extra follow-up (n=21) Social limitations * 
Emotional burden ** 
Fev1 at inclusion * 
 0.09 (0.01-0.72) 
 4.39 (1.50-12.85) 
-0.0236 
Education: character disease  (n=32) Age (in years) *** -0.0469 
Education: control regimen (n=83) Physical complaints * 
Social limitations * 
Emotional burden* 
Age (in years) *** 
 1.89 (1.07-3.33) 
 0.32 (0.12-0.82) 
 0.39 (0.18-0.88) 
-0.0298 
Education: other (n=25) Age (in years) *** -0.0528 
Counselling: physical condition (n=109) Social limitations *  1.87 (1.03-3.38) 
Counselling: emotional condition (n=48) Physical complaints ** 
Emotional burden ***  
 0.34 (0.15-0.77) 
 7.33 (2.93-18.33) 
logistic regressions (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) 
# estimates are presented in case of continuous variables 
 
GPs' and patients' opinions about the procedure 
In the semi-structured questionnaires, all the GPs mentioned that they had welcomed the 
information about physical limitations; the large majority (11) had found the information 
about physical complaints useful and more than half of them were positive about the other 
information. The patients had greatly appreciated the personal monitoring: 92-96% of the 
repondents (n=122) mentioned that they had enjoyed completing the quality of life 
questionnaire, that it had cost little time and that they were prepared to continue doing so 
in the future. The majority of the respondents (68%) felt that the GPs would receive more 
information using this approach. 
 
Discussion 
Quality of life information proved to be easy to collect using a self-report questionnaire 
and the patients felt positive about the procedure. This study also demonstrated an 
association between quality of life information, presented by patients during consultation, 
and subsequent GP interventions. 
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 The goals of treatment for chronic disease are to diminish the burden on the patient and 
to prevent or slow down disease progression. It has been recommended that periodical 
assessments of patients' quality of life be performed as part of comprehensive care16. 
However, no 'state of the art' method has been developed yet, nor has the effectiveness of 
various methods been examined fully. Our findings are in line with those of Bertakis19, but 
contrary to those of other studies20-23. In the latter studies, however, the completed health 
questionnaires were not handed over during consultation, but attached to patients' charts 
beforehand. In our cross-sectional explorative study, in which asthma and COPD can be 
considered representative for other chronic diseases, the procedure of completing disease-
specific self-report questionnaires and handing them over during routine consultations, 
proved to be feasible. This result should be interpreted with caution: as our study was 
performed on patients most of whom already participated in a regular monitoring system, 
the results might be biased by their high compliance attitude. 
 Furthermore, the results support the hypothesis that the chosen procedure of real-time 
patient-provided assessment of quality of life can draw the physician's attention to patients' 
needs and can stimulate tailored interventions. The results of a recent pilot study point in 
the same direction: disease-specific health information, gathered from 18 patients with 
cancer and handed over to the physician during consultation, increased discussions about 
quality of life topics24. However, a controlled randomized study design will be needed to 
find out whether this type of quality of life monitoring does indeed influence medical 
decision making. The reliability of the results could be enhanced by using other techniques 
for data gathering instead of self-recording by GPs, for instance by applying observational 
methods. If it can be demonstrated that periodic assessment of quality of life influences 
medical behaviour, then a study of its impact on the outcomes of care would be justified.  
 The majority of GPs were positive about the contents of the questionnaire and its 
usefulness. However, they were reluctant to continue this personal monitoring procedure 
after the experiment. This is in line with the results of other studies, which have shown 
barriers against implementing changes that physicians otherwise consider to be 
worthwhile25,26. Further improvement of the procedure and greater user-friendliness, for 
example reducing the number of questions and integrating the answers into the electronic 
patient record, might overcome the barriers for broader implementation during routine care 
3,10,11,27-31. 
 At present, it is an important finding that medical practitioners' interventions are related 
to a patient's personal status as well as to the disease status. This creates the opportunity to 
stimulate tailoring of medical care to individual needs, which is currently seen as a black 
box of clinical effectiveness6,32. 
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Abstract 
Objective 
The objective of this study was to assess the effects of routine monitoring of health-related 
quality of life of patients with asthma or COPD during normal primary care. 
Methods 
Design: a multicentered controlled trial with random allocation of general practices. 
Setting: 12 general practices (n=27 general practitioners) using a monitoring and feedback 
system on clinical outcomes and process of care. Subjects: 309 patients with asthma or 
COPD aged ≥18. Excluded were patients being treated by a chest physician or having 
serious physical or psychosocial disabilities. Intervention: addition of a short disease-
specific quality of life questionnaire to the monitoring routine during follow-up visits. The 
patient questionnaire was completed just before the visit and given to the general 
practitioner. Practices received graphic presentation of patient scores and lists of patients 
with impaired or deteriorating quality of life. Outcome measures: quality of life (QoL-RIQ 
and MOS-SF 36), patient-reported exacerbations, absenteeism from work or domestic 
duties, FEV1  % predicted, smoking status, satisfaction with care and education. 
Results 
After a year patients had had on average 2.49 (intervention) and 2.52 (control) follow-up 
visits. Of the 154 patients in the intervention group, 54 reported at least once an impaired 
quality of life on a dimension of the questionnaire. No significant influence of the 
intervention on patient outcomes was found. 
Conclusions  
A successful integration of real-time quality of life monitoring in routine primary care does 
not, on its own, lead to improved patient outcomes. More attention should be paid to the 
impact on patient-doctor interaction and medical decision-making.  
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Introduction 
The main treatment goals for patients with mild to moderate chronic respiratory diseases as 
outlined in international guidelines are to minimize symptoms, optimize lung function, 
reduce drug dependence and side effects, and preserve or improve functional status and 
quality of life1-3. Medical care is traditionally more directed at physical signs and 
symptoms than at problems in health-related quality of life (qol) of chronic patients. 
During regular follow-up visits various physical outcomes are usually assessed, but the 
issue of patient-perceived qol receives less attention4,5. However, perceived health and 
coping with the disease are relatively independent factors in the treatment process, 
influencing the outcomes of medical interventions6,7. Health-related qol in patients with 
asthma or chronic obstructive pulmonary disease (COPD) cannot be directly deduced from 
symptoms or lung function8-10, nor can physicians rely upon their own assessments about 
patients' qol11-17. Gathering information on qol might help the physicians to tailor their 
interventions to patients' needs and preferences. From this can be hypothesized that 
regular, systematic assessment of patients' qol may provide important information for 
(family) physicians in modifying their follow-up interventions in patients with COPD. 
 Research until now on gathering information on patients' qol concerned feedback of 
patient reports to physicians or addition of previously gathered data to medical records18-22, 
23,24. Some studies in outpatient oncology clinics were aimed at integration of real-time 
patient-perceived quality of life information during visits25-27. However, in these studies the 
circumstances of care were changed due to the research, making it impossible to attribute 
changes in performance to the monitoring of qol. In addition, these studies involved only 
small numbers and included selected patients. As we were interested in the effects of qol 
monitoring during regular primary care and directed at all patients under treatment, we 
integrated real-time quality of life assesment in routine follow-up visits of patients with 
asthma and COPD. We investigated to what extent qol monitoring improved outcome of 
care. 
 
Methods 
Design 
A one-year cluster-randomised controlled trial involving a total of 12 general practices was 
undertaken. The intervention condition consisted of the standardised monitoring by the 
general practitioner (GP) of health-related qol, during regular follow-up visits in addition 
to usual respiratory signs and symptoms patients perceived. The control condition 
consisted of  the usual respiratory signs and symptoms monitoring (see Box). Practices 
were stratified on practice size, location (urban or rural) and form (single-handed, pair or 
group) and randomly allocated to the intervention or control condition. Each practice 
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recruited its own patients and asked for their written informed consent. The study protocol 
was approved of by a medical ethics committee. Patients were included if they had: 
•  a physician diagnosis of asthma or COPD,  
• were 18 years or older, 
• currently using medication for chronic respiratory complaints (i.e. bronchodilators or 
anti-inflammatory medication) 
• and/or had a Forced Expiratory Volume in 1 second (FEV1) below normal minus 1.64 x 
the standard deviation (sd) of the predicted value  
• and/or had a day-night variability of lung function that is greater than 15%. 
Patients currently under the treatment of a chest physician were excluded from the study as 
well as patients with serious physical or psychosocial disabilities, making them unfit to 
participate in the research project. A multilevel power calculation assuming a mean of 50 
and a sd of 10 in the scores on the MOS-SF 36 (α 5%, β 80%, ICC 0.05) showed 225 
patients to be needed to demonstrate a clinical relevant difference of 0.5.  
 
Box A monitoring and feedback system for asthma and COPD 
A group of twelve academic general practices used a system for continuous monitoring for patients with 
asthma or COPD and received physician feedback with regard to such. Use of the monitoring and feedback 
system was assumed to focus the attention of the GPs on key features of the treatment process and 
treatment outcomes as derived from the national evidence-based guidelines. The basic monitoring routine for 
asthma and COPD involved the following elements: 
• four follow-up visits a year; 
• during or after each follow-up visit, completion of a registration form by the physician with 
information on the patient's measured lung function (FEV1), medication, smoking cessation advice, 
relevant referrals, and follow-up appointments. The registration forms were then returned to the 
research unit 
• provision of physician feedback three times a year with respect to follow-up frequency of patients, 
strong declines in lung function, not having given a smoking cessation advice for patients who were 
still smoking and prescription of bronchodilators at least twice daily without the prescription of anti-
inflammatory drugs. In addition, the results of aggregated comparisons to other practices using the 
monitoring system and lists of  patients concerned were also sent to the practices. 
One year after implementation of the basic registration system, the majority of the patients were found to 
have a relatively stable physical condition and to be regularly monitored28. 
The system was mainly professional-driven: quality improvement was based on recordings of professional 
performance and clinical findings. The present refinement of the monitoring system is aimed at the 
incorporation of patient-perceived quality of life into the monitoring system to make it more sensitive to 
patients' needs and preferences.  
 
Intervention 
The one-year intervention consisted of the use of a short disease-specific qol questionnaire, 
completed by the patients before entering the consulting room and handed over to the GP29. 
The questionnaire was composed of 27 items derived from the already validated 55-item 
Quality of Life for Respiratory Illness Questionnaire (QoL-RIQ)30,31. Questions addressed 
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four dimensions of qol: experienced physical symptoms, emotional complaints, physical and 
social limitations. The questions are responded to along a four (symptoms and complaints) or 
five-point (limitations) Likert scale (1 = not troubled at all; 2 = a little troubled; 3 = pretty or 
considerably troubled; 4 = much or very much troubled by the disease and 5 = not been able 
to do). Two questions regarding the number of days absent from work and from domestic 
duties were added to the questionnaire. The GPs were instructed to pay particular attention to 
those items with a patient score of three or higher and to absenteeism of a week or more. The 
completed patient qol questionnaires were returned —in addition to the basic physician 
consultation registration forms— to our research unit. Above the standard feedback to the 
general practitioners with regard to the registration forms, the physicians in the intervention 
group were also given patient qol feedback (i.e., a graphic representation of successive patient 
scores for the four dimensions of the qol questionnaire and lists of patients with identified qol 
problems). 
 
Outcome measures 
At the start of the study and within six weeks after its completion the following measures 
were collected:  
− Qol as measured by the 55-item disease-specific QoL-RIQ, shaped in 7 or 8-point Likert 
scales ranging from "no bother at all" (=1) to "not having been able to do so because of 
the disease" (=8). 
− Qol as measured by the generic MOS-SF 36. 
− Absenteeism due to illness from work or domestic duties: two questions about the 
number of days during the past three months. 
− Lung function, i.e. FEV1 in % of predicted value: the best value from three forced 
expiratory maneuvers measured by the Micro-Spiro Plus after a period of at least eight 
hours without bronchodilation. 
− Smoking behaviour: a prestructured yes/no-question concerned with actual smoking. 
− Satisfaction with care: six questions responded to along a six-point Likert scale ranging 
from poor (=1) to excellent (=6) care provision.  
− Satisfaction with patient education: four questions regarding patient needs for 
information rated along the same six-point Likert scale. 
 
Analysis 
Two-sided T-tests and Chi-squares tests were used to test for initial differences between 
the intervention and the control groups. For the effect analyses T-tests, Chi-square tests, 
multi-level logistic regression analyses and multi-level linear regression analyses (MIXED 
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procedure from the SAS-package) were performed. The latter two sets of analyses were 
performed at the level of the patient while taking the level of physicians into account. The 
multilevel logistic regression analyses were performed on the dichotomous variables 
concerning present smoking status, having had exacerbations in the past three months, ≥ a 
week's absenteeism from domestic duties and ≥ a week's absenteeism from work. The 
multi-level linear regression analyses were performed on the pre-post differences for all of 
the continuous variables: % FEV1 predicted, satisfaction with care and patient education, 
qol as measured by the QoL-RIQ and the MOS-SF 36. Subanalyses were performed with 
respect to potentially modifying factors: impaired or not impaired qol at baseline (mean 
sumscore < 3.5 and ≥ 3.5 on QoL-RIQ); presence of comorbidy; and frequency of the 
follow-up practice visits. 
 
Results 
Practices 
The group of six intervention practices (n=14 general practitioners) was evenly distributed 
across the categories of practice form (i.e., single-handed, pair or group) while the group of 
control practices (n=13 general practitioners) involved one single-handed, three pair and 
two group practices. With regard to the other stratification aspects both groups were 
similar. The intervention group contained more female GPs (4 vs 1) and its GPs had three 
years less practice experience on average than the GPs in the control group (10 vs 13 
years). 
 
Patient population 
At pretest, 389 patients were included by the practices: 200 in the intervention group and 
189 in the control group. Posttest measurement was subsequently obtained for 309 patients 
(79.4%), 154 patients in the intervention and 155 in the control group. The reasons for 
drop-out of the monitoring system were: death (1x), change of practice (3x), referral to a 
specialist (2x), (other) serious illness (8x), agreement between GP and patient to reduce 
frequency of follow-up visits (24x) and non-compliance with follow-up visits (8x). Of the 
remaining patients 34 did not send back the posttest questionnaire. The characteristics of 
the 80 drop-out patients did not differ significantly from those who stayed in the 
monitoring system. The lung function and symptom scores for our population of patients 
are characteristic for a primary care population with a mild to moderate respiratory 
disease.28 
 The intervention and control groups differed significantly with respect to the sex of the 
patients, level of education, and asthma/COPD distributions. In the multivariate analyses 
we adjusted for these differences. At baseline, no significant differences with respect to the 
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outcome measures existed between the groups. Finally, compared to the rest of the 
population, the subgroup of 17 patients who reported an impaired qol at baseline (QOL-
RIQ ≥ 3.5) contained more lower educated smoking patients reporting more serious 
symptoms (see Table 1). 
 
Overwiew of qol monitoring  
The 309 patients had on average 2.5 follow-up visits after their inclusion in the monitoring 
system. This was a mean of 2.49 for the intervention group and 2.52 for the control group. 
 Of the 154 patients in the intervention group, 54 reported an impaired qol for one or 
more dimensions of the monitoring questionnaire during at least one follow-up visit. 
During the intervention period, the intervention practices were given feedback with regard 
to their patients' qol on three occasions.  
 
Table 1: Patient characteristics at baseline and for subpopulations with impaired (QoL-RIQ ≥ 3.5) or not 
impaired (QoL-RIQ < 3.5) quality of life  
 
 Intervention 
(n=154) 
Control 
(n=155) 
Impaired qol 
(n=17) 
Not impaired qol
(n=292) 
mean age 52.5 (sd 16.4) 52.9 (sd 15.0) 56.4 (sd 14.8) 52.1 (sd 15.6) 
% male 56.5 43.2 * 52.9 50.9 
% education level (low/middle/high) 46/47/7 65/28/7 ** 87/13/0 52/40/8 * 
% having a job 38.4 39 35.3 45.6 
%  smoking 35.7 32.9 53 32.8 
FEV1 % predicted 74.7 (sd 20.5) 76.5 (sd 21.7) 71.8 (sd 18.8) 75.5 (sd 21.1) 
% having COPD 35.2 52.6 ** 64.7 41.2 
years duration of symptoms 15.4 (sd 16.2) 18.1 (sd 16.2) 20.9 (sd 18.2) 16.3 (sd 15.9) 
symptom severity (mean sumscore 
MRCQ, R 1-8) 
  3.5 (sd 1.9)   3.3 (sd 2.0)  5.2 (sd 1.3)   3.4 (sd 1.9) *** 
*  Chi-square p< 0.05 
**  Chi-square p< 0.005 
***  T p< 0.001 
 
Effects of the intervention 
The results with respect to the outcome measurements are presented in Table 2. The 
regression results showed no significant influence of the intervention, although the figures 
for absenteeism in the intervention group had increased. The mixed multilevel regression 
analyses on subpopulations having a lower qol or a comorbid condition at baseline, or 
having a low frequency of follow-up visits (≤ 2) during the intervention period also 
showed no significant differences with the exception of absenteeism. In these specific 
subgroups we observed more absenteeism from work in the intervention group compared 
to the control group.   
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Table 2: Outcomes of patients after one year of quality of life monitoring 
 
 intervention group 
(n=154) 
control group 
(n=155) 
 Before (sd) After (sd) Before (sd) After (sd) 
mean FEV1 % predicted value 74.7 (20.5) 73.9 (21.1) 76.5 (21.7) 76.8 (22.0) 
% having had exacerbation past 3 months 21.3 19.5 21.5 21.2 
% smoking 35.7 32.6 32.9 31.0 
mean sumscore satisfaction about care (R 1-6)   3.90 (1.2)   3.64 (1.2)   3.92 (1.3)   3.68 (1.2) 
mean sumscore satisfaction about education (R1-6)   3.56 (1.2)   3.48 (1.3)   3.61 (1.4)   3.48 (1.3) 
mean sumscore on QoL-RIQ (R 1-7)   2.03 (0.8)   2.08 (0.8)   2.06 (1.0)   2.12 (0.9) 
mean score MOS-SF 36 physical component 46.3 (9.6) 45.5 (10.0) 47.0 (9.4) 46.2 (9.2) 
mean score MOS-SF 36 mental component 50.7 (10.2) 49.6 (11.7) 50.1 (9.8) 50.3 (11.0) 
% ≥ 5 days absenteeism from work during past 
three months (only patients with job) 
  8.8 19.4   8.8   5.5 
% ≥ 7 days absenteeism from domestic duties past 
3 months 
  6.7 17.6   3.4   8.6 
 
 The results for the patients with an impaired qol at baseline (QoL-RIQ ≥ 3.5) are 
presented in Table 3. Given the low numbers of subjects, no further statistical analyses 
were performed. Visual inspection of the results, however, shows a decrease in patient-
reported exacerbations and an increase in absenteeism for the intervention group. 
 
Table 3: Outcomes of  subset of  patients with impaired quality of life at baseline (QOL-RIQ ≥ 3.5) 
 
 intervention group 
(n=6) 
control group 
(n=11) 
 Before (sd) After (sd) Before (sd) After (sd) 
mean  FEV1 % predicted value 71.6 (15.3) 68.6 (16.3) 72.0 (21.2) 70.7 (13.8) 
% having had exacerbation past 3 months 66.7 16.7 54.6 45.5 
% smoking 66.7 50 45.5 40 
mean sumscore satisfaction about care (R 1-6)   4.3  (1.2)   4.0 (0.7)   3.7 (1.6)   3.2 (1.4) 
mean sumscore satisfaction about education (R1-6)   3.9 (1.5)   4.4 (0.6)   3.4 (1.5)   3.0 (1.2) 
mean sumscore on QoL-RIQ (R 1-7)   4.2 (0.6)   3.5 (0.7)   4.4 (1.0)   3.6 (1.1) 
mean score MOS-SF 36 physical component 30.0 (9.6) 32.9 (9.6) 36.1 (7.3) 35.1 (6.0) 
mean score MOS-SF 36 mental component 40.9 (15.4) 35.8 (3.5) 38.5 (12.2) 44.2 (12.3) 
% ≥ 5 days absenteeism from work during past 
three months (only patients with job) 
50  100   0   0 
% ≥ 7 days absenteeism from domestic duties past 
3 months 
33.3 75 18.2 14.3 
 
Discussion 
In the present study, we successfully integrated real-time standardised qol measurements as 
a novelty into routine follow-up visits of patients with asthma and COPD. After a year of 
such monitoring, no significant effects were found in terms of generic or disease-specific 
qol, exacerbations, lung function, smoking status or satisfaction with care. The finding of a 
tendency of increased absenteeism in the intervention condition should be interpreted with 
caution as so few patients were involved. Various explanations could be offered for the 
observed increase: e.g. increased awareness of disease burden as a consequence of qol-
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monitoring or the provision of more or different life-style recommendations by the general 
practitioner. Further investigation is needed to explain this outcome. 
 Our results are nevertheless in line with those of other controlled experiments18,19,22,32 
and they give rise to some considerations concerning the methodology of the study and the 
intervention used. 
 
Methodological considerations 
Tot start with, not all of the selected outcome measures can be expected to be highly 
susceptible to change as a result of the intervention. For instance, a change in lung function 
is difficult to achieve in such a short period of study and smoking cessation mostly requires 
intensive counseling. Nevertheless, on the basis of reviews concerned with patient-
centredness33 and interventions aimed to modify the interaction between patients and 
practitioners34, we had expected some positive influence on the other outcome measures 
such as qol and satisfaction with care. Perhaps the inclusion of other parameters, such as 
measures of coping and self-efficacy, could have provided greater insight into the efficacy 
of routine qol monitoring. 
 Second, it is possible that a number of ceiling effects occurred as a result of the 
generally high quality of the care delivered in the participating practices using the regular 
monitoring and feedback system (see Box). The patients in both groups were found to be 
highly satisfied with their care at baseline and most of them did not show much qol 
impairment. Moreover, the patients were not newly diagnosed but had already coped with 
their disease for a long time.  
 Third, the medical intervention during a follow-up practice visit is just one of many 
factors possibly influencing a patient's health-related qol and the other measures 
considered here. Patients' functioning and well-being is not identical to medical outcome35; 
the relative influence of a doctor's interference with outpatients with mild to moderate 
chronic asthma and particularly COPD should not be overestimated. 
 
Considerations concerning the intervention 
In our experiment we evaluated the link between qol assessment during general practice 
visits and patient outcomes. Questions to be raised here are: was the intervention fit for the 
purposes set and carried out well and how did the physicians react to the extra information 
they received? 
 Among others, Nelson formulated the main prerequisites for a good clinical screening or 
monitoring instrument. Apart from good psychometric properties he underlined the 
importance of brevity, ease of administration, ease of scoring and simplicity of 
interpretation36. Wasson emphasised the necessity of integration into the "complex 
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ecosystem in a practice"37 and Deyo38 and Curtis9 additionally mentioned the need to 
educate health care professionals about the mehods and interpretion of health status 
assessment. In our opinion, the qol assessment instrument and the procedure we used 
fullfilled those demands although further improvement has been worked on in the form of 
further shortening the instrument and integration in the electronic patient record39. 
 For standardised needs assessment and/or monitoring to have an impact on patient 
outcomes, it must presumably influence such intermediary factors as physician awareness 
of patient's health status, the patient-doctor interaction, medical decision-making, and 
medical action. The literature on this topic shows conflicting results: Street21 found little 
evidence of health status data influencing the physicians' behaviour while Velikova27 found 
that qol data influenced the discussion of certain topics during practice visits. In a review 
of 35 trials, Griffin34 found mixed but promising results for interventions involving the 
activation of physicians via preconsultation notes or patient questionnaires. Our research 
methodology does not allow us to draw conclusions with regard to the effects of the 
intervention on patient-doctor interactions. However, in line with the results of Bertakis40, 
the cross-sectional analyses of our data revealed a significant association between the qol 
information provided by the patients and the medical actions undertaken by the physicians 
in the form of a changed prescription of medication, the provision of patient education, 
and/or counseling29. The intervention seems to have influenced the consultation process 
itself. 
 Rubenstein's 1989 observation that more powerful interventions than the provision of 
information and the education of physicians are needed to influence a patient's functional 
status still holds today18. As Meadows already found41, general practitioners are not 
unwilling to incorporate health-related qol measures in routine patient management. This 
attitude will only be lip service42, unless the physician's awareness of patient-perceived 
health status is raised and subsequently medical behaviour is attuned to the needs and 
preferences of the patient. Considering the frequently observed discrepancy between 
patient-perceived qol and the physician's knowledge or awareness of patients' well-being 
4,13, methods to stimulate patient-centeredness and to objectivate the assessment of qol and 
needs as part of the history-taking process are warranted43. To determine whether the use 
of a short monitoring questionnaire can foster a change in the routine care process, more 
indepth study methods using observations and interviews are needed. The effectiveness of 
such patient-driven and presumably more reliable history-taking has yet to be demonstrated 
adequately.  
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Abstract 
Background 
Guidelines recommend monitoring of patients with asthma and COPD. Record-keeping 
and feedback on key-parameters may improve patient care.  
Aim 
To implement a patient-tailored computerised monitoring- and feedback system and to 
evaluate its effects on patient outcomes. 
Design and study setting 
A cluster-randomised controlled trial in 24 general practices. During two years the 
intervention group received a pre-structured monitoring system attached to the electronic 
patient record, disease-specific questionnaires to monitor quality of life and six times 
feedback on process and disease indicators. The control group continued usual care.  
Methods 
Process measures were the number of practice visits and parameter recordings. Outcome 
measures were symptoms, quality of life, smoking status and satisfaction with care. 
Intention to treat analysis used multilevel linear or logistic regression.  
Results 
The intervention practices recorded 1557 visits. In the intervention condition the mean 
number of follow-up visits increased from 0.6 to 1.2 a year, whereas it decreased in the 
control condition from 0.7 to 0.5 (T 9.99, p < 0.001). The number of exacerbation visits 
decreased in both conditions. Intervention patients (n=215) were more satisfied with care 
and education than patients receiving usual care (n=249). No other effects on patient 
outcomes were found, although in the intervention condition smoking and respiratory 
symptoms tended to decrease and absenteeism from domestic duties tended to increase.  
Conclusion 
A patient-tailored computerised monitoring and feedback system for asthma and COPD 
improves compliance with follow-up and enhances patients' satisfaction. The mixed 
influence on other patient outcomes raises questions about follow-up recommendations in 
guidelines. 
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Introduction 
The majority of patients with asthma and COPD are treated and controlled in primary care. 
In recent years different guidelines were published outlining optimal asthma and COPD-
management1-5, including a variety of recommendations for regular follow-up. Literature 
shows that physicians do not always adhere to all recommendations of guidelines5-7. 
Physicians experience difficulties in adapting their personal performance, partly due to the 
complexity of the respiratory diseases and subsequent guideline recommendations for 
diagnosis and disease management8. For that reason different methods to support 
physicians' adherence to guidelines and to improve the quality of care for chronic patients 
have been tested. Support methods can be aimed at professionals, at patients, at the 
organisation of care or at financial or (juridical) regulations. Reviews have shown that 
computerised decision support was mostly effective9,10. Professional-tailored interventions 
using guidelines-based devices for the individual monitoring of chronic patients and 
feedback of the results to the general practitioners (GPs) were often effective on care 
process and had mixed effects on patient outcomes9,11-13. Pre-structured monitoring of 
patients' quality of life during follow-up visits may direct GPs' attention to patient-
percieved health status and coping with the disease15,16. Patient-mediated interventions 
showed mixed effects and multifaceted interventions combining single effective 
interventions may or may not raise the quality of care9,16,17. To support GPs' adherence to 
central issues in the treatment guidelines we developed a multifaceted intervention 
integrating professional and patient perspectives. As computerised decision support was 
often effective we put this in the centre of a guidelines-based monitoring and feedback 
system for the management of asthma and COPD in general practice. The system was 
tailored at individual patients by including needs assessment procedures. By linking the 
system to the GPs' electronic medical records it provided a monitoring device for real time 
use during practice visits as well as a method to gain systematic insight in actual individual 
patients' needs. The aim of our study was to investigate whether the implementation of this 
multifaceted support method raised the quality of care and improved patient outcomes. 
 
Methods 
Design 
We performed a cluster randomised controlled trial in 24 general practices in the eastern 
regions of The Netherlands. The level of randomisation was the practice to forestall spill-
over of the intervention to the controls, while the effects were analysed on patient level.  
 To standardise basic conditions for spirometry all practices received a hand-held 
spirometer (MicroSpiro Plus) and a user-training. Baseline and post measurements took 
place in the same season with an interval of two years. Patient data at baseline and post 
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intervention were gathered by independent trained research assistants at the practice 
location. 
 
Inclusion and allocation 
The practices were recruited by a mailing amongst the users of a specific general practice 
record system (ProMedico). Practices, equally fit for participation, were included in order 
of the speed of their computer which was tested by a telephone query using a stopwatch. 
The top 24 practices were stratified on practice size, form (single-handed, duo, group), 
urban or rural location and the current level of care for asthma and COPD and two 
comparable groups were randomly allocated to the intervention or control condition. For 
the level of care a score was constructed, containing the positive answers on six questions: 
use of a spirometer in the practice, having separate surgery hours for asthma and COPD 
and a regimen of 3-monthly control visits, having made regional arrangements with 
respiratory nurses or chest physicians and performance of periodic checks on inhalation 
technique.  
 In total 225 patients would be needed to demonstrate a clinical relevant difference of 5 
on one of the primary outcome measures (MOS-SF 36), assuming a mean of 50 and a sd of 
10 in the scores on the MOS-SF 36 (α 5%, β 80%, ICC 0.05, multilevel power 
calculation). Recruitment of patients was based on prescriptions for asthma and COPD in 
the previous year. Criteria were: age ≥ 18, having been prescribed a bronchodilator at least 
three times or anti-inflammatory medication at least twice in the past year. The patients' 
own GPs were asked to confirm the diagnosis of asthma or COPD and to judge the 
capability to participate in the study. Exclusion grounds were: under control by a chest 
physician, serious active physical comorbidity, a serious psychosocial condition or mental 
incapacity to complete a questionnaire and insufficient command of the Dutch language. 
The selection of practice patients was stratified into groups younger and older than 50 
years of age and random samples per practice were taken, with numbers related to national 
prevalence figures and practice size. Recruited patients were invited to participate, to give 
their written informed consent and to visit the practice for the baseline measurement.  
 The study was approved of by the regional medical ethical committee Dekkerswald. 
 
Intervention 
The intervention group (I) received a patient-tailored computerised monitoring and 
feedback system whereas the control group (C) continued usual care delivery. The 
intervention took two years and consisted of the delivery of monitoring software attached 
to the EMR and short quality of life questionnaires to be completed by the patients just 
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before a practice visit. Periodically aggregated feedback on performance and on individual 
patients was given (for details see Box 1).  
 
Box 1. The intervention: a patient-tailored computerised monitoring and feedback system  
Practices were asked to perform patient follow-up visits according to the recommendation in the guidelines 
for the treatment of asthma and COPD. To support guideline adherence a computerised system for the 
management of asthma and COPD combining professional and patient-tailored elements was delivered. The 
system concentrated on the preparation, proceedings and follow-up of practice visits.  
Preparation of a practice visit 
Pre-structured disease-specific questionnaires on quality of life were administered to the patients. They 
were instructed to complete the questionnaire at home or in the waiting room and to hand it over to the 
general practitioner or nurse assistant to be recorded in the monitoring system just before or during a 
practice visit. The questionnaire contained 27 items, divided into five dimensions of quality of life: physical 
complaints, emotional complaints, physical and social limitations and absenteeism (at home or at work) due to 
the disease. A statistical and content validation procedure on data of 1050 patients had been applied to derive 
a 25-item short version from a validated 55-item disease-specific questionnaire (QoL-RIQ)18. On request of a  
panel of GPs two items about absenteeism from work and domestic duties were added to this short 
questionnaire. The answering categories on the first 25 items formed a four or 5 point Likert scale (1 = not 
troubled at all; 2 = a little troubled; 3 = pretty or considerably troubled; 4 = much or very much troubled by 
the disease; 5 = unable to do so). The GPs were instructed that the scores ≥ 3 might "signal" a problem with 
patients' quality of life. The number of scores ≥ 3 per quality of life dimension and the number of days with 
absenteeism could be recorded in the system. The recordings of quality of life scores as well as the 
recordings of other parameters ( e.g. lung function) were summarised in partly graphical historic overviews 
by the record system which could be viewed before or during the practice visit.   
Proceedings during practice visits 
A monitoring application focussing on key elements derived from guidelines for the diagnosis and 
treatment of asthma and COPD was added to the normal EMR (see Figure 2). It contained three screens 
(history taking, diagnosis, treatment). In two former studies paper prototypes of the contents were tested on 
relevancy and applicability13,14. Software prototypes were tested on transparency and applicability in two 
practices. The large majority of answers could be noted down in pre-structured answering categories. A 
manual and a one hour introduction at the location of the practice after installment of the application was 
part of the intervention. 
The follow-up of practice visits 
Recordings in the system were periodically sent to a support agency which transformed the data in written 
feedback which was supplied to the practices three times a year. It contained figures on the practice level as 
well as lists of invidual patients concerned (see Figure 3 presenting combined data of all intervention 
practices).  
 
Variables and instruments 
We used physical measurements (spirometry), structured patient questionnaires and 
content analysis of the EMR and monitoring records. 
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Figure 2: Monitoring screens attached to the EMR 
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Patient outcome measures 
a) health status 
− Disease-specific quality of life (qol), measured by the 55-item Quality of Life-
Respiratory Index Questionnaire (QoL-RIQ) using 7 or 8-point Likert scales ranging 
from "no bother at all" (=1) to "not having been able to do so because of the disease" (= 8) 
18. 
− Generic qol, measured by the MOS-SF 36. 
− Patient-reported exacerbations during the past three months. An exacerbation was 
defined as an episode of more than three days with an increase of at least three of the 
five following indicators: phlegm, cough, dyspnoea, wheezing and use of 
bronchodilators (dichotomous yes/no answering categories) . 
− Degree of dyspnoea, derived from the MRC-symptoms questionnaire 19 (0 = no 
dyspnoea, 1 = dyspnoea when in a hurry, 2 = when walking with others on flat ground,  
3 = having to stop for breathlessness or worse). 
− Presence of chronic cough (yes/no) and chronic phlegm (yes/no).  
− Lung function: the best result of three forced expirations measuring FEV1 in % of 
predicted value, measured by the Micro-Spiro Plus after a period of at least eight hours 
without bronchodilation.  
− Reversibility: difference in FEV1 pre and post bronchodilation (15-20 minutes after 
inhalation of 400 mcg salbutamol). 
− Absenteeism from work or domestic duties because of illness: number of days during 
the past three months. 
b) Smoking status: yes/no actual smoking. 
c) Patient satisfaction 
− with care: six questions responded to along a six-point Likert scale ranging from poor 
(=1) to excellent (=6). 
− with education: four questions regarding patients' needs for information rated along the 
same six-point scale. 
 
Patient characteristics: age, gender, level of education, being employed. 
Process measures:  
− Number of regular follow-up visits and visits because of exacerbations. Content analysis 
of the EMR using a query containing keywords regarding symptoms, physical 
examination, diagnosis and prescriptions. 
− Number and contents of parameter recordings in the monitoring system. 
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Statistics 
Analysis was performed on an intention to treat basis including all patients who had a 
baseline measurement by calculating the means of the response groups concerned. Changes 
within groups were analysed with McNemar and paired T-tests. Baseline differences 
between I en C were tested with unpaired T-tests, Mann-Whitney U tests and Chi-square 
tests. For effect analyses we used multivariate multilevel linear or logistic regression, 
including confounders as covariates. The models also accounted for repeated 
measurements (SAS Proc Mixed and Glimmix). Explorative subgroup analyses were 
performed for the group of patients presenting an impaired quality of life (QoL-RIQ ≥ 3.5 
and/or presenting relatively more symptoms (MRCQ sumscore > 3) at baseline, who had 
actually been monitored ≥ 3 times a year. Two other subgroup analyses were performed on 
patients having COPD (FEV1 pb < 80% and reversibility < 9% predicted) and those having 
asthma or a mixed syndrom. The SAS statistical software package (SAS Institute Inc., 
Release V8.2) was used.  
 
Results 
Response  
For inclusion and response of practices and patients see the study profile in Figure 1. In 
Table 1 the characteristics of practices and patients are presented.  
 Of 597 patients a baseline measurement could be obtained. The patient characteristics 
did not differ significantly between I and C. Baseline difference in satisfaction with 
provided care and information was corrected for in the analyses. The post measurement 
was completed by 464 patients (77.7%), 215 in I en 249 in C. The mean period between 
pre and post measurement in I and C was 23.5 (sd 0.89) and 23.7 (sd 1.43) months 
respectively.  
 
Table 1: Baseline characteristics of general practices and patients 
 
 Intervention group Control group 
practices n=10 n=12 
number of GPs 16 19 
urban location 3  3  
practice form: single-handed/duo/group 4/5/1 6/5/1 
treatment quality score: ≥ 3 3 3  
regional dispersal: north/middle/south   1/9/0  4/7/1 
practice size > 3000 patients 5 4  
   
patients  n=286 n=311 
mean age (sd) 50.8 (16.9) 52.8 (18) 
% male 52.1 54.2 
education level: % high/middle/low 15/33/52 9/40/51 
% being employed  49.8 41.2 
% having COPD 32.9 38.2 
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Figure 1: Study profile 
 
Recruitment letters to 294 general practices 
 
60 practices interested 
38 practices fit for inclusion and ranked to computer speed 
 
top 24 stratified in 2 groups according to practice form, location and level of care for asthma and COPD 
(quality score <3 or ≥ 3). Random allocation of groups to intervention or control condition 
 
Intervention (monitoring and feedback) 
12 general practices 
 Control (usual care) 
12 general practices 
 
 
2 practices dropped out  
due to illness of GPs and lack of time 
   
 
 
Stratified selection of patients with 
asthma or COPD. 
Number of patients selected: 
310 
 Stratified selection of patients  
with asthma or COPD. 
Number of patients selected: 
366 
 
 
Patients consenting and 
having a baseline measurement: 
286 
 Patients consenting and 
having a baseline measurement: 
311 
 
 
Intervention 
Use of comupterised monitoring system attached to 
EMR + needs assessment forms + 6 x feedback on 
process and patient parameters. 
Patients actual recorded in the monitoring system: 
181 
 No intervention: "usual care" 
 
 
Patients having a post measurement: 
215 
 Patients having a post measurement: 
249 
 
Intervention process 
A) USE OF THE MONITORING SYSTEM 
In total the intervention practices recorded 1557 practice visits. Of the 215 study patients 
who completed the study, 181 (84.2%) were actually included in the monitoring system 
(125 had ≥ 3 visits recorded, 56 had 2). Furthermore practices recorded the visits of 320 
patients who were not included in the study. Spirometry was recorded during almost every 
regular follow-up visit (99.2%) and in 75.3% of the visits because of exacerbations. The 
integration of qol-data in the monitoring routine showed a considerable range over the 
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practices (from 12.5 to 86 % of the visits). Of the 215 study patients, 111 (52%) completed 
once or more the qol-questionnaire and had scores recorded.  
 
B) FEEDBACK 
The intervention practices received six times feedback on the monitoring recordings. The 
aggregated figures from the end of the study are presented in Figure 3.  
 
Figure 3: Example feedback report, here presenting overall figures of all participating practices 
 
FEEDBACK REPORT ASTHMA/COPD MONITORING 
 
Practice ALL 
(records incorporated up to and including latest set date: (13Sept-6Oct) 
 
FEEDBACK OF PARAMETERS OF CARE 
(only for the recorded patients from the study) 
C. Recorded number of control visits because of asthma/COPD  
 (without consultations for exacerbations) from September 16 in the past year  
• Number of patients with 0 visits (see - table 3 -): 38 
• Number of patients with 1 visit (see - table 3 -): 52 
• Number of patients with 2 visits: 45 
• Number of patients with 3 visits: 55 
• Number of patients with 4 or more visits: 51 
 
D. Rapid lung function decline (only if measured at least at three control visits) 
• Number of patients who have a mean yearly lung function decline of more than 160 ml 22 
 (see - table 4 – for a list of these ‘fast decliners’) 
 
E. Smoking cessation advice 
• Number of smokers in the study (according to patient questionnaire premeasurement): 66(26%) 
• Number of smokers recorded in the monitoring system: 45 
• Recorded smokers without smoking cessation advice in the past year: 4 
 (see - table 5 - for a list of patients who did not receive a smoking cessation advice during the past year) 
 
F. Preventive medication 
• Number of patients with a prescription for bronchodilators more than twice daily:  105 
• Number of patients who did not get a prescription for preventive medication as well: 21 
  (see – table 6 – for a list of patients who did not receive preventive medication) 
 
G. Quality of life (only if minimal three quantitatively recorded control visits) 
• Number of patients with a relatively poor and at the same time worsening score on at least  
one of the six quality of life dimensions in the blue questionnaire for asthma/COPD control 
(complaints, feelings, physical and social activities, work/sickness and home): 27 
 (see - table 7 - for a list of patients with poor and at the same time deteriorating quality of life) 
• Number of patients with a tendency towards deterioration of the score on at least two out of  
 six quality of life dimensions, mentioned in the blue questionnaire for asthma/COPD control:  6 
 (see - table 8 - for a list of patients with a tendency towards deterioration of quality of life) 
 
CHAPTER 7 
 113
 
Practices received lists of the patients who at that time had a rapid lung function decline 
(22x), received no smoking cessation advice (4x), were without recommended anti-
inflammatory medication (21x) and reported a deteriorating quality of life (27x and 6x). 
 
Effects 
Number of practice visits: in I the mean number of regular follow-up visits a year increased 
from 0.6 to 1.2, whereas in C it decreased from 0.7 to 0.5. Between group differences were 
statistically significant (T 9.99, p < 0.001). The mean number of visits because of 
excerbations decreased in both conditions (-0.17 in I and –0.13 in C), which was not 
statistically significant.  
 Patient outcomes: the results of the multilevel repeated measurements analyses are 
presented in Table 2. Within I eight out of the 14 outcome parameters had significantly 
improved compared to three within C. Smoking, cough and mucus production decreased 
more in I but the difference with C was not statistically significant, nor was the tendency of 
intervention patients to report more exacerbations and absenteeism. Patients in I were 
significantly more satisfied with care and information. 
 
Table 2: Effects of the monitoring system on patient outcomes; additional effects calculated by multilevel 
repeated measurements analyses, corrected for baseline differences in patient satisfaction.  
 
 Intervention group 
(n=286) 
Control group 
(n=311) 
 before 
means 
after 
means 
before 
means 
after 
means 
Additional effect 
Intervention vs. 
control 
(CI 95%) 
% FEV1 predicted 73.13 79.30 ••• 72.07 76.53 •••  0.77 (–1.30 +2.84) 
% reversibility   6.36   5.28  •   5.87   5.73 -0.90 (–2.18 +0.37) 
degree of dyspnoea (range 0-3)   1.16   0.84  •••   1.27   0.92 •••  0.04 (-0.14 +0.27) 
satisfaction about information (range 1-6)   3.12    3.31  •   3.48*   3.44  0.30 (+0.11 +0.48)**
satisfaction about care (range 1-6)   3.41   3.61  •   3.72*   3.71  0.22 (+0.03 +0.42)* 
quality of life sumscore QoL-RIQ (range 1-7)   2.22   2.17   2.12   2.05  0.01 (-0.12 +0.15) 
MOS-SF 36 physical 46.92 46.68 45.74 46.04 -0.63 (–2.12 +0.87) 
MOS-SF36 mental 49.63 50.12 51.06 50.91 -0.04 (–1.86 +1.78) 
 percent. percent. percent. percent. OR (CI 95%) 
having had an exacerbation past 3 months 24.13 26.79 25.81 21.49    1.39  (0.83-2.34) 
chronic cough 24.83 13.99 ••• 19.94 15.76    0.67  (0.42-1.08) 
chronic mucus production 25.52 13.99 ••• 18.33* 13.18 •  0.71  (0.45-1.13) 
smoking 25.44 20.10  • 26.77 23.85  0.86  (0.62-1.18) 
absenteeism from domestic duties ≥ 7 days   4.55   5.24   5.14   3.54  1.73  (0.67-4.44) 
absenteeism from work ≥ 7 days   4.32   8.42   3.23   2.13  2.51  (0.42-14.88) 
Between-group differences * = p ≤  0.05, ** = p ≤  0.01. Intra-group differences • = p ≤  0.05, •• = p ≤  0.01, ••• = p ≤ .001. 
 
At baseline a subgroup of 190 patients (n=98 in I and 92 in C) were more seriously 
affected by their disease considering symptoms and qol. Fifty-three of the 98 patients in I 
had been regularly monitored (≥ 3 times a year). The results in this subgroup were similar 
to overall results: chronic symptoms tended to improve more in I and exacerbations tended 
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to decrease more in C, but only the improvement of patient satisfaction in I was 
significantly different.  
 
Explorative analyses revealed similar patterns in the subgroup of patients with COPD (94 
in I and 119 in C): significantly more satisfied patients in I and yet an increase in reported 
exacerbations in the past three months (OR 2.57, CI 1.08-6.07, p <0.03) and absenteeism 
from domestic duties (OR 6.32, CI 1.18-33.99, p <0.03). In both COPD-groups the number 
of smokers decreased, but the between-group differences were not statistically significant. 
However, the results in the asthma and mixed syndroms group (n=192 in I and 192 in C) 
were different: in I patients with asthma or mixed syndroms were not more satisfied nor 
did they report more exacerbations. Analyses on the differences between the asthma groups 
showed tendencies towards decrease of smokers (OR 0.63, CI 0.39-1.02, p <0.06) and 
chronic coughing (OR 0.59, CI 0.32-1.09, p <0.09), and improvement of quality of life 
(MOS-physical component scale –1.64, CI –3.44 + 0.17, p <0.07) in I. 
 
Discussion  
We successfully introduced a patient-tailored computerised monitoring and feedback 
system in routine general practice to support guideline adherence and to focus GP's 
attention to actual patient perceived health status. The implementation of this multifaceted 
support method brought the mean number of regular follow-up visits more in line with 
guidelines recommending review four times a year. The integration of routine qol-
monitoring proved feasible but compliance varied between the practices. The intervention 
lead to an improvement in patient satisfaction with care and tendencies to report more 
exacerbations and absenteeism from work, mainly in the group of patients with COPD, in 
spite of less smoking, cough and mucus production. 
 The study was an effectiveness trial trying to integrate a support system in real practice. 
We included sufficient patients and practices to demonstrate possible effects. The actual 
implementation of the intervention was above our expectations as the practices included 
additionally more than 300 non-study patients in the system. However, not every study 
patient was monitored and quality of life monitoring was only partially executed with a 
large variety over the practices. It should be taken into consideration that, but for the lung 
function, all patient outcome measures were patient-reported. Many studies investigated 
the effects of computerised support on professional performance and care process, the 
effects on patient outcomes are less well studied10,20. Our study involved both type of 
measures. 
 In both study groups an improvement in FEV1 and respiratory symptoms could be 
observed and additionally within the intervention group the reversibility improved as well. 
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Maybe this is due to the introduction of spirometry in both groups to equalise baseline 
conditions. The result would be in line with Spann21 who demonstrated an improvement in 
respiratory symptoms after introduction of spirometry. As spirometers were provided to 
general practices by the pharmaceutical industry on a large scale a design sorting out the 
single effect of spirometry was no longer possible. 
 The improvement of satisfaction in invervention patients is in line with many other 
implementation studies aimed at decision support and organisation of care delivery15,22.  
 Interestingly, despite more follow-up visits, more satisfaction with care and a tendency 
towards improvement of chronic symptoms intervention patients tended to report more 
exacerbations and absenteeism than patients receiving usual care. Considerations about the 
influence of structured disease management on patients' disease awareness and subsequent 
coping should be made. Depending on the policy perspective one takes these results can be 
positively or negatively interpreted, either as a justified individual adaptation to physical 
limitations and a sense of awareness to adequately manage the disease or as an increase of 
societal costs due to the intervention and absenteeism.  
 The fact that no influence on disease-specific or generic quality of life could be 
demonstrated, leaves us with the question wether quality of life composed of many 
dimensions is a measure wich can be influenced by multifaceted interventions with an 
emphasis on professional performance. One may assume that to demonstrate any effects in 
intervention studies the interventions should be clearly related to subsequent recognisable 
dimensions of qol. 
 The patient-tailored computerised monitoring and feedback system for asthma and 
COPD improved GPs' compliance with follow-up recommendations and enhanced patients' 
satisfaction with care. The mixed and limited influence on other patient outcomes may give 
rise to reconsider and differentiate follow-up frequencies recommended in the guidelines. 
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Abstract 
Aims 
To test the feasibility and acceptability of a computerised monitoring system for patients 
with asthma or COPD in general practice. The system intended to stimulate adherence to 
follow-up guidelines by focussing attention to the recommended contents and frequency  
(4 times a year). Patient-centredness was stimulated by a procedure of feeding forward 
quality of life information just before a practice visit. 
Methods 
An evaluation of the implementation process of the monitoring system in 10 general 
practices (16 general practitioners, 286 patients) was undertaken. After 24 months the 
actual use of the monitoring system (patients included, frequency) was derived from its 
recordings. Patient characteristics and their acceptance of frequency and contents were 
asked in pre-structured questionnaires. Descriptive statistics (frequencies), Chi-square, T-
tests and multiple logistic regression analysis were performed. 
Results 
Post measurement questionnaires were received from 215 patients (75%) and 1557 practice 
visits were recorded. Of the study patients 20 % were monitored once or twice and 55% 
three times or more. Quality of life monitoring was performed in 111 patients (39%). The 
majority of patients (60%) preferred a fixed control schedule, this was associated with 
older age. About one third preferred control visits only in case of deteriorating symptoms. 
Patients favoured spirometry and physical examination above education and counselling. 
Age, gender and education level were associated with these preferences. Younger patients 
< 40 and males were more in favour of spirometry than older patients and females. Lower 
educated people wanted less education on coping than patients with higher education. Most 
patients having participated in the quality of life monitoring were positive about it.  
Conclusions 
The monitoring system proved to be applicable in routine general practice. Patients were 
divided in their preferences concerning frequency and contents of the follow-up. Tailoring 
care needs focussing not only on clinical features of the disease but also on assessing these 
preferences. 
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Introduction 
In The Netherlands most patients with mild to moderate respiratory diseases are under 
control in general practice. General practices vary in their control policies: from complaint-
related patient-initiated contacts to disease management systems with fixed control 
frequencies and contents.  
 Primary care guidelines for the treatment of COPD and asthma recommend regular 
follow-up of patients1-4. To stimulate the implementation of follow-up recommendations in 
routine general practice care we developed a computerised monitoring and feedback 
system in which protocolised care for this category of chronic patients is combined with 
tailoring to individual patient needs and preferences. The system focuses general practice 
professionals on key items of the guidelines which have to be recorded during practice 
visits, thus structuring the consultation according to the guideline recommendations. Part 
of this structure is systematic attention for patients' health status and complaints. To 
stimulate this aspect short patient questionnaires were completed just before a consultation 
and the results had to be recorded in the monitoring system during the consultation.  
 Many studies on effects of computerised decision support systems including reminders 
for chronic disease management show positive results on clinical performance5-7. 
Systematic preconsultation subjective health or needs assessment has shown to influence 
patient-doctor interaction and to improve patient outcomes.8 However, little is known 
about actual applicability of support systems for chronic disease management in routine 
care and even less is known about the compliance of patients with control policies and their 
acceptance of the accompanying tools. Both can influence the effectiveness of the system 
in the end. In the present study we describe the feasibility of the patient-tailored monitoring 
and feedback system system during daily general practice. Furthermore we assess its 
acceptability for patients and try to get insight in possible types of patients more or less fit 
for inclusion in the systematic monitoring and feedback system, seen from the patient’s 
point of view. 
 
Methods 
An evaluation of the implementation process of a computerised monitoring and feedback 
system for asthma and COPD in 10 general practices (16 GPs) was undertaken.  
 
The monitoring system 
A computerised patient-tailored monitoring system was introduced to stimulate regular 
follow-up according to the recommendations of national clinical general practice 
guidelines. It contained: 
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• the provision of hand-held spirometers (Micro Spiro Plus) and a subsequent 2 hour 
training at the practice location for the GPs and their practice assistants. During the 
first hour of the training videotaped cases of spirometry had to be scored on a 
performance quality checklist. In the second hour the technique had to be excercised 
in role plays. 
• delivery of monitoring software to be attached to the regular electronic medical 
records (EMRs). The software consisted of three screens regarding history-taking, 
physical examination and pharmaceutical and non-pharmaceutical treatment (see 
Figure 1). Two combined key touch actions were needed to swich from the 
monitoring screens to the EMR and vice versa. Data storage in the monitoring system 
was still separated from the regular EMR. During the installation of the software the 
contents and the treatment guidelines were explained to the general practice team. 
The system could produce graphics of repeated lung function measurements as well 
as overviews of various other measures. 
• provision of a 27-item paper questionnaire on quality of life (qol) to be completed by 
the patients at home just before practice visits. The questionniare was derived from a 
validated 55-item disease-specific questionnaire (QoL-RIQ)9. The answering categories 
on the first 25 items formed a four or 5 point Likert scale (1 = not troubled at all; 2 = a 
little troubled; 3 = pretty or considerably troubled; 4 = much or very much troubled by 
the disease; 5 = unable to do so). The GPs were instructed that the scores ≥ 3 might 
'signal' a problem with patients’ quality of life. The number of scores ≥ 3 per quality of 
life dimension and the number of days with absenteeism could be recorded in the 
system.  
Following the Dutch general practice guidelines it was recommended to schedule patients 
for a regular control visit every three months. During the visit the lung function should be 
measured by the spirometer and quality of life should be assessed and recorded.  
 After the training the implementation of the monitoring system was accompanied by 3-
monthly feedback reports on the recorded data in the monitoring system. The recordings 
were sent to a department of the Radboud University Nijmegen in order to produce the 
feedback reports. The number of patients included, the control frequency and critical items 
were reported (in total and at individual patient level). The latter referred to rapid lung 
function decrease (> 160 ml/y), no smoking cessation advice for smokers, prescription of 
bronchodilation > twice daily without anti-inflammatory medication and deteriorating 
quality of life scores.  
 During 24 months this monitoring system was supported by the research department. 
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Figure 1:  Monitoring screens for the follow-up of COPD and asthma 
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Populations 
The monitoring and feedback system was introduced in 10 general practices of various 
composition (see Table 1). The practices were included by a mailing amongst the users of a 
specific general practice information system (ProMedico). Requirements for inclusion 
were: having regularly used a medication prescription module during patient encounters for 
at least a year; willingness of all general practitioners in the practice to participate; a 
practice list size of at least 1600 patients and availability of a fast computer to allow the 
intervention software to function properly. Practices, equally fit for participation, were 
included in order of the speed of their computer which was tested by a telephone query 
using a stopwatch. 
 
Table 1:  Characteristics of participating general practices and GPs 
 
Practices (n=10)  
urban location 3  
practice form: single-handed/duo/group 4/5/1 
treatment quality score: ≥ 3 3 
regional dispersal: north/middle/south   1/9/0  
practice size > 3000 patients 5 
  
GPs (n=16)  
Mean age (sd) 46 (4.8) 
Number of practising years (sd) 14 (6.3) 
% involved in professional teaching  56 
 
Patients with asthma or COPD were included according to their GP's diagnosis after a pre-
selection based on prescription of bronchodilators (≥ 3x past year) or of inhaled 
corticosteroids (≥ 2 x past year) assuming that these patient had sufficient disease severity. 
Exclusion criteria were: < 18 years of age; under control of a pulmonary physician; serious 
active physical comorbidity; a psychosocial or mental condition or insufficient command 
of the Dutch language disabling them to complete a questionnaire. At baseline the patients 
were included in the study by a letter of their GP inviting them to visit the practice; 
spirometry (using a Micro-Spiro Plus) was performed by trained research assistants at the 
practice location. During this visit and partly at home patients completed a questionnaire 
regarding personal and disease characteristics, quality of life (QoL-RIQ and MOS SF 36) 
and satisfaction with patient education and treatment (four and six questions respectively 
responded to along a six-point Likert scale ranging from poor (=1) to excellent (= 6). At 
baseline 286 patients gave their informed consent to be included in the study (Table 2 shows 
their characteristics). After the patients had been included in the study the practices gradually 
included them in the monitoring system. 
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Table 2:  Patient characteristics (n=286) 
 
mean age 50.8(16.9) 
% male 52.1 
education level: % high/middle/low 15/33/52 
% being employed  49.8 
% having COPD 32.9 
% smoking  25.44 
  
% FEV1 predicted 73.13 
% reversibility   6.36 
degree of dyspnoea (range 0-3)   1.16 
% having had an exacerbation past 3 months 24.13 
% chronic cough 24.83 
% chronic mucus production 25.52 
mean severity airway symptoms (MRC, range 0-6)   2.63 
  
satisfaction about information received from GP (range 1-6)   3.12  
satisfaction about care GP delivery  (range 1-6)   3.41 
quality of life sumscore QoL-RIQ (range 1-7)   2.22 
MOS-SF 36 physical 46.92 
MOS-SF36 mental 49.63 
% absenteeism from domestic duties ≥ 7 days   4.55 
% absenteeism from work ≥ 7 days   4.32 
 
Measures 
The present study focuses on the actual use of the monitoring system by the practices and 
the acceptability of the procedures for the patients. 
 The actual use of the monitoring system could be derived from the recordings in the 
system itself. The measures are: 
• number of patients included in the monitoring system 
• frequency of follow-up per patient (times a year)  
• frequency and contents of quality of life monitoring 
The acceptability for the patients was measured by means of pre-structured questionnaires 
sent to the patients about 18 months after their inclusion. Their opinion was asked on: 
• preference for follow-up frequency with the answering categories: no control, only in 
case of worsening symptoms, once ≤ 3 months, once every 6 months, once a year, 
once every 2 years 
• preference for follow-up contents with the answering categories: spirometry to test 
the lung function, physical examination, discussion of disease-related limitations, 
discussion of concerns about the disease, prescription of medication, instruction on 
medication use, education on coping with complaints 
• evaluation of quality of life monitoring: five questions on individual suitability of the 
contents with five answering categories ranging from 0 = totally agree to 5 = totally 
disagree.  
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• future continuation of the monitoring procedure: willing to complete a questionnaire 
during every visit or willing to do so once a year. 
In studying the relations between actual use, acceptability and patient characteristics, the 
latter were classified according to: age (≤ 40, 40–60, > 60), gender, disease-severity 
(dyspnoea-scores derived from the MRC-questionnaire ranging from 0 = no dyspnoea to 6 
= having to stop for breathtaking or worse; scores dichotomised as  <3 or ≥ 3), educational 
level (low, midde, high) and disease (asthma or COPD). 
 
Statistics 
Descriptive statistics (frequencies), Chi-square, T-tests were performed. Multiple logistic 
regression analysis with p ≤ 0.05 as criterium for significant differences was used to 
explore associations between patient characteristics and preferences. 
 The data was analysed using SAS 9.1 for AIX platform (Copyright (c) 2002-2003 by 
SAS Institute Inc., Cary, NC, USA.). 
 
The study was approved of by the Medical Ethical Committee of the University Lung 
Centre Nijmegen. 
 
Results 
Response 
From 215 of the patients (75%) a post measurement questionnaire could be received. Drop-
out analysis showed that non-respondents were significantly overrepresented in women (p 
< 0.01) and in patients with a high educational level (p < 0.02).  
 
Actual use of the monitoring system 
During the study period in total 1557 practice visits of patients with asthma or COPD were 
registered in the computerised monitoring programme which stimulated a fixed control 
contents and a frequency of four times a year. Some practices hesitated to start with the 
programme, but in the end 10 out of the 16 GPs completed the monitoring programme 
during every practice visit and another four did so after the visit. Spirometry was 
performed and recorded in 74% of the visits. Half of the practice assistants was involved in 
the monitoring, e.g. performing spirometry and supplying the qol questionnaires.  
 The number of registrations for the study patients varied: 12% of the study patients were 
not registered in the monitoring system, 20% once or twice and 55% were registered three 
times or more. During the intervention period practices reported that 13% of the patients 
could no longer be included in the monitoring system for various reasons (e.g. decease, 
move to another place, serious other illness).  
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 The quality of life monitoring was performed in 111 (39%) patients. The repeated (at 
least 3x) recordings showed that 27 patients experienced a relatively bad and diminishing 
quality of life.  
 
Acceptability for the patients  
Table 3 shows the preferences of the responding study patients concerning control 
frequency after the intervention period. About one third of the patients wanted to have a 
control visit only in case of deteriorating symptoms. The majority (60%) preferred a fixed 
control schedule. Of the responding patients 36% preferred the 3-monthly control 
frequency recommended in the guidelines, a few preferred a more intense frequency. The 
multiple regression analysis showed that older patients above 60 were significantly more in 
favour of a control frequency ≥ 3 months a year than younger patients. No other relations 
with patient characteristics were found. 
 
Table 3:  Follow-up preferences of patients after the study 
 
Frequency % of patients (n=215) 
No follow-up    0.5 
Only in case of deriorating symptoms at own initiative   36.6 
Every 3 months or more frequently  39.5 
Every 6 months   13.7 
Every year   5.4 
Other frequency   4.4 
 
In Table 4 the preferences of the patients for various content aspects of the follow-up visits 
are presented, showing that spirometry and physical examination are favoured above 
education and counselling. The significant results from the multiple logistic regression 
analyses are presented in Table 5, showing that age, gender and education level partly 
predict some of the preferences. Younger patients are more in favour of spirometry as well 
as more males compared to females. Lower educated patients express less preference for 
education on how to cope with the complaints compaired to patients of middle education 
level.  
 
Table 4:  Preferences of patients for the contents of regular control visits after the study 
 
Contents of control % of patients (n=215)  in favour of 
Spirometry 76 
Physical examination 73 
Prescription of medicine 39 
Education about coping with complaints  33 
Discuss worries 23 
Instruction on medicine use 23 
Discuss limitations 22 
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Almost all patients who completed once or more a qol questionnaire agreed that the 
instrument provided important information about their health status to the general 
practitioner, although the mulilevel logistic regression revealed that older patients > 60 
years of age were significantly more positive than younger ones (OR 0.107, 95% CI 0.021-
0.539). Nevertheless more patients with COPD agreed that the topics on the questionnaire 
were irrelevant for them personally compared to patients with asthma (OR 2.593, 95% CI 
1.096-6.133). Patients were asked if the general practitioner would be beter informed if 
they completed a qol questionnaire. Of the total group of respondents 57% thought that the 
general practitioner would be better informed, 13% thought not so and 30% had no 
opinion. The repondents having experience with the qol questionnaire were more positive 
(73% yes, 9% no and 18% no opinion). Almost all patients who had ever completed a qol 
questionnaire before consultation were willing to complete a questionnaire during every 
practice visit regarding their respiratory disease (92%). 
 
Table 5:  Significant associations between patient characteristics and preferences for disease control  
 
Patients  in favour of Significant characteristic predictors OR 95% CI 
•  Control frequency ≥ 3 x year Age (≤ 40 vs > 60) 0.160 0.055 - 0.469 
•  Spirometry Age (≤ 40 vs > 60) 
Gender (male vs female) 
3.914        
1.937        
1.540 - 9.947 
1.002 - 3.745 
•  Education on complaints Education level (low vs middle) 0.341        0.181 - 0.642 
 
Discussion 
We introduced a computerised monitoring and feedback system for patients with asthma or 
COPD to be used during normal general practice consultations. Despite the limited 
technical integration in the usual electronic medical records the system proved to be 
feasible in routine general practice and a large number of consultations was recorded. 
Applicability in general practice may be enhanced in future by technical solutions 
resolving present barriers, such as an easier accessible sofware interface, real-time 
feedback of information generated by the computer programme itself and a seamless 
integration with the usual medical record system.  
 Despite the present restrictions the results were very promising and the system can be 
considered as a feasible mechanism to implement follow-up guidelines by both focussing 
the general practice professionals to key issues in these guidelines and tailoring the care to 
individual patients.  
 However the future application of such a monitoring system depends on the 
acceptability for patients as well. This concerns on the one hand their acceptance of the 
contents of the follow-up recommendations and on the other hand their acceptance of 
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components of the monitoring system. The results raise some questions on how to combine 
protocolised care and indivdual patients' whishes. 
 Patients' preferences may give rise to reconsider recommendations about control 
frequencies in the guidelines. Although a majority of patients preferred a fixed control 
schedule, about one fifth of them preferred a less intense frequency than the recommended 
3-monthly control visits. Moreover, a large minority only wanted to have contact with the 
general practice in case of worsening symptoms. This was measured after most patients 
had experienced the pros and cons of a regular follow-up schedule. First of all there is no 
clear medical evidence on what control frequency is best for primary care patients with 
mild to moderate respiratory diseases. Recently two tendencies can be observed. One is 
frequent control in the more seriously ill people, an option sometimes supported by 
telemedicine facilities. The other is a trend towards more self-management, especially in 
higher educated younger people. Our results reflect these two tendencies in the patient 
population. We see elderly patients more or less in favour of frequent control visits, 
irrespective of the kind of disease (having asthma or COPD) or of its severity as these 
variables did not influence patients' preferences. The younger ones are more in favour of 
visiting the practice at their own initiative. As not all patients matched this typology 
checking the preferences at an individual level will always be wanted.  
 Preferences about the contents of the monitoring system were sometimes difficult to 
interprete. Only about half of the patients had at least once completed a pre-consultation 
quality of life questionnaire as part of the monitoring system. The results showed that those 
who had completed the questionaires were very positive about it but that one third of all 
patients had no opinion on the benefit of the procedure. This suggests that this component 
of the monitoring system was not well implemented in some of the practices. Practice or 
professional based reasons for non-compliance should be explored first before drawing 
conclusions on acceptability for patients in general. 
 Interestingly patients clearly favoured the more traditional clinical aspects of a control 
visit, i.e. spirometry and physical examination. Especially younger and male patients were 
more in favour of spirometry during consultations. Overall prescriptions and coping advice 
came second and education and counselling were least preferred. Maybe this has 
something to do with the relatively old age of the patients in our study having often 
suffered from their chronic respiratory disease for many years and who radiate that they 
can handle the resulting discomfort. But it may also reflect the current practice in which 
there is relatively little attention for the actual coping, the actual medical intake and 
technique of medication and the psychosocial consequences of the disease10,11. Our 
research method using evaluation questionnaires after the study does not allow us to draw 
any further conclusions. Partly non-respondents overlapped patients who dropped out of 
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the monitoring system for various reasons non-directly related to the system as such. As 
both patients' positive opinions and non-compliance may also reflect the GPs' attitudes, 
future research on follow-up preferences of patients with mild to moderate disease will 
need indepth interviewing during and after the implementation of a monitoring system as 
well as an exploration of patient expectations beforehand. 
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Section 1 of this thesis showed the development and evaluation of supportive instruments 
for patient-tailored primary care management of asthma and COPD. Prototypes of the 
instruments were integrated in the multifaceted interventions in the two trials reported in 
Section 2. The trials gave indications of the effectiveness and feasibility of the instruments 
in routine daily care. The two trials also showed the effects of the introduction of 
guidelines-based disease management systems for asthma and COPD in general practice. 
After a short overview of the results of the studies we will discuss their relevancy and 
repercussions for daily primary care management of asthma and COPD. 
 
Results 
 
Validity and feasibility of tools to support disease management 
The 10-item shortform (RIQ-MON10) for monitoring quality of life (qol) in patients with 
repiratory diseases maintained the psychometric properties of the original qol instrument 
(QoL-RIQ). The RIQ-MON10 showed good internal consistency and met most validity 
requirements. Integration of the (longer) prototypes in routine care during the two trials 
showed that completion and feed forward just before and during practice visits was easily 
feasible. The procedure was well accepted by patients and by a majority of the general 
practitioners. Further reliability testing is recommended mainly to confirm the sensitivity 
to change of the instrument. The instrument is promising for asssessing and monitoring 
quality of life in adult patients with mild to moderate respiratory diseases during primary 
care practice visits. 
 
The content analyses of clinical guidelines and the written and oral Delphi procedures for 
the selection and development of topics for an electronic patient (monitoring) record 
resulted in detailed formats for recording diagnosis, treatment and follow-up for patients 
with asthma. Involving content experts and future users in the developmental procedures 
was a time-consuming operation. However, both procedures were necessary to establish 
relevant, acceptable and concrete recording recommendations. Detailed and clear 
guidelines can be of great help for the selection of topics, indicators and cut-off criteria for 
the registration. While performing the procedures, inconsistencies or unclearness in the 
guidelines had to be dealt with. Application of a less detailed prototype for the monitoring 
of asthma and COPD in the second trial showed the usefulness of guidelines-based 
structured monitoring formats. It also showed the necessity of seamless integration in 
normal practice recording systems.  
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The development of instruments to assess real-time needs for education in patients with 
asthma and COPD was also guidelines-based. The circular procedures (content analysis of 
guidelines ⇒ Delphi rounds in patients and health care professional ⇒ feasibility testing 
⇒ adjustment and group interviews in patients ⇒ retesting) led to two guidelines-based 
educational needs assessment forms, the QPEN-A and the QPEN-C. The developmental 
procedure showed the necessity to applicate a variety of research methods to establish 
validity, reliability and acceptability of the instruments. Patients preferred completion at 
home before practice visits, especially shortly after diagnosis of the disease.  
 
Effects of monitoring systems 
Trial One concerned the completion of short quality of life questionnaires by patients in the 
waiting room just before a regular follow-up visit. The effects of this method on 
performance of general practitioners and on patient outcomes in six general practices were 
derived from a comparison with the usual monitoring in the six control practices. The 
results showed that the information about quality of life of patients, gathered systematically 
and routinely directly before consultation, could be integrated into the complex medical 
decision-making process. The general practioners who saw the patients' results on the qol-
questionnaire before or during a follow-up visit reported significantly more patient 
education, change of prescriptions, counselling and extra follow-up in case of impaired 
quality of life.  
 About one third of the patients reported at least once an impaired quality of life on a 
dimension of the questionnaire. However, although the scores seem to influence the 
professional behaviour no subsequent influence of the intervention on patient outcomes 
like symptoms, quality of life or statisfaction with care delivery, was found. 
 
Trial Two incorporated a protocolised yet patient-tailored computerised monitoring and 
feedback system in routine general practice care. Formerly selected guidelines-based 
monitoring topics were transformed into screens in the monitoring device. Quality of life 
questionnaires were part of the system and quarterly feedback was provided to general 
practitioners in ten practices. 
 Considering the numbers of patients included in the system the process of integration in 
routine care proved to be successful. Despite the shortcomings with regard to the sofware 
integration in the existing electronic patient records 85% of the study population had been 
included in the monitoring system. The control frequency had significantly improved in the 
intervention group and about half of the GPs was in favour of future integration of the 
monitoring software in their recording system.  
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 Patients who were included in this monitoring system were more satisfied with care. 
Although patients in the intervention condition reported less smoking behaviour and 
respiratory symptoms, the difference in these outcomes was not statistically significant 
compared to the usual care control condition.   
 
Methodological considerations 
Some remarks are required considering the research methods used in the two trials. 
 
Design and measures 
Both trials had a controlled design, but were set up as practice-based effectiveness studies. 
This means that the interference with normal care delivery was minimised to get a good 
picture of the effects of the intervention in normal practice conditions. On the one hand the 
restricted interference gave a clear view on the feasibility of the monitoring and feedback 
systems in routine care, but on the other hand it made it more difficult to establish effects 
on patients, because application in some practices was suboptimal. Futhermore this choice 
lead to data gathering methods which relied heavily upon medical records and self-reports 
of GPs and patients. Inspection of the usual medical records in the second trial showed a 
considerable variation in recording behaviour and terminology, making it pretty difficult to 
sort out the consultations for asthma or COPD in both study conditions. We managed to 
develop and test a query using terms indicating symptoms, diagnosis and physical 
examinations which made it possible to select the asthma and COPD consultations in the 
medical records and draw conclusions on follow-up frequency1. In the intervention 
condition we got information on the contents of the consultation from the monitoring 
system, but, especially in the control condition, it was not easy to establish the actual 
contents of the encounter. In the intervention conditions the ongoings during the actual 
doctor-patient encounter were recorded. For instance, patient education was recorded in 
case of deteriorating qol, but the actual contents of the education could not be retrieved. 
More adequate instruments to measure actual performance during consultations (like 
video-obervations) would have intervened too much.  
 Boths trials had a short intervention period (12 and 24 months respectively) in which the 
professionals had to get accustomed to the monitoring system and at the same time 
gradually include the study patients. This lead to a broad range of follow-up frequencies in 
the study population. By subanalyses in groups of patients monitored ≥ 3 times we tried to 
get an impression of the outcomes when patients were monitored more according to the 
recommended frequency. As the results in the frequently monitored subgroups did not 
differ from the overall results we felt free to draw conclusions from the overall results.   
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 One could reflect on the possible impact of regular follow-up (frequency + fixed 
contents) on the outcome measures we chose, e.g. quality of life. Follow-up by medical 
professionals is not the only influence on patients. Were we too ambitious to expect 
improvement in clinical outcomes due to more systematic follow-up in patients with mild 
to moderate respiratory diseases? It took some time to improve the follow-up processes in 
the practices according to the monitoring protocols. There was clearly room for process 
improvements, but at the start of the experiments it was not clear how much room there 
was for improvement in clinical patient outcomes. Especially in the first trial the room for 
improvement was limited in the academic practices having already systematically 
monitored their patients for a year. In the second trial the room for improvement was 
shown afterwards as various patient outcomes improved in both study conditions. 
Moreover, in the intervention as well as in the control condition the number of 
consultations because of exacerbations decreased. Probably this was partly due to the 
introduction of practice-based spirometry and subsequent medical actions in both study 
arms. This is a somewhat speculative finding, which is however supported by the findings 
of Spann2, who reported a signficant improvement in repiratory symptoms after actual 
application of spirometry. Spirometry on its own can be a tool in disease management 
approaches, e.g. in supporting smoking cessation counseling, although the effects in this 
latter function are still unclear3,4. 
 Recent discussions on the selection of reliable and valid indicators for the quality of care 
for chronic respiratory diseases show how difficult it is to include patient outcome 
indicators. Quality indicators used in practice visits, accreditation and reimbursement  
systems therefore usually focus on process indicators of care like the number of patients 
with a diagnosis confirmed  by spirometry, the number of smoking patients having 
received a smoking cessation advice or prescription figures5,6. Nevertheless, considering 
the impact of regular follow-up on (time) investment of patients and health professionals 
and on costs of care, it seemed appropriate to chose measures indicating the final goals of 
care for patients with COPD and asthma, i.e. lung function, chronic symptoms, occurence 
of exacerbations and disease-related qol. After all, measuring the effects on patient 
outcomes is the final target of evaluating disease management systems.7 
 
Patient population 
In our trials we did not differentiate between populations with asthma or COPD. At the 
time of our studies the recommendations for follow-up frequency as well as for most 
follow-up contents were equal for both populations in the Dutch general practice 
guidelines. Moreover, the proportion of mixed or unclear chronic respiratory syndroms in 
adults was still considerable in general practice, if reversibility of bronchial obstruction 
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was taken as a differential diagnostic instrument. So it seemed appropriate to focus on key 
elements of care delivery instead of making large efforts to differentiate beforehand 
between diagnosis categories and restriction of the experiments to those patients with a 
clearcut diagnosis of COPD or asthma. Our pragmatic decision to avoid diagnostic pitfalls 
seems to be legitimised by recent findings on subcategories of patients with COPD 
showing asthma-like inflammation patterns8.  
 
Considerations on feeding forward of patient information during routine care 
An important component of the patient-tailored monitoring systems we introduced is real-
time feeding forward of patient-provided information during practice visits. The 
assessment tools for educational needs and quality of life were especially developed for 
integration in routine care. The computerised monitoring system we tested contained ample 
space to record the information gathered that way. The feeding forward procedures proved 
to be feasible during routine care. Our first trial showed the effects of feeding forward 
quality of life information on the medical actions of general practitioners, but showed no 
influence on patient outcomes. This is in line with former other research. Taenzer et al.9 
showed that feeding forward of computerised quality of life information just before a clinic 
appointment led to more discussion of quality of life issues during the appointment. They 
conclude that this feeding forward is a time-effective and acceptable means of improving 
patient-provider communication. In a review of 13 studies on the integration of patient-
based measures of health in routine care, Greenhalgh and Meadows10 found only two 
studies having an impact on patient ouctomes (i.e. aspects of mental health). However, 
Griffin et al.11 come to a different conclusion in their review of 35 studies on interventions 
to alter the interaction between patients and practitioners. They found three studies directed 
at activation of practitioners by a preconsultation note or questionnaire and conclude that 
they all showed significant improvements in functional status or anxiety. Considering the 
difference between the conclusions of both reviews, we strongly support the plea of Griffin 
et al to replicate promising studies using rigorous methods in which effects on 
communication and interaction characteristics (process) are linked to health outcomes. 
 
Considerations on multifaceted implementation strategies 
Our trials made use of multifaceted intervention strategies, here a combination of 
professional education (practice visit + written information), delivery of instruments for 
spirometry, feed-forward of real-time qol and tools for medical recording and feedback on 
professional performance and patient outcomes (written quarterly reports). The feed-
forward and monitoring devices included guidelines-based topics thus stimulating general 
practice professionals to perform according to the guideline recommendations. We cannot 
CHAPTER 9 
 137
 
sort out the separate effects of the components of the intervention strategies. However, we 
can conclude that these multifaceted strategies contributed to the implementation of the 
guidelines: follow-up frequencies rose, spirometry was performed more often and lots of  
patients underwent systematically structured control visits which were focussed on key 
issues in the guidelines.  
 
Facilitators and barriers  
The two trials introduced a patient-tailored disease management system for asthma and 
COPD in the existing practice infrastructure. The multifaceted implementation strategies 
were sometimes bothered by practice preconditions. For instance, in both trials there could 
only be a limited integration of the monitoring system in the practice software. Future 
application of more advanced recording systems (e.g. computerised datagathering in the 
waiting room or at home, integrated disease management screens in the medical records, 
automatically and real-time generation of feedback) may enhance the effects of the 
combined implementation strategy.12 
 In both trials there was at that time a still limited substitution of tasks from general 
practitioners to practice assistants or nurses. In some practices practice assistants 
performed the spirometry and/or the collection of the qol questionnaires, but in general 
extra efforts to raise the amount and quality of follow-up visits were added to the workload 
of the general practitioners. More supportive personnel in general practice taking care of 
the follow-up of patients with chronic diseases would probably have raised the inclusion of 
patients and the professional compliance with the monitoring systems under study.  
 General practices can be considered as complex systems, interrelated with surrounding 
systems (e.g. home care, hospitals, pharmacies, insurance companies and regulations). 
Implementation strategies should be flexible enough to be tailored to the systems to 
maximise possible effects. Because of study reasons researchers are inclined to develop 
designs with standardised implementation strategies thus passing over the need to tailor the 
implementation strategy to the complex 'practice ecology'13. Ideally system approaches 
account for the philosophy and working styles of the GPs, the practice organisation, its 
infrastructure, features of the patient population and interrelations with the surrounding 
systems. Strategies to implement complex disease management approaches, composed of 
several tasks and role players, may benefit from a tailored system approach, meaning that 
practice-based choices in the implementation strategy as well as in the intervention itself 
should be possible. E.g. choice modules for task division, patient selection options 
depending on the specific demographic situation. Indeed, for study reasons our 
multifaceted approaches in the two trials were standardised and the results might have 
benefited from a more flexibly shaped intervention. Disease management does not only 
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mean protocolised yet targetted to individual patients, but also protocolised yet targetted to 
the complex practice system. To reconcile these potential conflicting requirements is the 
challenge of our days. It seems that prestructured combined yet flexible interventions are 
needed to meet these requirements. 
 
Relevancy and repercussions for primary care disease management of COPD and 
asthma 
What implications do the study results have for routine primary care and especially the 
follow-up of patients with mild to moderate asthma or COPD?  
 In both trials the process of care delivery improved in the direction of the guideline 
recommendations. However, the results in both trials show no significant effects on clinical 
outcomes although in the second trial some tendencies on patient-reported symptoms 
reduction (cough and mucus production) were found. Contrary to this some tendencies in 
the direction of more patient-reported exacerbations and abenteeism from work were found 
as well. Engers14 found similar short-time results on absenteeism after patients received 
more attention for low back pain management. One may assume that frequent follow-up 
can raise patients' awareness of the disease and in case of chronic respiratory diseases it is 
unclear if the reported behaviour is a justified adaptation to the disease or an unjustified 
and unwellcome side effect of getting more attention in protocolised disease management 
systems.  
 The only patient measure that significantly improved in both trials was satisfaction with 
care. Other disease management projects show similar results11,15. Rising expectations in 
the beginning of an experiment contribute to patient satisfaction. The dificulty is to keep 
patients satisfied in the long run. Patient satisfaction as such is an important outcome in 
client-centred care delivery. Clear logistic procedures and systematic and frequent attention 
from health care professionals making clear what patients can expect may contribute to this 
outcome. However, medical evidence and costs-effectiveness must be incorporated in the 
design of an optimal disease management system as well. Without such evidence the 
development and implementation of primary care based systems for the management of 
adult asthma and COPD is just a matter of reconciliation of professional and patient 
preferences.  
 
Follow-up 
From the results in our studies no clearcut frequency recommendations for the follow-up of 
patients with mild to moderate asthma or COPD can be derived. The studies intended to 
implement recommended follow-up frequencies of four times a year for all adult patients 
with COPD and asthma, irrespective of disease severity or self-management capacities. 
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During the trials patients with severe and yet well-controlled and (self-)managed disease 
were subjected to the same regimen as for instance patients with a less severe disease, 
having bad compliance with treatment recommendations. A review of guidelines did not 
come up with clear medical evidence on what control frequency is best for primary care 
patients with mild to moderate respiratory diseases. Recommendations in more recent 
guidelines are more focused on self-management than former ones, but they still 
recommend regular reviews and recalls (see tables in Chapter 1). Tailoring seems the 
magical word, but how and what criteria for differentiation should be used? To prevent 
drop-outs the inclusion of patients in a disease management system would benefit from 
patient assessments resulting in typologies of disease severity and stability, coping and 
self-management capacities. Preferences of individual or groups of patients should be 
taken into account as well. A majority of patients and GPs in the second trial were in 
favour of the regular and structured follow-up. However a large minority of patients 
preferred control visits only in case of worsening symptoms.  
 Recently two tendencies can be observed. One is frequent control in the more seriously 
ill people, an option sometimes supported by telemedicine facilities. The other is a trend 
towards more self-management, especially in higher educated younger people. Our results 
reflect these two tendencies in the patient population. We see elderly patients more or less 
in favour of frequent control visits, irrespective of the kind of disease (having asthma or 
COPD) or of its severity. The younger ones are more in favour of visiting the practice at 
their own initiative. As this is just a rough group typology checking individual preferences 
will always be needed. Integration of tailoring and differentiation of follow-up in the 
practice routines is a challenge for modern management of chronic diseases. It can 
probably only be realised by consistent and well-disciplined recording in the electronic 
medical records.   
 Tailoring the frequency of follow-up has not only repercussions for the inclusion of 
patients in disease management systems, but also for the treatment guidelines and the 
subsequent indicators to measure quality of care with the purpose of registration, 
accreditation or reimbursement. The recent developed set of indicators for measuring the 
quality of care in Dutch general practice (12 and 11 for asthma and COPD respectively)16 
is partly dependent on process parameters related to follow-up frequencies, e.g. having 
provided a smoking cessation advice. When disease management is more heavily based on 
patient-doctor partnership and self-management other indicators like patient education or 
accessibility in case of emergency will become more relevant and need to be part of formal 
accreditation and assessment systems. 
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Monitoring quality of life 
Guidelines recommend regular attention to patients' health related quality of life (qol). In 
our first trial we specifically looked at the added value of qol monitoring. It proved that 
patient-reported qol differences were related to differences in professional actions but that 
after a year no significant effects on patients' health status were found. As in the second 
trial the qol monitoring was integrated in the multifaceted control regimen no conclusions 
about the additional effect could be drawn. What does this mean for disease management? 
 First of all an assessment of patients' subjective health status will be needed to tune 
treatment to psychosocial consequences of the disease and to coping abilities. A certain 
amount of objectivation by using standardised instruments as a basis for a differentation of 
care can be helpful in daily clinical practice. The newly developed RIQ-MON10 is a 
sensitive instrument for this purpose, especially in primary care patients with mild to 
moderate respiratory diseases.  
 However, in spite of the positive judgements of patients having frequently completed 
the questionnaires, our trial results do not support the use of qol questionnaires as a 
frequent monitoring device for all patients. Here too tailoring the regimen is probably the 
more optimal approach compared to fixed control regimens irrespective of disease severity 
or patients' personal characteristics. Stable patients with mild to moderate chronic diseases 
should not be bothered by frequent administering of questionnaires and calls for control 
visits. Frequent protocolised follow-up only as a reassurance for the professional and/or the 
patient would not be an efficient spending of limited health care resources. The challenge 
is to define good typologies of patients, based on disease severity, stability and coping 
behaviour including compliance with medicine intake devices and lifestyle advices. The 
difficulty here is to define stability which implicitely means a repeated measure of some 
indicators. Repeated administering of a short health status questionnaire can be part of the 
datagathering to assess stability as various recent guidelines recommend.  
 
Tools  
The various tools to support primary care disease management obviously met some needs 
in care providers. The dissemination of the tools went on in spite of scientific needs for 
further testing and validation. 
 The contents for the the electronic patient record for asthma were used in the procedures 
to establish frameworks for software developers by the Dutch College of General 
Practitioners (NHG). Similar procedures were performed to establish the formats for the 
COPD medical record. The guidelines of the NHG provided ample clues for the selection 
of monitoring topics. The challenge is to keep the formats up to date and tuned to 
developments regarding integrated care and joint medical record building. The procedure 
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based on guideline analyses and active involvement of future users can serve as an 
example how to proceed in building the structure and contents of an electronic medical 
record. 
 The instruments to assess patients' educational needs were adopted by the Dutch Asthma 
Foundation and put on their website for free download. Actual use will depend on patient 
and provider preferences and need not be restricted to primary care. Especially embedding 
the QPEN-A and the QPEN-C in the process of self-management education could be 
useful17.   
 At request the RIQ-MON10 was delivered to various researchers and practitioners to 
integrate the instrument in their research or care for respiratory patients. However, further 
research is needed to get more information on short-term individual sensitivity to change 
and clinical relevant cut-off points.  
 
Repercussions for future research 
Our studies integrated several components of disease management: guidelines based 
provider education, decision support and feedback, patient education, planned follow-up 
visits and monitoring of patients, tailoring care to individual patient needs. The approach 
benefited the care process, but its single components were still not optimal nor was the 
combined programme. Further investigation on programmes with optimised components 
(e.g. improved computerised facilities and extended role of practice nurses and integrated 
care options) as well as regarding the optimal mix of existing or new components (e.g. 
inclusion of lifestyle counseling) would contribute to our knowledge of the effectiveness of 
general practice based monitoring and feedback systems.  
 
To study the effects of patient-centred monitoring and feedback systems, multi-level 
approaches are needed investigating the relationship between process improvement and 
patient outcomes. Efficacy of such systems regarding patient outcomes can only be 
demonstrated in those patients showing evident room for outcome improvement. Inclusion 
of patients in this type of research should take the room for improvement into account. 
 
In our study only age differentiated between patients either or not in favour of regular 
follow-up. Further research is needed on typologies of patients fit for inclusion in 
protocolised disease management programs implying regular review. Guidelines give little 
information on how to act in a patient-provider partnership. Patient preferences for self-
management and patient initiated care should be taken seriously and weighed against the 
responsibilities of proactive professionals.18 Unnecessary medicalisation should be 
prevented. The right balance needs further investigation.  
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The results of our studies are in line with several other studies showing large disease 
management efforts and changes in care delivery processes for patients with COPD and 
asthma, but yet moderate effects on patient outcomes15,19. Our studies contribute to the 
evidence on the effectiveness of primary care based disease management systems for 
adults with respiratory diseases. So far, few studies in a well-controlled design have been 
performed20. Further research on the clinical outcomes and cost-effectiveness of primary 
care based disease management systems is still wanted.  
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Asthma and chronic obstructive pulmonary disease (COPD) are highly prevalent chronic 
respiratory diseases. In The Netherlands a large majority of patients with mild to moderate 
asthma or COPD are treated in general practice. Professional guidelines contain 
recommendations on how to manage these diseases according to the latest evidence and 
professional consensus. However, it is not easy to implement these recommendations in 
routine daily care. This thesis is focused on instruments and procedures to support the 
mplementation of the guidelines for treatment and regular follow-up in daily general 
practice.  
 After an introduction the studies are presented in two sections. In Section 1 (Chapters 1-
4) the development and validation of three kinds of tools for patient-centred disease 
management are described. Section 2 (Chapters 5-8) reports the results of two pragmatic 
randomised controlled trials on monitoring of asthma or COPD (including patients' quality 
of life), in which one or more of the tools were incorporated. 
 
Chapter 1 introduces the study topics and their background.  
 COPD is a disease characterised by airflow limitation that is not fully reversible. 
Typical symptoms of COPD are cough, sputum production, and dyspnoea. The major 
cause of COPD is smoking behaviour. The prevalence is estimated at 2,4% in men and 
1,7% in women with highest figures in elderly men (up to 16% in age 80-84) and in people 
with a low social-economic status. It is estimated that about 249.000 patients are 
predominantly treated in primary care.  
 Asthma is a chronic inflammation that causes an associated increase in airway 
hyperresponsiveness leading to recurrent episodes of wheezing, breathlessness, chest 
tightness, and coughing, particularly at night or in the early morning. Allergy is the 
predominant feature associated with asthma in children. Most children with mild asthma 
have a good prognosis but the children with moderate or severe asthma will probably 
continue to have some airway hyperresponsiveness throughout life. Moreover, 5 to 10 
percent of the children with mild asthma will suffer from severe asthma in later life. The 
prevalence in The Netherlands among adults was estimated at 1,3% and about 80% of the 
patients with asthma are were solely treated in primary care. 
 The introduction chapter gives an overview of the recommendations in several national 
and international guidelines on how to perform follow-up in adults once the diagnosis has 
been confirmed. Most guidelines recommend symptoms and lung function monitoring but 
are rather vague on aspects like patient education and action plans. Few guidelines contain 
recommendations for the frequency of monitoring and if so, these are not evidence-based. 
The guidelines vary heavily on the organisation of the follow-up, especially concerning the 
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roles of patients and their self-management on the one side and the pro-active role of 
professionals on the other. 
 Many chronic patients do no receive care according to the guideline recommendations. 
Disease management and integrated care models give a picture of how care ideally should 
look like:  
• co-ordinated comprehensive care delivery along the continuum of a disease and 
across health care delivery systems 
• according to (self-management-) protocols for groups of patients  
• targeted at systematic quality improvement of care using evidence on (cost-
effectiveness 
• yet stimulating patient-centredness and needs assessment. 
Information and communication technology is an important medium to support this 
approach. Primary care and general practice in particular build an important chain of 
actions in the disease management process. The studies in this thesis were focused on 
improving this chain with an emphasis on structuring the follow-up of patients as a core 
element in the management of COPD and asthma. The key issues targeted at were derived 
from the recommendations in the treatment guidelines:  
• evaluation of complaints and patients' quality of life 
• lung function  
• patient education and smoking cessation advice 
• medication prescription 
• follow-up frequency. 
 Researchers have the difficult task not only to evaluate components of integrated care 
or disease management programmes, but to evaluate the (cost-)effectiveness of disease 
management programmes as a whole. Up till now evidence on the (cost-)effectiveness of 
integrated packages for patients with mild to moderate chronic diseases, whether hospital 
or primary care based, is still inconclusive. Therefore, the studies in this thesis are not only 
focused on some of the components (in Section 1) but also on the effectiveness of 
monitoring systems as a whole (Section 2).  
 
Section 1:  
Tools. Development of instruments to support patient-tailored disease management in 
primary care 
Stimulating patient-centredness and needs assessment is an important component of 
disease management approaches. Daily care has to deal with individual patients, their 
needs and capacities. We developed some tools which can support the medical professional 
to focus on patients' needs and preferences in the context of guidelines-based primary care. 
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Chapter 2 describes the development and validation of a short instrument to assess and 
monitor quality of life (qol) in adults with COPD and/or asthma. The ultimate goal of 
medical attention and treatment is to stabilise and preferably improve disease-related qol. 
Treatment guidelines recommend regular attention for patients' physical complaints and a 
few recommend monitoring their quality of life. To get a feasible instrument for 
application during routine care we shortened the 55-item Quality of Life for Respiratory 
Illness Questionnaire (QoL-RIQ). Statistical procedures on the data of three controlled 
studies (n=328, 502 and 555 patients respectively) resulted in a 10-item shortform, the 
RIQ-MON10, consisting of two 5-item factors: (1) physical and emotional complaints and 
(2) physical and social limitations. Dyspnoea, forced expiratory volume in 1 s (FEV1), 
COOP/WONCA charts, the Medical Research Council-ECCS symptoms questionnaire and 
the MOS-SF 36 served as criteria to test its validity and responsiveness. The correlations of 
the shortlist with dyspnoea (r from 0.57 to 0.60), the generic health status instruments (r 
from 0.39 to 0.59) and lung function (r from 0.10 to 0.15) fulfilled the criteria. The short 
instrument proved to be reliable as the intraclass correlation between repeated scores in a 
stable group was 0.82. It showed discriminative responsiveness considering a clinical 
relevant score difference (>0.5) between upper and lower quartiles of convergent 
instruments and a standardised response mean of 0.86 in an improved group of patients. 
The RIQ-MON10 is a promising tool for the regular assessment of qol during routine 
primary care visits in patients with mild to moderate respiratory diseases. The instrument is 
presented in the Appendices section. 
 
Chapter 3 is focused on the development of formats for the electronic monitoring of 
patients with asthma during follow-up visits. We present a guidelines and consensus-based 
developmental procedure to outline the medical records for asthma in general practice. 
Clinical relevance, easy access and tuning to the needs of medical professionals were the 
main goals to aim at during the development. Apart from IT-specialists clinicians should 
be involved in the assessment of the content and the structure of medical records. That is 
why we involved a panel of general practitioners in selecting relevant and feasible 
recording topics and in choosing the recording formats in a series of adapted Delphi 
procedures. The basis formed a set of general practice guidelines for the diagnosis and 
treatment of asthma. Content analyses by a multidisciplinary team lead to a proposal of 
topics to be judged on relevance and recording feasibility in daily practice. In the following 
written and oral Delphi rounds the selection of topics was refined and registration formats 
were assessed. This procedure resulted in a relevant and applicable format for a disease-
specific electronic medical record as a supportive tool for the management of asthma in 
general practice.  
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 Both written and verbal commentary rounds proved to be necessary and the existence of 
a well-accepted set of guidelines was essential. The procedure is replicable for other 
diseases as well and was also applicated to establish a format for recording the 
management of COPD (not reported here).  
 
In Chapter 4 the process of development and validation of instruments to assess the 
educational needs of patients with ashma and COPD is presented. Good patient education 
is an essential part of disease management programmes in order to raise compliance with 
treatment, enhance self-management capacities and improve health outcomes. However, 
patient education is often suboptimal and not very patient-directed. It is well-known that 
patients often forget large parts of the information provided and that their needs of 
information are not met. We assume that stimulating patients' question-asking on the one 
hand and raising professionals' awareness of the educational needs of patients on the other 
can contribute to the quality of care. For that reason educational guidelines for asthma and 
COPD were transformed into educational needs assessment instruments to be fed forward 
just before or during a consultation. In the study in this chapter the instruments, the QPEN-
A and QPEN-C, were validated from the patient's point of view. Trial data of 104 patients 
having twice completed a prototype of the asthma instrument before practice visits, were 
used to test the content validity, internal consistency, sensitivity to change and 
acceptability of this prototype. Individual reading tests and focus group-interviews were 
performed to test readability and acceptability of final versions of both instruments. The 
asthma prototype had five dimensions (four of which showed moderate to good internal 
consistency) and was sensitive to change. In questionaires almost all patients (95%) 
confirmed the clarity of the instructions and the language of the prototype instrument. The 
acceptance was high as 90% or more of the patients agreed that the instrument was useful 
to them and that the completion procedure in the waiting room just before a practice visit 
was feasible. However, the subsequent reading tests and focusgroup interviews revealed 
various shortcomings. The prototype had to be revised in lay-out and phrasing and this 
resulted in a one-sided 38 topic list for asthma with space left to add personal topics about 
which information is wanted. A parallel procedure for COPD resulted in a 35 topic list. 
Patients in the focus groups considered the instruments especially useful shortly after 
diagnosis of the disease and preferred completion at home. Most patients were not in 
favour of continuous use during follow-up, but considered the instruments useful in case of 
change of treatment or their health status. The QPEN-A and QPEN-C can be used to 
stimulate patient-tailored structuring of education during routine primary care. The 
instruments are presented in the Appendices section. 
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Section 2: Effects. Implementation of monitoring systems in general practice: two RCT's 
The first two chapters report the results of a pragmatic cluster-randomised trial in 12 
general practices related to the Radboud University Medical Centre. These practices had 
used a monitoring system to record guidelines-based key items in the management of 
patients with asthma or COPD for a year. From the Department of General Practice they 
received feedback at practice and patient level concerning patients at risk or discrepancies 
between treatment recordings and the national guidelines. Our trial added a new 
component to this monitoring system: assessment and recording of patient's quality of life 
(qol) just before or during a regular follow-up visit. Gathering information on subjective 
health status may help the general practitioners to tailor their interventions to patients' 
needs and preferences. This is particularly relevant as in asthma and COPD individual 
patients' health perceptions or health-related qol cannot be directly deduced from their 
symptoms or lung function. Six practices continued the usual monitoring, the six practices 
in the intervention group performed qol-monitoring and received periodic feedback on 
patients with bad of deteriorating qol. For the monitoring a longer prototype of the RIQ-
MON10 was used to be completed in the waiting room before a regular follow-up visit. 
 
Chapter 5 shows the association between patient-reported qol and the medical 
interventions of the general practitioners. Information about qol, gathered systematically 
and routinely directly before consultation, could be integrated into the medical decision-
making process. Cross-sectional analyses (multivariate logistic regression analyses) on the 
monitoring data of 175 patients in 537 follow-up consultations showed that scores were 
related to various therapeutic interventions. Reported physical complaints were positively 
associated with changes in medication prescription (OR 1.7; 95% CI 1.0-2.8) and with 
education about the control regimen (OR 1.9; 95% CI 1.1-3.3). Reported emotional 
complaints were related to extra follow-up appointments (OR 4.3; 95% CI 1.5-12.8) and to 
counselling (OR 7.3; 95% CI 2.9-18.3). In general, more advanced age was related to less 
patient education. The majority of patients and GPs were positive about the qol 
monitoring.  
 
In Chapter 6 we analysed the effects of the qol-monitoring on various patient outcomes. 
The research question was if the regular extra attention to the disease-realated qol could 
improve patients' quality of life (measured by the QOL-RIQ and the MOS-SF 36), patient-
reported exacerbations, absenteeism from work or domestic duties, lung function (FEV1 % 
predicted), smoking status and their satisfaction with care delivery and education. Posttest 
measurements could be obtained from 309 patients (79.4%), 154 patients in the 
intervention and 155 in the control group. In both study conditions the 309 patients had on 
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average 2.5 follow-up visits after their inclusion in the monitoring system. The mixed 
multilevel regression analyses showed no statistical signifcant differences in the patient 
outcomes under study. Analyses on subpopulations having a lower qol or a comorbid 
condition at baseline, or having a low frequency of follow-up visits (≤ 2) during the 
intervention period also showed no significant differences with the exception of more 
absenteeism from work in the intervention subgroups. Although the qol-monitoring could 
be well integrated in the follow-up routine the question remains if we have selected the 
appropriate outcome measures and if this component of the disease management approach 
is worthwhile in the long term.  
 
The second cluster-randomised trial on monitoring and feedback of COPD and asthma was 
performed in general practices not related to the University Medical Centre. In a 
multifaceted intervention a guidelines-based computerised monitoring system was 
introduced in 10 practices. It was connected to the eletronic medical records already in use. 
The system included regular qol-monitoring using a prototype of the RIQ-MON10, to be 
completed at home or in the waiting room just before a practice visit. Control practices 
continued usual care but all practices in the experiment received spirometers and a short 
training on how to use them. Additionally the professionals in the 10 intervention practices 
got a short training on the treatment guidelines for COPD and asthma during installment of 
the electronic monitoring system. Quarterly the data from the system were downloaded and 
elaborated in feedback reports signalling patients at risk because of rapid lung function 
decline or deminishing qol, not having received smoking cessation advice or the proper 
medication. The following two chapters report the effects on patient outcomes and the 
acceptance of the monitoring regime by the patients involved.  
 
Chapter 7 presents the effects of the computerised monitoring and feedback system on 
patients' symptoms, qol, smoking behaviour and satisfaction with care after 24 months. 
The monitoring system was frequently used as 1557 practice visits were recorded. In the 
intervention condition the mean number of follow-up visits increased from 0.6 to 1.2 a 
year, whereas it decreased in the control condition from 0.7 to 0.5 (T 9.99, p<0.001). Visits 
because of exacerbations decreased in both conditions. In the intervention group eight out 
of 14 patient outcome parameters had improved compared to three in the control condition. 
In the intervention condition smoking and respiratory symptoms tended to decrease and 
absenteeism from domestic duties tended to increase. Multilevel linear or logistic 
regression on an intention to treat basis revealed only a statistical significant difference in 
patient satifsation. The intervention patients (n=215) were more satisfied with care and 
education than patients receiving usual care (n=249). The mixed influence on other patient 
SUMMARY 
152  
 
outcomes give rise to reconsider the recommendations about follow-up frequency in the 
guidelines. 
 
What patients themselves thought about the follow-up and the monitoring system is 
presented in Chapter 8. From 215 patients (75%) pre-structured questionnaires were 
received containing their opinion about the frequency and contents of follow-up. Of the 
study patients 20% were monitored once or twice and 55% three times or more. Quality of 
life monitoring was performed in 111 patients (39%). The majority of patients (60%) 
preferred a fixed control schedule, this was associated with older age. About one third 
preferred control visits only in case of deteriorating symptoms. Patients favoured 
spirometry and physical examination above education and counselling. Multiple logistic 
regression analyses showed that age, gender and education level were associated with these 
preferences. Younger patients < 40 and males were more in favour of spirometry than 
older patients and females. Lower educated people wanted less education on coping than 
patients with higher education. Most patients having participated in the qol-monitoring 
were positive about it. So patients were divided in their preferences concerning frequency 
and contents of the follow-up. Tailoring care needs focussing not only on clinical features 
of the disease but also on assessing these preferences. 
 
Chapter 9 presents a short overview of the results of the various studies in this thesis and a 
general discussion. 
 Some methodological considerations were presented, e.g. on the difficulties in 
performing real-life effectiveness trials in which a balance has to be found between 
restriction of the intervention interferences on the one hand and stimulating actual 
performance on the other. The chosen outcome measures were reconsidered, especially 
quality of life as many other influences beside the medical treatment in general practice 
can have an impact on this outcome. 
 The contribution of our studies to the knowledge base of multi-faceted implementation 
strategies was discussed as well. Our multi-faceted strategies contributed to the 
implementation of the guidelines: follow-up frequencies rose, spirometry was performed 
more often and lots of patients underwent systematically structured control visits which 
were focussed on key issues in the guidelines. 
 Repercussions for the management of COPD and asthma and future research were 
discussed. The main conclusions of this thesis are that there are various tools and methods 
to improve primary care based disease management of patients with asthma and COPD, 
but that follow-up recommendations need differentiation and tailoring, not least to patient 
preferences.  
  
 
 
 
Samenvatting 
 
SAMENVATTING 
154  
 
Astma en COPD (chronisch obstructief longlijden) zijn veel voorkomende 
luchtwegaandoeningen. In Nederland wordt het merendeel van de patiënten met mild of 
matig astma of COPD behandeld in de huisartspraktijk. Professionele richtlijnen bevatten 
aanbevelingen over het management van deze ziekten, gebaseerd op de nieuwste 
wetenschappelijke bewijzen en consensus onder de zorgprofessionals. Het is echter niet 
gemakkelijk om deze aanbevelingen in te passen in de dagelijkse zorgroutine. Dit 
proefschrift is gericht op instrumenten en procedures die de implementatie van de 
richtlijnen voor behandeling en regelmatige controles in de dagelijkse huisartspraktijk 
kunnen ondersteunen.  
 Na een inleiding worden de studies in twee secties gepresenteerd. In Sectie 1 
(Hoofdstuk 1-4) worden de ontwikkeling en validering van drie soorten instrumenten voor 
patiëntgericht ziektemanagement beschreven. Sectie 2 (Hoofdstukken 5-8) bevat de 
resultaten van twee pragmatische gerandomiseerde gecontroleerde onderzoeken over 
monitoring van astma en COPD (incl. de kwaliteit van leven van patiënten). Bij die 
monitoring werd gebruik gemaakt van een of enkele van de instrumenten uit Sectie 1. 
 
Hoofdstuk 1 introduceert de studie-onderwerpen en hun achtergrond.  
COPD is een ziekte die wordt gekarakteriseerd door een luchtwegbeperking die niet 
volledig reversibel is. Typische symptomen van COPD zijn hoesten, slijmproduktie en 
benauwdheid. De voornaamste oorzaak van COPD is rookgedrag. De prevalentie wordt 
geschat op 2,4% bij mannen en 1,7% bij vrouwen, waarbij de hoogste prevalentie wordt 
gevonden onder oudere mannen (tot 16% in de leeftijd 80-84) en bij mensen met een lage 
sociaal-economische status. Naar schatting zijn in Nederland ongeveer 249.000 patiënten 
primair onder behandeling in de eerste lijn. 
 Astma is een chronische luchtwegontsteking die leidt tot een toename van 
hyperreactiviteit van de luchtwegen met als gevolg herhaald optredende episodes van 
piepen, kortademigheid, benauwdheid en hoesten, 's nachts of vroeg in de ochtend. Het 
voornaamste kenmerk van astma bij kinderen is allergie. De meeste kinderen met mild 
astma hebben een goede prognose, maar de kinderen met matig of ernstig astma houden 
waarschijnlijk gedurende hun hele leven enige mate van hyperreactiviteit van de 
luchtwegen. Bovendien, 5 tot 10% van de kinderen met mild astma zal op latere leeftijd 
aan ernstig astma gaan lijden. De prevalentie onder volwassenen wordt in Nederland 
geschat op 1,3% en ongeveer 80% van de patiënten wordt louter in de eerste lijn 
behandeld. 
 Het introductie-hoofdstuk geeft een overzicht van de aanbevelingen in diverse nationale 
en internationale richtlijnen over het controlebeleid bij volwassenen, nadat de diagnose is 
bevestigd. De meeste richtlijnen bevelen aan om symptomen en longfunctie te monitoren 
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maar zijn tamelijk vaag over aspecten als patiëntenvoorlichting en actieplannen. Weinig 
richtlijnen bevatten aanbevelingen over de frequentie van de monitoring; deze zijn dan niet 
op wetenschappelijk bewijs gestoeld. De richtlijnen verschillen onderling aanzienlijk met 
betrekking tot de organisatie van het controlebeleid, met name waar het gaat om de rol van 
de patiënten en hun zelfmanagement enerzijds en de pro-actieve rol van de professionals 
anderzijds. 
 Veel chronische patiënten ontvangen niet de zorg die de richtlijnen aanbevelen. 
Modellen voor ziektemanagement en geïntegreerde zorg geven een beeld van hoe de zorg 
er idealiter uit zou moeten zien: 
• gecoördineerde alomvattende zorgverlening voor alle stadia van een ziekte en door 
systemen van zorgverlening heen 
• volgens (zelfmanagement) protocollen voor groepen van patiënten 
• gericht op systematische kwaliteitsverbetering van de zorg, gebaseerd op 
wetenschappelijk bewijs van (kosten-)effectiviteit 
• en toch gericht op het centraal stellen van de patiënten en de inschatting van hun 
behoeften. 
Informatie- en communciatietechnologie is een belangrijk medium om deze aanpak te 
ondersteunen. Eerstelijnszorg en huisartsgeneeskunde in het bijzonder vormen een 
belangrijke keten van acties in het proces van ziektemanagement. De studies in dit 
proefschrift waren erop gericht deze keten te verbeteren met de nadruk op het structureren 
van de controles bij patiënten als een kernelement in het management van COPD en astma. 
De studies richtten zich op kernonderwerpen die waren ontleend aan de aanbevelingen uit 
de behandelingsrichtlijnen:  
• evaluatie van de klachten en de kwaliteit van leven van de patiënten 
• longfunctie 
• patiëntenvoorlichting en stop-roken advisering 
• medicatievoorschriften 
• controlefrequentie. 
Onderzoekers hebben de moeilijke taak om niet alleen onderdelen van geïntegreerde zorg 
of ziektemanagement programma's te evalueren, maar ook de (kosten-)effectiviteit van 
deze programma's als geheel. Tot nu toe zijn de wetenschappelijke bewijzen over de 
(kosten-) effectiviteit van geïntegreerde zorgpakketten voor patiënten met een milde tot 
matige chronische aandoening, hetzij aangestuurd vanuit het ziekenhuis hetzij vanuit de 
eerstelijn, niet eenduidig. Daarom zijn de studies in dit proefschrift niet alleen gericht op 
enkele componenten (in Sectie 1) maar ook op de effectiviteit van monitoringsystemen als 
geheel (Sectie 2).  
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Sectie 1. Instrumenten. Ontwikkeling van instrumenten om patiëntgericht 
ziektemanagement in de eerstelijn te ondersteunen 
Een belangrijke component van ziektemanagement benaderingen is het stimuleren van 
gerichtheid op de patiënten en de inschatting van hun behoeften. De dagelijkse 
zorgverlening moet zich bezighouden met individuele patiënten, hun behoeften en 
vermogens. We ontwikkelden enkele instrumenten die de medische professional kunnen 
helpen om zich, binnen de context van op richtlijnen gebaseerde eerstelijns zorg, te richten 
op de behoeften en voorkeuren van patiënten. 
 
Hoofdstuk 2 beschrijft de ontwikkeling en validering van een kort instrument om de 
kwaliteit van leven van volwassenen met COPD en/of astma in te schatten en te volgen. 
Het uiteindelijke doel van medische aandacht en behandeling is het stabiliseren en zo 
mogelijk verbeteren van de ziektegerelateerde kwaliteit van leven. Behandelingsrichtlijnen 
bevelen aan dat men regelmatig aandacht besteedt aan de fysieke klachten van de 
patiënten, enkele bevelen ook aan om hun kwaliteit van leven te monitoren. Om een 
hanteerbaar instrument te krijgen dat toepasbaar is in de routinematige zorg hebben we de 
uit 55 items bestaande Quality of Life Respiratory Illness Questionnaire (QoL-RIQ) 
ingekort. Statistische procedures op de data van drie gecontroleerde studies (respectievelijk 
n = 328, 502 en 555 patiënten) resulteerden in een kort formulier van 10 items, de RIQ-
MON10, bestaande uit twee factoren van 5 items: (1) fysieke en emotionele klachten en (2) 
fysieke en sociale beperkingen. Benauwdheid, longfunctie (FEV1 = forced expiratory 
volume in 1 seconde), COOP/WONCA kaarten, de symptoomvragenlijst van de Medical 
Research Council-ECCS en de MOS-SF 36 dienden als criteria voor het testen van 
validiteit en responsiviteit. De correlaties van het korte formulier met benauwdheid (r van 
0.57 tot 0.60), de generieke gezondheidstoestand instrumenten (r van 0.39 tot 0.59) en de 
longfunctie (r van 0.10 tot 0.15) voldeden aan de criteria. Het korte instrument bleek 
betrouwbaar gezien de intraclass correlatie van 0.82 tussen de herhaalde scores in een 
stabiele groep patiënten. Het instrument vertoonde discriminatoire responsiviteit gelet op 
een klinisch relevant verschil in scores (>.5) tussen de bovenste en laagste kwartielen van 
convergente instrumenten en een gestandaardiseerd response gemiddelde van 0.86 in een 
groep verbeterde patiënten. De RIQ-MON10 is een veelbelovend instrument voor het 
regelmatig inschatten van de kwaliteit van leven van patiënten met milde tot matige 
luchtwegaandoeningen gedurende routinematige consulten in de eerstelijns zorg. Het 
instrument staat onder de Appendices weergegeven. 
 
Hoofdstuk 3 is gericht op het ontwikkelen van formats voor de elektronische monitoring 
van patiënten met astma gedurende controleconsulten. We presenteren een op richtlijnen 
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en op consensus gebaseerde ontwikkelingsprocedure, waarmee de vorm en de inhoud van 
de medische dossiers voor astma in de huisartspraktijk kunnen worden bepaald. Klinische 
relevantie, gemakkelijke toegankelijkheid en afstemming op de behoeften van de medische 
professionals waren de voornaamste doelen waarop de ontwikkeling was gericht. Naast 
ICT-deskundigen horen clinici betrokken te zijn bij het bepalen van de structuur en de 
inhoud van medische dossiers. Daarom werd in een serie van Delphi procedures een panel 
van huisartsen gevraagd relevante en toepasbare registratieonderwerpen te selecteren 
alsmede de formats voor de registratie. De basis werd gevormd door een set van richtlijnen 
voor de diagnose en behandeling van astma. Een multidisciplinair team deed daarop een 
inhoudsanalyse die leidde tot een voorstel voor registratie-onderwerpen die vervolgens 
moesten worden beoordeeld op relevantie en registratiemogelijkheden in de dagelijkse 
praktijk. In de daarop volgende schriftelijke en mondelinge Delphi rondes werd de selectie 
van onderwerpen verfijnd en werden registratieformats voorgesteld en beoordeeld. Deze 
procedure resulteerde in een relevant en toepasbaar format voor een ziektespecifiek 
elektronisch medisch dossier als een ondersteunend instrument voor het management van 
astma in de huisartspraktijk. Zowel schriftelijke als mondelinge commentaarrondes bleken 
noodzakelijk te zijn en het was essentieel dat er een goed geaccepteerde set van richtlijnen 
bestond. De procedure is herhaalbaar voor andere aandoeningen en werd ook toegepast 
voor het ontwikkelen van een registratieformat voor het management van COPD (hier niet 
gerapporteerd). 
 
In hoofdstuk 4 wordt het ontwikkelings- en valideringsproces gepresenteerd van 
instrumenten om de educatiebehoeften van patiënten met astma en COPD in te schatten. 
Goede patiëntenvoorlichting vormt een essentieel onderdeel van ziektemanagement 
programma's om compliantie met de behandeling te verkrijgen, het vermogen tot 
zelfmanagement te vergroten en de gezondheidsuitkomsten te verbeteren. Echter, 
patiëntenvoorlichting is vaak suboptimaal en niet erg patiëntgericht. Het is bekend dat 
patiënten vaak grote delen van de verkregen informatie vergeten en dat niet wordt 
ingespeeld op hun informatiebehoeften. We nemen aan dat het stimuleren van het stellen 
van vragen bij de patiënten enerzijds en het stimuleren van aandacht voor de 
voorlichtingsbehoeften van patiënten bij de professionals anderzijds positief bijdragen aan 
de kwaliteit van de zorgverlening. Daarom werden voorlichtingsrichtlijnen voor astma en 
COPD omgevormd tot instrumenten waarmee vlak voor of tijdens een consult de 
voorlichtingsbehoeften kunnen worden bepaald. In dit hoofdstuk worden deze 
instrumenten, de QPEN-A en de QPEN-C, gevalideerd vanuit het gezichtspunt van de 
patiënt. Om de inhoudsvaliditeit, sensitiviteit voor verandering en acceptatie van het astma 
instrument te toetsen gebruikten we de data uit een gecontroleerde studie waarin 104 
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patiënten tweemaal een prototype van het astma instrument vlak voor consulten hadden 
ingevuld. Individuele leestests en focusgroep interviews werden toegepast om de 
leesbaarheid en acceptatie van de definitieve versie van beide instrumenten te testen. Het 
astma prototype had vijf dimensies (vier ervan vertoonden matige tot goede interne 
consistentie) en was gevoelig voor verandering. In hun antwoorden in een vragenlijst 
gaven bijna alle patiënten (95%) aan dat de instructies en de taal van het prototype helder 
waren. Ook de acceptatiegraad was hoog aangezien 90% of meer van de patiënten het 
ermee eens was dat het instrument nuttig was voor hen en dat de invulprocedure in de 
wachtkamer vlak voor een consult goed toepasbaar was. Echter, de leestests en focusgroep 
interviews onthulden diverse gebreken. Het prototype moest worden bijgesteld qua lay-out 
en zinsbouw. Dit leidde tot een enkele pagina van 38 voorlichtingsonderwerpen voor astma 
met ruimte om persoonlijke onderwerpen waarover men informatie wenste daaraan toe te 
voegen. Een paralelle procedure voor COPD resulteerde in een lijst met 35 onderwerpen. 
De patiënten in de focusgroepen vonden de instrumenten vooral nuttig vlak nadat een 
diagnose is gesteld en gaven er de voorkeur aan ze thuis in te vullen. De meeste patiënten 
waren geen voorstander van een continu gebruik gedurende controles maar beschouwden 
de instrumenten nuttig ingeval hun behandeling of gezondheidstoestand zouden 
veranderen. De QPEN-A en QPEN-C kunnen worden gebruikt om patiëntgerichte 
structurering van de voorlichting gedurende routinematige eerstelijnszorg te stimuleren. De 
instrumenten staan weergegeven onder de Appendices. 
 
Sectie 2. Effecten. Implementatie van monitoringsystemen in de huisartspraktijk: twee 
gerandomiseerde gecontroleerde studies 
In de eerste twee hoofdstukken worden de resultaten gepresenteerd van een pragmatische 
clustergerandomiseerde trial in 12 huisartspraktijken die aan het UMC St Radboud waren 
gelieerd. Deze praktijken gebruikten al een jaar lang een monitoringsysteem om op 
richtlijnen gebaseerde kernonderwerpen voor het management van patiënten met astma of 
COPD te registreren. Van de Afdeling Huisartsgeneeskunde ontvingen zij feedback op 
praktijk- en patiëntniveau over risicopatiënten of discrepanties tussen hun registraties en de 
nationale richtlijnen. Onze trial voegde een nieuwe component aan dit monitoringsysteem 
toe: het inschatten en registreren van de kwaliteit van leven van de patiënt vlak voor of 
tijdens een regulier controleconsult. Het verzamelen van informatie over de subjectieve 
gezondheidstoestand van patiënten kan de huisartsen helpen om hun interventies af te 
stemmen op de behoeften en voorkeuren van patiënten. Dit is vooral relevant omdat bij 
astma en COPD de gezondheidsbeleving van patiënten of hun kwaliteit van leven niet 
rechtstreeks afgeleid kunnen worden van hun symptomen of longfunctie. Zes praktijken 
gingen door met de gewone monitoring, de zes praktijken in de interventiegroep volgden 
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tevens de kwaliteit van leven en ontvingen periodiek feedback over patiënten met slechte 
of achteruitgaande kwaliteit van leven. Voor de monitoring werd een langer prototype van 
de RIQ-MON10 gebruikt die in de wachtkamer vlak voor een regulier controleconsult 
moest worden ingevuld. 
 
Hoofdstuk 5 laat de associaties zien tussen door de patiënten gerapporteerde kwaliteit van 
leven en de medische interventies van de huisartsen. Informatie over de kwaliteit van 
leven, systematisch en routinematig verzameld vlak voor een consult, kon worden 
geïntegreerd in het proces van medische besluitvorming. Cross-sectionele analyses 
(multivariate logistische regressie) op de monitoringgegevens van 175 patiënten in 537 
controleconsulten lieten zien dat de scores samenhingen met diverse therapeutische 
interventies. Gerapporteerde last van fysieke klachten hing positief samen met verandering 
van medicatievoorschriften (OR 1.7; 95% CI 1.0-2.8) en met voorlichting over het 
controlebeleid (OR 1.9; 95% CI 1.1-3.3). Gerapporteerde last van emotionele klachten hing 
samen met extra controleafspraken (OR 4.3; 95% CI 1.5-12.8) en met counseling (OR 7.3; 
95% CI 2.9-18.3). Over het algemeen hing een hogere leeftijd samen met minder 
patiëntenvoorlichting. De meerderheid van de patiënten en de huisartsen was positief over 
het monitoren van de kwaliteit van leven. 
 
In hoofdstuk 6 analyseerden we de effecten van het monitoren van de kwaliteit van leven 
op diverse patiëntuitkomsten. De onderzoeksvraag was of de regelmatige extra aandacht 
voor de ziektespecifieke kwaliteit van leven leidde tot verbeteringen in de kwaliteit van 
leven van de patiënten (gemeten via de QOL-RIQ en de MOS-SF 36), de door de patiënten 
gerapporteerde exacerbaties, hun werkverzuim of verzuim bij het huishouden, de 
longfunctie (FEV1 in % van voorspeld), hun rookstatus en hun tevredenheid over de 
zorgverlening en de voorlichting. Van 309 patiënten (79.4%) konden nametingen worden 
verkregen, 154 in de interventie- en 155 in de controlegroep. In beide studiecondities 
hadden de patiënten gemiddeld 2.5 maal een controleconsult nadat ze in het 
monitoringsysteem waren opgenomen. De mixed multilevel regressie-analyses lieten geen 
statistisch significant verschil in patiëntuitkomsten zien. Analyses bij subpopulaties die bij 
het begin van de studie een lagere kwaliteit van leven hadden of comorbiditeit, of bij 
patiënten die weinig controles hadden gedurende de interventieperiode (≤ 2) lieten ook 
geen significant verschil zien met uitzondering van meer werkverzuim in de interventie 
subgroepen. Hoewel de kwaliteit van leven-monitoring goed kon worden geïntegreerd in 
de controleroutine blijft het de vraag of we wel de juiste patiëntuitkomsten hebben 
geselecteerd en of deze component van het ziektemanagement op de lange duur de moeite 
waard blijkt.  
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De tweede clustergerandomiseerde trial betreffende monitoring en feedback bij COPD en 
astma werd uitgevoerd in huisartspraktijken die niet aan het UMC waren gelieerd. Met 
behulp van een gecombineerde interventie werd een op richtlijnen gebaseerd 
gecomputeriseerd monitoringsysteem in 10 praktijken geïntroduceerd. Dit was verbonden 
met de elektronische medische dossiers die al in gebruik waren. In het monitoringsysteem 
was regelmatige kwaliteit van leven-monitoring opgenomen, waarbij een prototype van de 
RIQ-MON10 werd gebruikt dat thuis of in de wachtkamer vlak voor een controleconsult 
moest worden ingevuld. De praktijken in de controleconditie gingen door met hun 
gebruikelijke zorgverlening, maar alle praktijken ontvingen spirometers en een korte 
training in het gebruik ervan. Terwijl het elektronisch monitoringsysteem werd 
geïnstalleerd kregen de professionals in de 10 interventiepraktijken aanvullend een korte 
educatie over de behandelingsrichtlijnen voor COPD en astma. Per kwartaal werden de 
data uit het systeem gehaald en verwerkt in feedbackrapporten, waarin patiënten werden 
gesignaleerd die risico liepen wegens een snelle longfunctiedaling of vermindering van 
kwaliteit van leven, of die niet een stop-roken advies of de aanbevolen medicatie hadden 
ontvangen. De volgende twee hoofdstukken doen verslag van de effecten op 
patiëntuitkomsten en de acceptatie van het monitoringbeleid door de betrokken patiënten. 
 
Hoofdstuk 7 geeft de effecten weer van het gecomputeriseerde monitoring- en 
feedbacksysteem op patiëntuitkomsten, kwaliteit van leven, rookgedrag en tevredenheid 
over de zorg na 24 maanden. Blijkens de registratie van 1557 consulten werd het 
monitoringsysteem frequent gebruikt. In de interventieconditie steeg het gemiddelde aantal 
controleconsulten van 0.6 naar 1.2 per jaar, terwijl dit verminderde in de controleconditie 
van 0.7 naar 0.5 (T 9.99, p<0.001). Het aantal consulten wegens exacerbaties verminderde 
in beide condities. In de interventiegroep verbeterden acht van de 14 uitkomstparameters 
vergeleken met drie in de controleconditie. In de interventieconditie was er een tendens tot 
daling van het rookgedrag en luchtwegsymptomen, terwijl er een tendens tot stijging was 
in het verzuim bij huishoudelijke taken. Multilevel lineaire of logistische regressie op een 
‘intention to treat’ basis liet slechts in de tevredenheid over de zorg een statistisch 
significant verschil zien. De interventiepatiënten (n=215) waren tevredener over de zorg en 
de voorlichting dan de patiënten die de gebruikelijke zorg ontvingen (n=249). De 
gemengde invloed op de andere patiëntuitkomsten geeft aanleiding tot het heroverwegen 
van de aanbevelingen voor controlefrequentie in de richtlijnen. 
 
Wat de patiënten zelf vonden van het controle- en monitoringsysteem wordt in hoofdstuk 
8 gepresenteerd. Van 215 patiënten (75%) werden voorgestructureerde vragenlijsten 
ontvangen, waarin hun mening stond over de frequentie en inhoud van de controles. Van 
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de studiepatiënten was 20% een- of tweemaal gemonitord en 55% drie keer of meer. De 
monitoring van kwaliteit van leven was bij 111 patiënten (39%) gebeurd. De meerderheid 
van de patiënten (60%) gaf de voorkeur aan een vast controleschema; dit hing samen met 
een hogere leeftijd. Ongeveer een derde prefereerde controles slechts ingeval van 
verslechterende symptomen. De patiënten gaven de voorkeur aan spirometrie en 
lichamelijk onderzoek boven voorlichting en counseling. Multipele logistische regressie-
analyses lieten zien dat leeftijd, geslacht en educatieniveau samenhingen met deze 
voorkeuren. Jongere patiënten < 40 jaar en mannen gaven meer de voorkeur aan 
spirometrie dan oudere patiënten en vrouwen. Patiënten met een lagere scholing wilden 
minder educatie over het omgaan met de ziekte dan patiënten met een hoger 
opleidingsniveau. De meeste patiënten bij wie kwaliteit van leven was gemonitord waren 
positief daarover. De patiënten bleken dus verdeeld te zijn over de frequentie en de inhoud 
van de controles. Zorgverlening op maat houdt niet alleen in dat men aandacht heeft voor 
de klinische kenmerken van de ziekte maar ook voor deze voorkeuren van patiënten.  
 
Hoofdstuk 9 levert een kort overzicht van de resultaten van de diverse studies in dit 
proefschrift en een algemene discussie. 
 Enkele methodologische overwegingen worden gepresenteerd, vooral met betrekking tot 
de moeilijkheden van het uitvoeren van effectiviteitsonderzoek in de werkelijkheid van de 
praktijk van alledag, waarin een balans moet worden gezocht tussen een beperking van de 
interventiebemoeienissen enerzijds en het stimuleren van kwaliteitsverbetering in de 
zorgverlening anderzijds. De gekozen uitkomstmaten worden overwogen, in het bijzonder 
kwaliteit van leven, aangezien naast de medische behandeling in de huisartspraktijk vele 
andere invloeden deze uitkomstmaat kunnen meebepalen. 
 De bijdrage van onze studies aan de kennis over gecombineerde interventiestrategieën 
wordt eveneens besproken. Onze gecombineerde strategieën droegen bij aan de 
implementatie van de richtlijnen: controlefrequenties stegen, spirometrie werd vaker 
toegepast en vele patiënten kregen systematisch gestructureerde controleconsulten die 
waren gericht op de kernelementen uit de richtlijnen. 
 Repercussies voor het management van COPD en astma worden besproken. De 
voornaamste conclusies van dit proefschrift zijn dat er diverse instrumenten en methoden 
zijn om het op de eerstelijnszorg gebaseerde management van patiënten met astma en 
COPD te verbeteren, maar dat de aanbevelingen voor controles dienen te worden 
gedifferentieerd en op de individuele patiënt en ook op diens voorkeuren dienen te worden 
afgestemd. 
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Dankwoord 
 
Eindelijk is het af, het "boekje". Sommigen durfden er al niet meer naar te vragen. Ook de 
gepaste druk van promotor Richard Grol ("absolute prioriteit, resultaatgerichte afspraak 
nummer een") had lange tijd niet het gewenste effect. Ik moest vaak terugdenken aan wat 
Noud Bles, voormalig afdelingsbeheerder en manager van het cluster Biomedische 
Wetenschappen en Extramurale Geneeskunde, zei toen ik aankondigde te starten met een 
promotietraject naast het managen van de interuniversitaire Werkgroep Onderzoek 
Kwaliteit (WOK), inclusief een dag werken in Maastricht: "het is een hele lastige 
combinatie, het onderzoek komt vaak in de knel". En inderdaad, het was moeilijk te 
combineren. Het management ging altijd voor, de snelgroeiende afdeling in Nijmegen 
vergde veel aandacht en tijd. Managen en onderzoek doen vereisen ook een andere 
houding, het ene vraagt om snelle beslissingen, regelen, praten, vergaderen, korte notities 
en het andere vraagt vooral om reflectie, veel lezen en weloverwogen gedocumenteerde 
schriftelijke productie. Het switchen ging me moeilijk af en lukte eigenlijk alleen goed in 
rustige vakantieperiodes. Maar uiteindelijk ligt het proefschrift er dan. 
 Onderzoek doen op het gebied van implementatie van kwaliteitsverbeteringen in de zorg 
bevat in zichzelf ook weer een spanningsverhouding tussen het implementeren van de te 
onderzoeken interventies (dus ontwerpen, organiseren, regelen, stimuleren) en het 
evalueren van de resultaten van de interventies (valideren, analyseren, beschrijven). Dit 
type onderzoek is, zeker als het om grote patiënten- of praktijkpopulaties gaat, geen 
solistische onderneming maar teamwork. Bij mijn onderzoek heb ik kunnen profiteren van 
de inzet en kennis van veel interne en externe collega's. Op het gevaar af dat ik collega's 
vergeet wil ik hieronder enkelen persoonlijk noemen. 
 
Ik begin met Richard Grol, aanstichter en inspirator van zowel de WOK (inmiddels in 
Nijmegen omgedoopt tot de Afdeling Kwaliteit van Zorg) als van dit onderzoek. Het idee 
om kwaliteit van leven te gaan monitoren in de controles van patiënten met astma en 
COPD was van jou afkomstig. Dit was mijn eerste onderzoek. Het was stimulerend om het 
onderzoek in te bedden in de groeiende, vooral door jou geïnstigeerde en verzamelde 
kennis over de zin en onzin van strategieën en methoden van kwaliteitsverbetering en 
implementatie van richtlijnen voor de zorg. Bij het schrijven van het proefschrift heb ik 
graag gebruik gemaakt van die kennis, die onder de redactie van jou en Michel Wensing in 
het Handboek Implementatie is neergelegd. Je werd wel eens wanhopig van mijn gedraal; 
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de laatste jaargesprekken gingen vooral daarover. De volgende gesprekken worden beslist 
gevarieerder.  
 
Eloy van de Lisdonk, mede-auteur van het eerste onderzoeksvoorstel, dat bij het 
Nederlands Astma Fonds werd ingediend (deels geschreven in de keuken van je huis, zodat 
we met recht kunnen zeggen dat het voorstel uit jouw keuken kwam) en contactpersoon 
voor de Nijmeegse Monitoring Praktijken (NMP). Dank voor je steun en inzet, met name 
bij de eerste trial. 
 
Ivo Smeele, een tijdlang mijn roommate en nu enthousiaste coördinator van de CAHAG 
(COPD en Astma Huisartsen Advies Groep). Ik heb voor de beide trials uit mijn onderzoek 
veel aan je te danken: in je eigen promotie-onderzoek had je bij de NMP al een 
monitoringsysteem voor astma en COPD ontworpen, diverse vragenlijsten en 
meetinstrumenten kon ik van je overnemen, je gaf adviezen over hoe ik het best met de 
medewerkers uit de huisartspraktijken kon omgaan, je bemiddelde bij het verkrijgen van 
spirometers etc. etc. Zonder jou zouden de beide trials niet van de grond zijn gekomen.  
Leuk dat je mijn co-promotor bent.  
 
Chris van Weel, mijn tweede promotor, heeft mij in de laatste fase zeer gestimuleerd mijn 
artikelen af te ronden. In een reeks persoonlijke en mailcontacten was zijn kritische 
commentaar op de concepten erop gericht de implicaties van de studies voor de 
huisartsgeneeskundige praktijk goed te verwoorden. Chris, mijn dank voor het mij “achter 
de vodden zitten”. 
 
Geert Schattenberg, onderzoeksassistent van het eerste uur. Ik vergeet nooit meer hoe we 's 
nachts terugkerend van een implementatiebezoek in the middle of nowhere en met een 
bijna lege tank op zoek gingen naar een benzinepomp. Implementatie-onderzoek is 
spannend. We zijn zakelijk wat gebrouilleerd de laatste tijd, maar dat neemt niet weg dat ik 
je hartelijk wil danken voor je ondersteuning bij de beide experimenten. Je zorgvuldigheid 
in de contacten met de praktijken, bij het beheren van de databestanden en het opstellen 
van de monitoringschermen en feedbackrapporten in de tweede trial zorgden ervoor dat ik 
zonder twijfel op de gegevens uit het onderzoek kon vertrouwen.  
 Waling Tiersma, tweede onderzoeksassistent van het eerste uur, verwerkte de door 
Willem van Gerwen beheerde NMP-data in statistische programmatuur voor de eerste trial, 
maakte de monitoringprogrammatuur voor de tweede trial, voerde voor beide statistische 
analyses uit en zorgde ervoor dat mijn zeer gelaagde multilevel modellen tot hanteerbare 
proporties werden teruggebracht. In de laatste periode heeft Reinier Akkermans Waling's 
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taken overgenomen en op een efficiënte en heldere wijze meegedacht met de analyses en 
hun interpretatie. Heren, bedankt voor jullie assistentie.  
 
Wie ik ook zeker niet mag vergeten is Jolanda van Haren, die al jarenlang de secretariële 
ondersteuning verzorgt voor mijzelf en de onderzoeken uit mijn onderzoekslijn. Zij weet 
gelukkig dat ze me af en toe moet wijzen op dingen die ik dreig te vergeten en vangt 
telefoontjes voor me op. Ze mopperde wel als mijn planning te krap was maar deed haar 
eigen bel- en invoerklussen volgens schema. De lay-out en correcties van de artikelen en 
het drukklaar maken van het proefschrift kon ik met een gerust hart aan haar overlaten. 
Jolanda, dank je wel voor je jarenlange trouwe ondersteuning, waar ook de nieuwe 
promovendi uit de onderzoekslijn zeker veel baat bij zullen hebben. 
 
Het was teamwork zoals ik al schreef. Dit blijkt ook uit de co-auteurschappen van de 
artikelen. Een deel van de studies is voortgekomen uit de financiering door het Nederlands 
Astmafonds van een Research Ontwikkelings Plaats; waaraan onder meer Ben Bottema, 
Ben van Steenkiste, Marijke de Konink, Herman Levelink en Bart Thoonen hebben 
geparticipeerd. Beste collega's het was een inspirerend genoegen om met jullie aan de 
diverse projecten te werken.  
 
Een proefschrift zoals dit is een product van uitwisseling en samenwerking, vooral met 
collega's van de Afdeling Kwaliteit van Zorg (WOK), Huisartsgeneeskunde en de 
Voortgezette Opleiding tot Huisarts van het UMC Nijmegen. Het is onbegonnen werk om 
al degenen die met hun discussies, literatuur en tips aan dit product hebben bijgedragen 
persoonlijk te bedanken. Daarom een algemeen "dank jullie wel" aan de collega's van deze 
drie afdelingen. Ik wil hier tevens de hoop uitspreken dat de samenwerking tussen de 
afdelingen die onlangs is geformaliseerd in het Nijmeegs Universitaire Huisartsen Netwerk 
(NUHP), in de toekomst tot veel voor de huisartspraktijk inspirerend onderzoek en 
relevante producten moge leiden. 
 
Van de externe collega-onderzoekers wil ik Rianne Maillé, psychologe werkzaam bij het 
Julius Centrum en ontwikkelaar van de Quality of Life Respiratory Index Questionnaire, 
niet onvernoemd laten. We hebben geworsteld met de inkorting van haar vragenlijst tot een 
handzaam instrument voor de dagelijkse praktijk. Rianne, dank je voor de fijne 
samenwerking. 
 Met Annemone Bögels, tot voor kort werkzaam als programmacoördinator van het 
Nederlands Astma Fonds, werd jarenlang intensief samengewerkt om de 
patiëntenvoorlichting in de huisartspraktijk van richtlijnen en hulpmiddelen te voorzien. 
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Wij werden gedreven door het belang dat we beiden hechtten aan dit aspect van de zorg 
voor astma- en COPD-patiënten. Anemone, ook jij bedankt voor je inzet. 
 
Studies, zoals beschreven in dit proefschrift, kunnen in de huidige universitaire constellatie 
zelden worden uitgevoerd zonder subsidies van buitenaf. Bij deze wil ik mijn dank 
uitspreken voor de financiers van de onderzoeken: het Nederlands Astma Fonds en 
GlaxoSmithKline.  
 
Tot nu toe heb ik het alleen maar over collega's gehad, maar iedereen weet dat promotie-
onderzoek doen alleen maar goed mogelijk is bij een stabiel thuisfront, waar je begrip 
ondervindt als het eens tegenzit, je je ook eens met andere dingen kunt bezighouden dan 
met je werk en waar je je kunt onspannen. Bij mijn sollicitatie voor de functie als 
wetenschappelijk secretaris van de WOK in Maastricht werd mij gevraagd hoe de 
thuissituatie was. Kennelijk was de functie zo zwaar dat er men zich ervan wilde 
overtuigen dat het thuisfront liefdevol en zonder al te veel spanningen was. Ik antwoordde 
dat het "afgezien van eten koken en bewassing" wel snor zat met mijn partner Linie. Zij 
vormt al ruim twintig jaar een liefdevol thuisfront en mijn dank in deze vorm en op deze 
plek uitgedrukt is beslist inadequaat om haar belangrijke rol in mijn leven te 
weerspiegelen. 
 
De betrekkelijkheid van mijn werk en het onderzoek werd ons goed duidelijk door het 
stervensproces en overlijden in 2005 van mijn vader en in 2006 van mijn schoonmoeder. 
Zij kunnen zelf niet meer bij de promotieplechtigheid en het feest zijn, maar in onze 
gedachten zijn ze toch aanwezig. Het doet goed dat mijn moeder en overige familieleden 
nu eens bij een meer vrolijke gebeurtenis aanwezig kunnen zijn. 
 
Eigenlijk hadden ze bovenaan moeten staan, de medewerkers en patiënten van de 
praktijken die in mijn onderzoek waren betrokken. Zonder hen geen experimenten en geen 
gegevens waarop wetenschappelijke kennis kan voortbouwen. 
 Honderden astma- en COPD-patiënten hebben korte of lange vragenlijsten ingevuld, 
tientallen hebben meegewerkt aan individuele of groepsinterviews. Ik dank hen van harte 
voor hun medewerking. De medewerking van de NMP en van 22 niet aan het UMC 
Nijmegen gelieerde praktijken was onontbeerlijk voor het onderzoek. Naast hun drukke 
praktijk hebben de medewerkers extra formulieren moeten invullen en schriftelijk of 
mondeling allerlei vragen moeten beantwoorden. Ik dank hen hartelijk voor hun inzet en 
hoop dat de resultaten van het onderzoek op enigerlei wijze zullen bijdragen aan een 
optimale zorgverlening voor hun astma en COPD-patiënten. 
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Curriculum Vitae 
 
Annelies Jacobs is geboren in Malden en volgde als oudste uit een gezin met vier kinderen 
qua scholing een zogenaamd "tweede weg" traject. Na de MULO ging zij op haar 16e 
werken als schadecorrespondente op een verzekeringskantoor, in de avonduren deed zij de 
middelbare school (HBS) en volgde zij cursussen stenografie en Engels. In de roerige jaren 
zeventiger van de vorige eeuw studeerde zij sociologie en filosofie aan de Radboud 
Universiteit Nijmegen. Zij begeleidde als student-assistente onder meer werkgroepen in 
Kiel, Antwerpen en Nijmegen. Ze nam zitting in de subfaculteitsraad en 
onderzoekscommissie van de vakgroep Sociologie en schreef stukjes over het 
onderzoeksbeleid in studentenblaadjes. Geen duidelijk toekomstperspectief voor ogen 
hebbend, onderbrak zij haar studie en ging werken bij de administratie van de 
personeelsafdeling van het UMC St Radboud, alwaar ze eindigde als een soort eenvrouws 
sociale dienst voor ruim 300 gerechtigden op een werkloosheidsuitkering. 
 Uiteindelijk studeerde zij cum laude af in de Medische Sociologie (bij wijlen Jean 
Persoon) en werd zij in 1991 aangesteld als wetenschappelijk secretaris van de Werkgroep 
Onderzoek Kwaliteit (WOK). Naast het organiseren van halfjaarlijkse WOK-
bijeenkomsten en andere vormen van stafoverleg, kwam het accent al spoedig te liggen op 
het beheer van de snelgroeiende Nijmeegse poot van de WOK. Vanaf 1994 deed zij 
daarnaast eigen onderzoek, in het begin vooral op het gebied van het disease management 
bij chronische ziekten (met name bij COPD en astma), later meer op het terrein van 
lifestyle interventies, zoals stoppen met roken. In de loop der jaren verwierf zij subsidies 
voor ruim twintig projecten. 
 Momenteel is Annelies senior-onderzoeker en managementcoördinator bij de afdeling 
Kwaliteit van Zorg (WOK) van het UMC St Radboud. Zij is bestuurder van de CAHAG 
(COPD en Astma Huisartsen Advies Groep) en onder meer betrokken geweest bij de 
ontwikkeling van de landelijke richtlijnen voor COPD en voor de Behandeling van 
Tabaksverslaving. 
 Zij woont al 20 jaar samen met haar levenspartner Linie Plukker, schrijfster en eveneens 
sociologe. 
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Annelies Jacobs was born in Malden, The Netherlands, and as eldest of a family of four 
children she followed a staged educational pathway. After lower secondary school 
(MULO) she started working as a claim correspondent at an insurance office. In the 
evening hours she followed courses in stenography, English and finished secondary 
education (HBS). 
 In the roary seventies of the last century she studied sociology and philosophy at the 
University of Nijmegen. During her study period she also worked as a teaching assistant in 
Nijmegen, Kiel (Germany) and Antwerp (Belgium). She was a student representative in the 
council of the Department of Sociology and wrote short pieces about research policy in a 
student magazine. Lacking a clear perspective on her personal future she started working at 
the administration of the personnel department of the Radboud University Medical Centre, 
where she ended up as a kind of single-handed social service for more than 300 former 
employees entitled to an unemployment allowance. Finally she graduated cum laude in 
Medical Sociology (directed by the late Jean Persoon) and in 1991 she was appointed as 
scientific secretary of the Centre for Quality of Care Research (WOK) of the Universities 
of Nijmegen and Maastricht. Besides the organisation of half-yearly research meetings and 
staff conferences the main focus of work had soon to be put on the management of the fast-
growing Department in Nijmegen. Since 1994 she has part-time performed her own 
research next to these tasks. At the beginning mainly in the area of chronic disease 
management, especially of COPD and asthma, later more on topics concerning lifestyle 
interventions like smoking cessation. She acquired grants for over twenty research projects.  
 At the moment Annelies is a senior researcher at the Centre for Quality of Care 
Research (WOK) in Nijmegen and as its management coordinator she is a member of the 
Board of the Department. She is a member of the Board of the CAHAG (COPD and 
Asthma Advisory Group in General Practice) and among other things she participated in 
the development of national guidelines on diagnosis and treatment of COPD and on 
treatment of tabacco addicition.  
 For 20 years now she lives together with her partner Linie Plukker, a writer and 
sociologist as well. 
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A. How much have you been troubled during the past 4 weeks by the following complaints, because of 
your airway disease? 
 Æ Please circle just one answer in each row that most precisely fits your situation  
  
 
 
not 
at all 
 
(very) 
little 
 
pretty or 
considerably 
 
(very) much 
 
difficulty breathing in air ...............................
 
1 
 
2 
 
3 
 
4 
 
wheezing........................................................
 
1 
 
2 
 
3 
 
4 
waking up in the night or early in the 
morning because of breathing problems........ 1 2 3 4 
puzzled about my breathing problems...........
 
1 
 
2 
 
3 
 
4 
short-tempered, impatient with others ...........
 
1 
 
2 
 
3 
 
4 
 
 
B. How much have you been troubled during the past 4 weeks performing the following activities 
(because of your breathing problems)? 
Æ Please circle just one answer in each row that most precisely fits your situation 
 
 
 
 
not 
at all 
 
(very) 
little 
 
pretty or 
considerably 
 
(very) 
much 
 
unable 
to do so 
 
I didn't 
do this 
 
being unable to do my daily 
activities ..................................
 
1 
 
2 
 
3 
 
4 
 
5 O 
walking upstairs ...................... 1 2 3 4 5 O 
shopping .................................. 1 2 3 4 5 O 
kissing and/or cuddling ........... 1 2 3 4 5 O 
going out for a day-trip ........... 1 2 3 4 5 O 
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A.  Hoeveel last hebt u in de afgelopen 4 weken gehad van de volgende klachten, in verband met uw 
astma of COPD? 
 → Omcirkel op elke regel telkens één cijfer dat uw antwoord het beste weergeeft 
 
 geheel 
geen 
last 
erg weinig
of een 
beetje last 
redelijk 
of flink 
wat last 
veel of 
heel erg 
veel last 
 
Moeilijk kunnen inademen................................ 
 
 
1 
 
 
2 
 
3 
 
 
4 
 
Een piepende ademhaling.................................. 
 
 
1 
 
2 
 
3 
 
4 
 
's Nachts of  's morgens wakker worden door 
ademhalingsproblemen..................................... 
 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
Piekeren over mijn ademhalingsklachten......…. 
 
 
1 
 
2 
 
3 
 
4 
 
Ongeduldig, prikkelbaar tegenover anderen... 
 
 
1 
 
2 
 
3 
 
4 
 
B. Hoeveel last hebt u in de afgelopen vier weken gehad met het uitvoeren van de volgende 
activiteiten (als gevolg van uw ademhalingsproblemen)? 
→ Omcirkel op elke regel telkens één cijfer dat uw antwoord het beste weergeeft 
 
 
 
geheel 
geen 
last 
erg weinig
of een 
beetje last
redelijk 
of flink 
wat last 
veel of 
heel erg 
veel last 
kan ik niet 
te veel 
last 
niet 
gedaan
 
Niet mijn gewone 
werkzaamheden/ bezigheden 
kunnen uitvoeren....... 
 
 
 
1 
 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
O 
 
 
Trap lopen.................................... 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
O 
 
Winkelen, boodschappen doen, 
stadten......................................... 
 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
O 
 
Kussen en/of knuffelen.................. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
O 
 
De deur uitgaan voor een uitstapje 
(een dagje weg)............................. 
 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
O 
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YOUR QUESTIONS ABOUT ASTHMA 
All questions in this list are related to asthma. You can use the list as an aid for your visits to the general 
practice. If you would like to get an answer to some questions in this list you can tick them. In the practice 
you can hand over this list to the GP, the practice nurse or the receptionist. One of them can answer your 
questions. If you have many questions they may not be answered all together at the same time. For the 
remaining questions you can make a follow-up appointment.  
Asthma in general 
 What is asthma? 
 What causes asthma? 
 What exactly happens during an attack of 
shortness of breath? 
 What is hypersensitivity of the airways 
(hyperreactivity)? 
 What is an allergy?  
 What is the course of asthma in most people? 
 
Examination   
 What is a peak flow? 
 Why is my peak flow measured? 
 How can I measure my own peak flow? 
 In what way will I be tested for allergies? 
 Am I allergic to something? 
  
Treatment  
 What can be achieved with the treatment of 
my asthma? 
 How strictly should I follow the treatment 
instructions? 
 When should I contact the GP? 
 Do I have to see the GP for control visits? 
 When will the GP refer me to a chest 
physician? 
 
There are two ways to treat your asthma which 
can seperately or together lead to a reduction of 
the complaints: treatment without or besides 
medication and treatment with medication  
 
Treatment without or besides medication 
 What can I do to prevent allergic complaints? 
 Which measures can I take at home to reduce 
trouble from irritating substances? 
 Which measures can I take at my work to 
reduce trouble from irritating substances? 
 How important is physical exercise (sports) for 
my asthma? 
 What can I do to prevent exercise-induced 
asthma? 
 What is the effect of smoking and passive 
smoking on my asthma? 
 How can I quit smoking? 
 Why is it important for me to get a flu 
vaccination each year? 
 What can I do about my fear of breathlessness? 
 What can the Dutch Asthma Foundation and the 
patients' association VbbA mean to me?   
 
Treatment with medication 
 How do long-acting bronchodilators work? 
 How do short-acting bronchodilators work? 
 How do corticosteroids that you have to inhale 
work? 
 How do corticosteroids that you have to swallow 
work? 
 Why should I take or not take specific 
medication? 
 How often should I take my medication and how 
much? 
 In what way should I take my medication? 
 What are the side-effects of my medication? 
 What is the advantage of inhaling? 
 What is the right manner to inhale? 
 What can I do if I feel uncomfortable to take 
medication in company? 
 What should I do if my complaints worsen? 
 
Do you have any other questions about asthma 
that are not in the list? Please fill them in below. 
 
 ....……………………....…………………… 
 ....……………………....…………………… 
 ....……………………....…………………… 
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UW VRAGEN OVER ASTMA 
In deze lijst staan vragen die allemaal iets te maken hebben met astma. U kunt de lijst gebruiken als 
hulpmiddel voor uw bezoeken aan de huisartspraktijk. Als er vragen op de lijst staan waar u een antwoord 
op wilt weten, kunt u deze aankruisen. Geef deze lijst in de huisartspraktijk aan de huisarts, assistente of 
verpleegkundige. Eén van hen kan uw vragen beantwoorden. Als u veel vragen heeft, kunnen deze 
misschien niet allemaal worden beantwoord. Voor vragen die overblijven kunt u een vervolgafspraak 
maken.  
Astma in het algemeen 
 Wat is astma? 
 Waardoor ontstaat astma? 
 Wat gebeurt er precies tijdens een aanval van 
kortademigheid? 
 Wat is overgevoeligheid van de luchtwegen 
(hyperreactiviteit)? 
 Wat is allergie? 
 Hoe verloopt astma bij de meeste mensen? 
 
Onderzoeken 
 Wat is een piekstroom? 
 Waarom wordt mijn piekstroom gemeten? 
 Hoe kan ik zelf mijn piekstroom meten? 
 Op welke manier wordt bij mij allergie getest? 
 Ben ik zelf ergens allergisch voor? 
 
Behandeling 
 Wat kan er worden bereikt met de behandeling 
van mijn astma? 
 Hoe strikt moet ik de behandelingsvoor-
schriften naleven? 
 Wanneer moet ik contact opnemen met de 
huisarts? 
 Moet ik naar de huisarts voor controle-
bezoeken?  
 Wanneer verwijst de huisarts mij door naar een 
longarts? 
 
Er zijn twee manieren om uw astma te behandelen, 
die apart of samen kunnen leiden tot vermindering 
van de klachten: behandeling zonder of naast 
medicijnen en behandeling met medicijnen 
 
Behandeling zonder of naast medicijnen 
 Wat kan ik doen om allergische klachten te 
voorkomen? 
 Welke maatregelen kan ik thuis nemen zodat ik 
minder last heb van prikkelende stoffen? 
 Welke maatregelen kan ik op mijn werk nemen 
zodat ik minder last heb van prikkelende 
stoffen? 
 
 
 Hoe belangrijk is lichaamsbeweging (sport) voor 
mijn astma? 
 Wat kan ik doen om inspanningsastma te 
voorkomen? 
 Wat is het effect van roken en meeroken op mijn 
astma? 
 Hoe kan ik stoppen met roken? 
 Waarom is het belangrijk dat ik elk jaar een 
griepprik krijg? 
 Wat kan ik doen aan mijn angst voor 
benauwdheid? 
 Wat kunnen het Nederlands Astma Fonds en de 
patiëntenvereniging VbbA voor mij betekenen?   
 
Behandeling met medicijnen 
 Wat doen langwerkende luchtwegverwijders? 
 Wat doen kortwerkende luchtwegverwijders? 
 Wat doen ontstekingsremmers (corticosteroïden) 
die je moet inhaleren? 
 Wat doen ontstekingsremmers (corticosteroïden) 
die je moet inslikken? 
 Waarom moet ik bepaalde medicijnen juist wel of 
juist niet innemen? 
 Hoe vaak moet ik mijn medicijnen innemen en 
hoeveel? 
 Op welke manier moet ik mijn medicijnen 
innemen? 
 Wat zijn de bijwerkingen van mijn medicijnen? 
 Wat is het voordeel van inhaleren? 
 Wat is de goede manier van inhaleren? 
 Wat kan ik doen als ik moeite heb met het gebruik 
van medicijnen in gezelschap? 
 Wat moet ik doen als mijn klachten erger worden?
 
Heeft u andere vragen over astma die niet op de 
lijst staan? Vul ze dan hier in. 
 
 ....……………………....…………………… 
 ....……………………....…………………… 
 ....……………………....…………………… 
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YOUR QUESTIONS ABOUT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 
All questions in this list are related to COPD. You can use the list as an aid for your visits to the general 
practice. If you would like to get an answer to some questions in this list you can tick them. In the practice 
you can hand over this list to the GP, the practice nurse or the receptionist. One of them can answer your 
questions. If you have many questions they may not be answered all together at the same time. For the 
remaining questions you can make a follow-up appointment.  
 
COPD in general 
 What is COPD (chronic bronchitis or lung-
emphysema)? 
 What causes COPD? 
 What exactly happens during an attack of 
shortness of breath? 
 What is hypersensitivity of the airways 
(hyperreactivity)? 
 What is the course of COPD in most people? 
 
Examination 
 What does a lung-function meter (spirometer) 
measure? 
 Why will a trial with corticosteroid tablets be 
performed on me? 
 What other examinations can the GP refer me 
for? 
 
Treatment 
 What can be achieved with the treatment of my 
COPD? 
 How strictly should I follow the treatment 
instructions? 
 When should I contact the GP? 
 Do I have to see the GP for control visits? 
 When will the GP refer me to a chest 
physician? 
 What is a pulmonary rehabilitation 
programme? 
 
There are two ways to treat your chronic bronchitis 
or lung-emphysema which can seperately or 
together lead to a reduction of the complaints: 
treatment without or besides medication and 
treatment with medication 
 
Treatment without or besides medication 
 What is the effect of smoking and passive 
smoking on my COPD? 
 How can I quit smoking? 
 Which measures can I take at work to be less 
troubled by my COPD? 
 How important is physical exercise (sports) for 
my COPD? 
 Why is it important for me to get a flu 
vaccination each year? 
 What can I do about my fear of breathlessness? 
 What can the Dutch Asthma Foundation and the 
patients' association VbbA mean to me?   
 
Treatment with medication 
 How do long-acting bronchodilators work? 
 How do short-acting bronchodilators work? 
 How do anti-inflammatory medicines 
(corticosteroids) that you have to inhale work? 
 How do anti-inflammatory medicines 
(corticosteroids) that you have to swallow work? 
 What is the reason to use acetylcysteine? 
 Why should I take or not take specific 
medication? 
 How often should I take my my medication and 
how much? 
 In what way should I take my medication? 
 What are the side-effects of my medication? 
 What is the advantage of inhaling? 
 What is the right manner to inhale? 
 What can I do if I feel uncomfortable to take 
medication in company? 
 What should I do if my complaints worsen? 
 
Do you have any other questions about COPD that 
are not in the list? Please fill them in below 
 
 …........................................………………… 
 …........................................………………… 
 ….......................................………………… 
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UW VRAGEN OVER CHRONISCHE BRONCHITIS OF LONGEMFYSEEM (COPD) 
In deze lijst staan vragen die allemaal iets te maken hebben met chronische bronchitis of longemfyseem 
(COPD). U kunt de lijst gebruiken als hulpmiddel voor uw bezoeken aan de huisartspraktijk. Als er vragen 
op de lijst staan waar u een antwoord op wilt weten, kunt u deze aankruisen. Geef deze lijst in de 
huisartspraktijk aan de huisarts, assistente of verpleegkundige. Eén van hen kan uw vragen beantwoorden. 
Als u veel vragen heeft, kunnen deze misschien niet allemaal worden beantwoord. Voor vragen die 
overblijven kunt u een vervolgafspraak maken.  
 
COPD in het algemeen 
 Wat is COPD (chronische bronchitis of 
longemfyseem)? 
 Waardoor ontstaat COPD? 
 Wat gebeurt er precies tijdens een aanval van 
kortademigheid? 
 Wat is overgevoeligheid van de luchtwegen 
(hyperreactiviteit)? 
 Hoe verloopt astma bij de meeste mensen? 
 
Onderzoeken 
 Wat meet een longfunctiemeter (spirometer)? 
 Waarom wordt er een proefbehandeling met 
corticosteroïd-tabletten bij mij gedaan? 
 Voor welke andere onderzoeken kan mijn 
huisarts mij doorverwijzen? 
 
Behandeling 
 Wat kan er worden bereikt met de behandeling 
van mijn COPD? 
 Hoe strikt moet ik de 
behandelingsvoorschriften naleven? 
 Wanneer moet ik contact opnemen met de 
huisarts? 
 Moet ik naar de huisarts voor 
controlebezoeken?  
 Wanneer verwijst de huisarts mij door naar een 
longarts? 
 Wat is een longrevalidatieprogramma? 
 
Er zijn twee manieren om uw chronische bronchitis 
of longemfyseem te behandelen, die apart of samen 
kunnen leiden tot vermindering van de klachten: 
behandeling zonder of naast medicijnen en 
behandeling met medicijnen 
 
Behandeling zonder of naast medicijnen 
 Wat is het effect van roken en meeroken op 
mijn COPD? 
 Hoe kan ik stoppen met roken? 
 Welke maatregelen kan ik op mijn werk nemen 
zodat ik minder last heb van mijn COPD? 
 
 Hoe belangrijk is lichaamsbeweging (sport) voor 
mijn COPD? 
 Waarom is het belangrijk dat ik elk jaar een 
griepprik krijg? 
 Wat kan ik doen aan mijn angst voor 
benauwdheid? 
 Wat kunnen het Nederlands Astma Fonds en de 
patiëntenvereniging VbbA voor mij betekenen?   
 
Behandeling met medicijnen 
 Wat doen langwerkende luchtwegverwijders? 
 Wat doen kortwerkende luchtwegverwijders? 
 Wat doen ontstekingsremmers (corticosteroïden) 
die je moet inhaleren? 
 Wat doen ontstekingsremmers (corticosteroïden) 
die je moet inslikken? 
 Waarvoor wordt acetylcysteïne gebruikt? 
 Waarom moet ik bepaalde medicijnen juist wel of 
juist niet innemen? 
 Hoe vaak moet ik mijn medicijnen innemen en 
hoeveel? 
 Op welke manier moet ik mijn medicijnen 
innemen? 
 Wat zijn de bijwerkingen van mijn medicijnen? 
 Wat is het voordeel van inhaleren? 
 Wat is de goede manier van inhaleren? 
 Wat kan ik doen als ik moeite heb met het 
gebruik van medicijnen in gezelschap? 
 Wat moet ik doen als mijn klachten erger 
worden? 
 
 
Heeft u andere vragen over COPD die niet op de 
lijst staan? Vul ze dan hier in. 
 
 …........................................………………… 
 …........................................………………… 
 …........................................………………… 
 
 
